{"af5f9d46fe486de3bea9396706b7b2d51708f94c": [["Abstract 23Asymptomatic transmission of the coronavirus disease 2019 is an important topic.", [["coronavirus disease", "DISEASE", 44, 63], ["coronavirus", "ORGANISM", 44, 55], ["the coronavirus disease", "PROBLEM", 40, 63], ["coronavirus disease", "OBSERVATION", 44, 63]]], ["A recent 24 study in China showed that transmissibility of the asymptomatic cases is comparable to that 25 of symptomatic cases.", [["A recent 24 study", "TEST", 0, 17], ["the asymptomatic cases", "PROBLEM", 59, 81]]], ["To the best of our knowledge, this is the first time the relative transmissibility of 27 asymptomatic COVID-19 cases is quantified.", [["asymptomatic COVID", "TEST", 89, 107]]], ["28 29 Keywords: COVID-19; asymptomatic cases; relative transmissibility 30 31 32 33 Main text 35 Nishiura et al (Nishiura et al, 2020 ) estimated the asymptomatic ratio of COVID-19 was 41.6% 36 (5 out of 12 confirmed cases) among 565 Japanese individuals evacuated from Wuhan, China.", [["COVID", "TEST", 16, 21], ["asymptomatic cases", "PROBLEM", 26, 44], ["relative transmissibility", "TEST", 46, 71], ["Main text", "TEST", 84, 93], ["the asymptomatic ratio", "TEST", 146, 168], ["COVID", "TEST", 172, 177]]], ["37Abstract 23Mao et al (Mao et al, 2020) reported that 2 out of 78 confirmed cases are asymptomatic.", [["asymptomatic", "PROBLEM", 87, 99]]], ["One 38 of the two cases showed RT-PCT positivity 15 th days after first diagnosis.", [["RT-PCT positivity", "TEST", 31, 48]]], ["However, the 41 transmissibility of asymptomatic case is unclear, and the positive RT-PCT results only imply 42 the potential infectivity.", [["asymptomatic case", "PROBLEM", 36, 53], ["infectivity", "OBSERVATION", 126, 137]]], ["It is important to study the pattern of viral shedding and live virus 43 isolation.", [["live virus 43", "ORGANISM", 59, 72], ["viral shedding", "PROBLEM", 40, 54], ["live virus", "TREATMENT", 59, 69], ["viral", "OBSERVATION", 40, 45]]], ["W\u00f6lfel et al studied 9 hospitalized cases and found that live virus was isolated from 44 throat and lung-derived samples between 3 and 8 days after symptom onset (W\u00f6lfel et al, 45 2020) .", [["throat", "ANATOMY", 89, 95], ["lung", "ANATOMY", 100, 104], ["samples", "ANATOMY", 113, 120], ["throat", "ORGANISM_SUBDIVISION", 89, 95], ["lung", "ORGAN", 100, 104], ["live virus", "PROBLEM", 57, 67], ["lung", "ANATOMY", 100, 104]]], ["When the RNA concentration is above 10 6 copies per ml (or equivalent Ct-value lower 46 than 24), but not from stool samples, despite of high virus RNA concentration.", [["stool samples", "ANATOMY", 111, 124], ["stool samples", "ORGANISM_SUBSTANCE", 111, 124], ["the RNA concentration", "TREATMENT", 5, 26], ["Ct-value", "TEST", 70, 78], ["stool samples", "TEST", 111, 124], ["high virus RNA concentration", "TREATMENT", 137, 165]]], ["Above the 47 threshold, high RNA concentration yields high probability of live virus isolation.", [["high RNA concentration", "PROBLEM", 24, 46], ["live virus isolation", "TREATMENT", 74, 94], ["live virus isolation", "OBSERVATION", 74, 94]]], ["This 'dose-48 response' association highlights a patient's RT-PCR level should be higher than a threshold 49 to be effectively infectious.", [["patient", "ORGANISM", 49, 56], ["patient", "SPECIES", 49, 56], ["a patient's RT-PCR level", "TEST", 47, 71], ["infectious", "OBSERVATION", 127, 137]]], ["However, the mean infectious period (\u03b3 \u22121 ) of a symptomatic case may be longer than that of 102 an asymptomatic case hypothetically.", [["a symptomatic case", "PROBLEM", 47, 65], ["mean", "OBSERVATION_MODIFIER", 13, 17], ["infectious", "OBSERVATION_MODIFIER", 18, 28]]], ["Therefore, the combined effects of \u03c1 and \u03b3 \u22121 probably 103 lead to a higher reproduction number in the symptomatic group.", [["\u03c1", "SIMPLE_CHEMICAL", 35, 36], ["\u03b3 \u22121", "GENE_OR_GENE_PRODUCT", 41, 45], ["symptomatic", "OBSERVATION_MODIFIER", 103, 114]]], ["104 105 Additionally, Chen et al (Chen et al, 2020) showed that asymptomatic cases are more likely 106 to produce asymptomatic cases relatively speaking, since the 6 secondary cases from 107 asymptomatic primary cases consist 3 asymptomatic cases (50%).", [["asymptomatic cases", "PROBLEM", 64, 82]]], ["Whereas, 19 out of 126 108 (15%) are asymptomatic from symptomatic primary cases.", [["asymptomatic", "PROBLEM", 37, 49], ["symptomatic primary cases", "PROBLEM", 55, 80]]], ["The odds ratio (OR) is estimated 109 In summary, we conclude that the relatively transmissibility of asymptomatic case could be 127 significantly smaller than that of the symptomatic cases.", [["The odds ratio", "TEST", 0, 14], ["significantly smaller", "OBSERVATION_MODIFIER", 132, 153], ["symptomatic", "OBSERVATION_MODIFIER", 171, 182]]], ["The main contribution of (Chen et al, 128 2020) is that they raise the alarm of the existence of the transmissibility of the asymptomatic 129 cases.", [["main", "OBSERVATION_MODIFIER", 4, 8]]], ["We remark that how efficient of the transmissibility of asymptomatic cases comparing 130 to symptomatic cases warrants more study.", [["asymptomatic cases", "PROBLEM", 56, 74], ["more study", "TEST", 119, 129]]], ["287 288 We also reported the asymptomatic case ratio in Hong Kong over time due to a large number 289 of young imported case.", [["large", "OBSERVATION_MODIFIER", 85, 90]]], ["290 291Abstract 23To the best of our knowledge, this is the first time the relative transmissibility of 292 asymptomatic COVID-19 cases is quantified.", [["COVID", "DISEASE", 121, 126], ["asymptomatic COVID", "TEST", 108, 126]]]], "PMC7498224": [], "4d798796afdaea0ccbad6095f55936d771d172ae": [["IntroductionAround the world, chronic pain is a cause for significant suffering, functional limitation, and poor quality of life 1, 2 .", [["chronic pain", "DISEASE", 30, 42], ["Introduction", "TREATMENT", 0, 12], ["chronic pain", "PROBLEM", 30, 42], ["significant suffering, functional limitation", "PROBLEM", 58, 102], ["chronic", "OBSERVATION_MODIFIER", 30, 37], ["pain", "OBSERVATION", 38, 42]]], ["Recent COVID-19 outbreak led to closing all elective procedures, outpatients' services including chronic pain management services for limiting the spread of virus.", [["chronic pain", "DISEASE", 97, 109], ["Recent COVID", "TEST", 0, 12], ["all elective procedures", "TREATMENT", 40, 63], ["outpatients' services", "TREATMENT", 65, 86], ["chronic pain management services", "TREATMENT", 97, 129], ["the spread of virus", "PROBLEM", 143, 162]]], ["Patients were also requested to strict isolation, stay at home and social distancing.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8]]], ["3 Chronic pain conditions are often associated with impaired quality of life due to significant physical and psychological burden.", [["Chronic pain", "DISEASE", 2, 14], ["impaired quality of life", "DISEASE", 52, 76], ["Chronic pain conditions", "PROBLEM", 2, 25], ["significant physical and psychological burden", "PROBLEM", 84, 129], ["Chronic", "OBSERVATION_MODIFIER", 2, 9], ["pain", "OBSERVATION", 10, 14]]], ["With major psychological impact and isolation imposed by the pandemic may worsen pain, mental health and overall quality of life.", [["pain", "DISEASE", 81, 85], ["isolation", "TREATMENT", 36, 45], ["pain", "PROBLEM", 81, 85]]], ["This may in turn significantly rise the chronic pain and co-morbid conditions.", [["pain", "DISEASE", 48, 52], ["the chronic pain", "PROBLEM", 36, 52], ["co-morbid conditions", "PROBLEM", 57, 77], ["chronic", "OBSERVATION_MODIFIER", 40, 47], ["pain", "OBSERVATION", 48, 52]]], ["4 Previous studies demonstrated that yoga could improve pain measures 5 , and physical function 6 as well as reduce symptoms of anxiety and depression in people with chronic pain 7, 8 .", [["pain", "DISEASE", 56, 60], ["anxiety", "DISEASE", 128, 135], ["depression", "DISEASE", 140, 150], ["chronic pain", "DISEASE", 166, 178], ["people", "ORGANISM", 154, 160], ["people", "SPECIES", 154, 160], ["Previous studies", "TEST", 2, 18], ["pain measures", "TREATMENT", 56, 69], ["symptoms", "PROBLEM", 116, 124], ["anxiety", "PROBLEM", 128, 135], ["depression", "PROBLEM", 140, 150], ["chronic pain", "PROBLEM", 166, 178], ["chronic", "OBSERVATION_MODIFIER", 166, 173], ["pain", "OBSERVATION", 174, 178]]], ["Yoga Therapy is a form of Yoga to treat medical condition.", [["Yoga", "CHEMICAL", 0, 4], ["Therapy", "TREATMENT", 5, 12], ["medical condition", "PROBLEM", 40, 57]]], ["For chronic pain, multidimensional approach of Yoga therapy is used, from the physical, emotional, mental and spiritual to highest self-awareness 9 .", [["chronic pain", "DISEASE", 4, 16], ["chronic pain", "PROBLEM", 4, 16], ["Yoga therapy", "TREATMENT", 47, 59], ["chronic", "OBSERVATION_MODIFIER", 4, 11], ["pain", "OBSERVATION", 12, 16]]], ["It includes all methods of physical postures, breath control, sensory methods, affirmations and visualisations, chants and meditation.", [["breath control", "TREATMENT", 46, 60], ["meditation", "TREATMENT", 123, 133]]], ["In traditions, yoga therapy is primarily a science of self-healing aimed at relieving the disease of body and mind.", [["body", "ANATOMY", 101, 105], ["body", "ORGANISM_SUBDIVISION", 101, 105], ["yoga therapy", "TREATMENT", 15, 27], ["self-healing", "PROBLEM", 54, 66], ["the disease of body", "PROBLEM", 86, 105], ["disease", "OBSERVATION", 90, 97], ["body", "ANATOMY", 101, 105]]], ["Telemedicine have been used to provide support for chronic pain patients during pandemic 12 .", [["chronic pain", "DISEASE", 51, 63], ["patients", "ORGANISM", 64, 72], ["patients", "SPECIES", 64, 72], ["Telemedicine", "TREATMENT", 0, 12], ["chronic pain", "PROBLEM", 51, 63]]], ["Previous studies have found telehealth interventions for chronic pain feasible and possibly effective, including pain management, 13 physical exercise, 14 and psychological interventions.", [["chronic pain", "DISEASE", 57, 69], ["pain", "DISEASE", 113, 117], ["Previous studies", "TEST", 0, 16], ["telehealth interventions", "TREATMENT", 28, 52], ["chronic pain", "PROBLEM", 57, 69], ["pain management", "TREATMENT", 113, 128], ["psychological interventions", "TREATMENT", 159, 186], ["chronic", "OBSERVATION_MODIFIER", 57, 64], ["pain", "OBSERVATION", 65, 69]]], ["15, 16 Tele-yoga intervention has only been used in one study having patients with heart failure and chronic obstructive pulmonary disease, 17 which found intervention acceptable and applicable in other chronically ill patients.IntroductionTo date, there has been no previous study using tele-yoga therapy in chronic pain management.", [["heart", "ANATOMY", 83, 88], ["pulmonary", "ANATOMY", 121, 130], ["heart failure", "DISEASE", 83, 96], ["chronic obstructive pulmonary disease", "DISEASE", 101, 138], ["chronically ill", "DISEASE", 203, 218], ["chronic pain", "DISEASE", 309, 321], ["patients", "ORGANISM", 69, 77], ["heart", "ORGAN", 83, 88], ["pulmonary", "ORGAN", 121, 130], ["patients", "ORGANISM", 219, 227], ["patients", "SPECIES", 69, 77], ["patients", "SPECIES", 219, 227], ["Tele-yoga intervention", "TREATMENT", 7, 29], ["heart failure", "PROBLEM", 83, 96], ["chronic obstructive pulmonary disease", "PROBLEM", 101, 138], ["intervention", "TREATMENT", 155, 167], ["previous study", "TEST", 267, 281], ["tele", "TEST", 288, 292], ["yoga therapy", "TREATMENT", 293, 305], ["chronic pain management", "TREATMENT", 309, 332], ["heart", "ANATOMY", 83, 88], ["failure", "OBSERVATION", 89, 96], ["chronic", "OBSERVATION_MODIFIER", 101, 108], ["obstructive", "OBSERVATION_MODIFIER", 109, 120], ["pulmonary", "ANATOMY", 121, 130], ["disease", "OBSERVATION", 131, 138], ["chronic", "OBSERVATION_MODIFIER", 309, 316]]], ["Therefore, present study was designed to test yoga therapy sessions conveyed through a technical solution remotely on chronic pain patients.MethodsPresent study was a single arm nonrandomized clinical trial to investigate the impact of teleyoga therapy on patients with chronic pain.", [["chronic pain", "DISEASE", 118, 130], ["teleyoga", "CHEMICAL", 236, 244], ["chronic pain", "DISEASE", 270, 282], ["patients", "ORGANISM", 131, 139], ["teleyoga", "SIMPLE_CHEMICAL", 236, 244], ["patients", "ORGANISM", 256, 264], ["patients", "SPECIES", 131, 139], ["patients", "SPECIES", 256, 264], ["present study", "TEST", 11, 24], ["test yoga therapy sessions", "TREATMENT", 41, 67], ["a technical solution", "TREATMENT", 85, 105], ["chronic pain patients", "TREATMENT", 118, 139], ["a single arm nonrandomized clinical trial", "TREATMENT", 165, 206], ["teleyoga therapy", "TREATMENT", 236, 252], ["chronic pain", "PROBLEM", 270, 282], ["chronic", "OBSERVATION_MODIFIER", 270, 277], ["pain", "OBSERVATION", 278, 282]]], ["We specifically examined the efficacy of teleyoga therapy for pain relief, pain related disability, anxiety, and depression.MethodsPatients were recruited from Leicester, UK through flyers, social media, referrals from local surgery and complementary and alternative medicine practitioners.", [["teleyoga", "CHEMICAL", 41, 49], ["pain", "DISEASE", 62, 66], ["pain", "DISEASE", 75, 79], ["disability", "DISEASE", 88, 98], ["anxiety", "DISEASE", 100, 107], ["depression", "DISEASE", 113, 123], ["teleyoga therapy", "TREATMENT", 41, 57], ["pain relief", "PROBLEM", 62, 73], ["pain related disability", "PROBLEM", 75, 98], ["anxiety", "PROBLEM", 100, 107], ["depression", "PROBLEM", 113, 123], ["local surgery", "TREATMENT", 219, 232]]], ["Patients were included in the study if they were: 18 years of age to 60 years, having chronic nonmalignant pain for at least 3 months, having access to internet and video calls.", [["nonmalignant", "ANATOMY", 94, 106], ["nonmalignant pain", "DISEASE", 94, 111], ["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["the study", "TEST", 26, 35], ["chronic nonmalignant pain", "PROBLEM", 86, 111], ["chronic", "OBSERVATION_MODIFIER", 86, 93], ["nonmalignant", "OBSERVATION_MODIFIER", 94, 106], ["pain", "OBSERVATION", 107, 111]]], ["Patients were excluded if pregnant or breast-feeding, not willing to give written consent and patients with severe psychiatric or personality disorder.Study designProspective study with 6-weeks interventions period was conducted by Aarogyam, (UK) in Leicester, UK between April 2020 and June 2020.", [["breast", "ANATOMY", 38, 44], ["psychiatric", "DISEASE", 115, 126], ["personality disorder", "DISEASE", 130, 150], ["Patients", "ORGANISM", 0, 8], ["breast", "ORGANISM_SUBDIVISION", 38, 44], ["patients", "ORGANISM", 94, 102], ["Patients", "SPECIES", 0, 8], ["patients", "SPECIES", 94, 102], ["severe psychiatric or personality disorder", "PROBLEM", 108, 150], ["Study designProspective study", "TEST", 151, 180], ["breast", "ANATOMY", 38, 44]]], ["Convenience sample of chronic pain patients were considered eligible and were enrolled in the study after their written informed consent.", [["chronic pain", "DISEASE", 22, 34], ["patients", "ORGANISM", 35, 43], ["patients", "SPECIES", 35, 43], ["chronic pain", "PROBLEM", 22, 34], ["the study", "TEST", 90, 99], ["chronic", "OBSERVATION_MODIFIER", 22, 29], ["pain", "OBSERVATION", 30, 34]]], ["Patients were allowed to withdraw from the study at any point.Study designWhatsApp and zoom were found commonly used and easy to access by most participants.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["participants", "SPECIES", 144, 156], ["the study", "TEST", 39, 48], ["Study designWhatsApp", "TEST", 62, 82]]], ["Therefore, WhatsApp and Zoom video calls were used according to each participants convenience, starting from completing baseline assessment at first session and then all the participants were booked for twice weekly tele-yoga therapy sessions.Study designAll the patients provided written informed consent; ethics approval was taken from Independent Review Board.", [["patients", "ORGANISM", 263, 271], ["participants", "SPECIES", 69, 81], ["participants", "SPECIES", 174, 186], ["patients", "SPECIES", 263, 271], ["baseline assessment", "TEST", 120, 139], ["yoga therapy sessions", "TREATMENT", 221, 242]]], ["Procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 2008.Intervention:Yoga therapy for individualized based on each participant personal needs and clinical conditions.", [["human", "ORGANISM", 89, 94], ["human", "SPECIES", 89, 94], ["human", "SPECIES", 89, 94], ["Yoga therapy", "TREATMENT", 166, 178]]], ["Sessions were scheduled twice in a week with trained and experienced yoga therapist over the video conference for 45 minutes.Intervention:Each session included set of yoga practices combining yoga loosening exercises (sukshma Vyayama), Postures (Asana), Breathing exercises (Pranayama), Relaxation techniques and chanting (A, U, M sylabal chants) meditation.", [["yoga practices", "TREATMENT", 167, 181], ["yoga loosening exercises", "TREATMENT", 192, 216], ["sukshma Vyayama)", "TREATMENT", 218, 234], ["Postures (Asana)", "TREATMENT", 236, 252], ["Breathing exercises (Pranayama)", "TREATMENT", 254, 285], ["Relaxation techniques", "TREATMENT", 287, 308], ["chanting (A, U, M sylabal chants", "TREATMENT", 313, 345], ["meditation", "TREATMENT", 347, 357]]], ["Each session, participants were given home practice sets to follow every day.Outcome measuresAt baseline and post intervention, patients were given pain and practice diary to log daily practices, time to practice and pain score.", [["pain", "DISEASE", 148, 152], ["pain", "DISEASE", 217, 221], ["patients", "ORGANISM", 128, 136], ["participants", "SPECIES", 14, 26], ["patients", "SPECIES", 128, 136], ["intervention", "TREATMENT", 114, 126], ["pain", "PROBLEM", 148, 152], ["pain score", "PROBLEM", 217, 227]]], ["Specific questionnaires to evaluate intensity of pain, ability to perform normal daily activities, depression and anxiety symptoms were taken before and after 6-week of intervention.Outcome measuresPain intensity: visual-analogic scale (VAS), using pain level from 0 value (no pain) to 10 value (worst imaginable pain) evaluated pain intensity at baseline and end of 6-weeks.Outcome measuresPain Disability Index (PDI): PDI used to measure the disability caused by chronic pain.", [["pain", "DISEASE", 49, 53], ["depression", "DISEASE", 99, 109], ["anxiety", "DISEASE", 114, 121], ["Pain", "DISEASE", 198, 202], ["pain", "DISEASE", 249, 253], ["pain", "DISEASE", 277, 281], ["pain", "DISEASE", 313, 317], ["pain", "DISEASE", 329, 333], ["Pain", "DISEASE", 391, 395], ["disability", "DISEASE", 444, 454], ["chronic pain", "DISEASE", 465, 477], ["PDI", "PROTEIN", 420, 423], ["Specific questionnaires", "TEST", 0, 23], ["pain", "PROBLEM", 49, 53], ["depression", "PROBLEM", 99, 109], ["anxiety symptoms", "PROBLEM", 114, 130], ["intervention", "TREATMENT", 169, 181], ["Pain intensity", "PROBLEM", 198, 212], ["pain level", "TEST", 249, 259], ["pain", "PROBLEM", 277, 281], ["worst imaginable pain", "PROBLEM", 296, 317], ["pain intensity", "PROBLEM", 329, 343], ["Pain", "PROBLEM", 391, 395], ["PDI", "TREATMENT", 420, 423], ["chronic pain", "PROBLEM", 465, 477], ["chronic", "OBSERVATION_MODIFIER", 465, 472], ["pain", "OBSERVATION", 473, 477]]], ["Life activities are listed on each 7 categories and participants need to circle the number on the scale that described the level of disability they experience.Outcome measuresHospital Anxiety and Depression Scale (HADS): The HADS is a self-assessment scale has been used to assess anxiety, depression and emotional distress among patients.", [["disability", "DISEASE", 132, 142], ["anxiety", "DISEASE", 281, 288], ["depression", "DISEASE", 290, 300], ["emotional distress", "DISEASE", 305, 323], ["patients", "ORGANISM", 330, 338], ["participants", "SPECIES", 52, 64], ["patients", "SPECIES", 330, 338], ["Outcome measuresHospital Anxiety", "PROBLEM", 159, 191], ["Depression Scale (HADS)", "PROBLEM", 196, 219], ["anxiety", "PROBLEM", 281, 288], ["depression", "PROBLEM", 290, 300], ["emotional distress", "PROBLEM", 305, 323]]], ["It is composed by fourteen items, seven relating to anxiety and seven to depression.", [["anxiety", "DISEASE", 52, 59], ["depression", "DISEASE", 73, 83], ["anxiety", "PROBLEM", 52, 59], ["depression", "PROBLEM", 73, 83]]], ["Each item scores from 0 to 3 values Between 0-10 scale of program satisfaction, usefulness and technology rating were asked where 0 was worst and 10 was best.Outcome measures.", [["Each item scores", "TEST", 0, 16]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted July 17, 2020. .Statistical methodsMedCalc Statistical Software version 19.3.1 (MedCalc Software Ltd, Ostend, Belgium; https://www.medcalc.org; 2020) was used to conduct statistical analysis.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["Software version", "TEST", 315, 331], ["statistical analysis", "TEST", 430, 450], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["It was the first pilot study, so power analysis was not considered.", [["the first pilot study", "TEST", 7, 28], ["power analysis", "TEST", 33, 47]]], ["All the values are shown in numbers (%) and Mean \u00b1 Standard Deviation.", [["All the values", "TEST", 0, 14], ["numbers", "TEST", 28, 35], ["Mean", "TEST", 44, 48], ["numbers", "OBSERVATION_MODIFIER", 28, 35], ["Standard Deviation", "OBSERVATION", 51, 69]]], ["A preliminary study of distribution with Shapiro-Wilk test showed that scores were normally distributed.", [["A preliminary study", "TEST", 0, 19], ["Shapiro-Wilk test", "TEST", 41, 58], ["distributed", "OBSERVATION_MODIFIER", 92, 103]]], ["So, Paired Students' t test was used for variables.", [["Paired Students' t test", "TEST", 4, 27]]], ["Graphics show mean values because we used parametric tests for the statistical analysis.", [["parametric tests", "TEST", 42, 58], ["the statistical analysis", "TEST", 63, 87]]], ["Confidence interval is at 95%.ResultsTwenty-two participants were recruited in initial contact.", [["participants", "ORGANISM", 48, 60], ["participants", "SPECIES", 48, 60]]], ["Of these, twenty participants met the eligibility criteria.", [["participants", "SPECIES", 17, 29]]], ["One had to discontinue due to death in the family and one of the participants dropped out prior to the study end and was unavailable for post assessment.", [["death", "DISEASE", 30, 35], ["participants", "SPECIES", 65, 77], ["death", "PROBLEM", 30, 35], ["the study", "TEST", 99, 108], ["post assessment", "TEST", 137, 152]]], ["The 18 participants completed at least 10 of the 12 classes offered.ResultsOur sample was composed of 66% women and 34% men with an average age of 47.28 \u00b1 8.51 years old (21-58 years old), affected by non-specific chronic neck pain, back pain and knee pain, fibromyalgia, headache, arthritis characterized by chronic pain (Tab.", [["neck", "ANATOMY", 222, 226], ["back", "ANATOMY", 233, 237], ["knee", "ANATOMY", 247, 251], ["chronic neck pain", "DISEASE", 214, 231], ["back pain", "DISEASE", 233, 242], ["knee pain", "DISEASE", 247, 256], ["fibromyalgia", "DISEASE", 258, 270], ["headache", "DISEASE", 272, 280], ["arthritis", "DISEASE", 282, 291], ["chronic pain", "DISEASE", 309, 321], ["women", "ORGANISM", 106, 111], ["men", "ORGANISM", 120, 123], ["neck", "ORGANISM_SUBDIVISION", 222, 226], ["knee", "ORGANISM_SUBDIVISION", 247, 251], ["participants", "SPECIES", 7, 19], ["women", "SPECIES", 106, 111], ["men", "SPECIES", 120, 123], ["ResultsOur sample", "TEST", 68, 85], ["non-specific chronic neck pain", "PROBLEM", 201, 231], ["back pain", "PROBLEM", 233, 242], ["knee pain", "PROBLEM", 247, 256], ["fibromyalgia", "PROBLEM", 258, 270], ["headache", "PROBLEM", 272, 280], ["arthritis", "PROBLEM", 282, 291], ["chronic pain", "PROBLEM", 309, 321], ["non-specific", "OBSERVATION_MODIFIER", 201, 213], ["chronic", "OBSERVATION_MODIFIER", 214, 221], ["neck", "ANATOMY", 222, 226], ["pain", "OBSERVATION", 227, 231], ["back", "ANATOMY", 233, 237], ["pain", "OBSERVATION", 238, 242], ["knee", "ANATOMY", 247, 251], ["pain", "OBSERVATION", 252, 256], ["fibromyalgia", "OBSERVATION", 258, 270], ["arthritis", "OBSERVATION", 282, 291], ["chronic", "OBSERVATION_MODIFIER", 309, 316], ["pain", "OBSERVATION", 317, 321]]], ["There was no significant difference reported at baseline in pain intensity, disability, anxiety and depression scales among patients with different medical condition.", [["pain", "DISEASE", 60, 64], ["disability", "DISEASE", 76, 86], ["anxiety", "DISEASE", 88, 95], ["depression", "DISEASE", 100, 110], ["patients", "ORGANISM", 124, 132], ["patients", "SPECIES", 124, 132], ["significant difference", "PROBLEM", 13, 35], ["pain intensity", "PROBLEM", 60, 74], ["disability", "PROBLEM", 76, 86], ["anxiety", "PROBLEM", 88, 95], ["depression scales", "PROBLEM", 100, 117], ["different medical condition", "PROBLEM", 138, 165], ["no", "UNCERTAINTY", 10, 12], ["significant", "OBSERVATION_MODIFIER", 13, 24], ["difference", "OBSERVATION", 25, 35]]], ["Most of participants were Asian (77.7%), White (British) (11.1%) and Black (African) (11.2%).", [["participants", "ORGANISM", 8, 20], ["participants", "SPECIES", 8, 20]]], ["Out of Asian, most participants were Indian (61.1 %), Pakistani (11.1%) and Bangladeshi (5.5%).", [["participants", "ORGANISM", 19, 31], ["participants", "SPECIES", 19, 31], ["Bangladeshi", "TEST", 76, 87]]], ["Four participants (22.2%) were self-referred from the social media, 9 (50%) were referred by someone who has used the pain services before and 5 (27.8%) were referred by local health services and practitioners.Results.", [["pain", "DISEASE", 118, 122], ["participants", "SPECIES", 5, 17]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted July 17, 2020.Intervention acceptabilityAll the participants reported positive experience of doing yoga at home in their own convenience.", [["CC", "CHEMICAL", 0, 2], ["participants", "SPECIES", 308, 320], ["ND", "PROBLEM", 9, 11], ["Intervention acceptability", "TREATMENT", 274, 300], ["med", "ANATOMY", 105, 108]]], ["Home practices were given twice daily for 15-20 mins each time.", [["Home practices", "TREATMENT", 0, 14]]], ["All the participants found this helpful to have short time at once (9.6\u00b10.98).Intervention acceptabilityYoga postures were modified as per each participant and their feasibility.", [["participants", "SPECIES", 8, 20], ["Intervention acceptability", "TREATMENT", 78, 104]]], ["Patients satisfaction was reported at the end was very much satisfied (9.2 \u00b1 0.89).Intervention acceptabilityOne participant (5.5%) had difficulty following some of the practices of deep relaxation over the video conference, so video instructions were sent to follow during home practice.Intervention acceptabilityEight participants (44.4%) used zoom for yoga session and 10 participants (55.6%) were comfortable using WhatsApp video chat.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["participant", "SPECIES", 113, 124], ["participants", "SPECIES", 320, 332], ["participants", "SPECIES", 375, 387], ["Intervention acceptability", "TREATMENT", 288, 314], ["yoga session", "TREATMENT", 355, 367]]], ["Zoom was better rated (8.2 \u00b1 0.88) by participants than WhatsApp (7.2 \u00b1 0.78) with interference, connection and visibility issues.", [["participants", "SPECIES", 38, 50], ["Zoom", "TREATMENT", 0, 4]]], ["However, app was decided upon participants choice and convenience.Intervention acceptabilityOutcome measure:Intervention acceptabilitySignificant reduction in anxiety was reported in participants from baseline (11.72 \u00b1 3.54) to post intervention (5.61\u00b1 2.03), along with depression (13.05 \u00b1 3.22 vs 5.38 \u00b1 1.33) (p<0.0001).", [["anxiety", "DISEASE", 159, 166], ["depression", "DISEASE", 271, 281], ["participants", "SPECIES", 30, 42], ["participants", "SPECIES", 183, 195], ["Intervention acceptability", "TREATMENT", 108, 134], ["Significant reduction in anxiety", "PROBLEM", 134, 166], ["intervention", "TEST", 233, 245], ["depression", "PROBLEM", 271, 281], ["vs", "TEST", 296, 298], ["reduction", "OBSERVATION_MODIFIER", 146, 155], ["anxiety", "OBSERVATION", 159, 166]]], ["(Table 2, Figure 1 ) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted July 17, 2020. . https://doi.org/10.1101/2020.07.16.20154229 doi: medRxiv preprint Figure 3 : Change in Pain disability from baseline to post 6-weeks of intervention Paired students' t-test was conducted to assess the differences in means among the VAS baseline (7.48 \u00b1 0.95), VAS post 6-week intervention (3.39 \u00b1 1.42).", [["Pain disability", "DISEASE", 318, 333], ["Change in Pain disability", "PROBLEM", 308, 333], ["intervention", "TREATMENT", 367, 379], ["VAS post 6-week intervention", "TREATMENT", 491, 519], ["med", "ANATOMY", 59, 62]]], ["The test was significant p < .0001.", [["The test", "TEST", 0, 8]]], ["Also, the difference among mean values of pain disability at baseline (52.28 \u00b1 6.14) and 6-weeks post intervention (25.44 \u00b1 6.44) was significant p < .0001.", [["pain", "DISEASE", 42, 46], ["disability", "DISEASE", 47, 57], ["pain disability", "PROBLEM", 42, 57], ["intervention", "TREATMENT", 102, 114]]], ["Table 2 , Graph 2 and 3 shows the change in the Pain Intensity (VAS) and Pain Disability (PDI) at baseline and 6 weeks post yoga therapy respectively.DiscussionChronic pain is complex condition to treat and involves widespread issues in managing especially during pandemic.", [["Pain", "DISEASE", 48, 52], ["Pain", "DISEASE", 73, 77], ["Chronic pain", "DISEASE", 160, 172], ["the Pain Intensity (VAS)", "PROBLEM", 44, 68], ["Pain Disability", "PROBLEM", 73, 88], ["yoga therapy", "TREATMENT", 124, 136], ["Chronic pain", "PROBLEM", 160, 172], ["complex condition", "PROBLEM", 176, 193], ["change", "OBSERVATION_MODIFIER", 34, 40]]], ["Our research demonstrates that tele-yoga therapy may reduces pain, disability and psychological symptoms associate with chronic pain.DiscussionAll eighteen participants completed assessments, adhered to scheduled sessions, and completed home practices assigned.", [["pain", "DISEASE", 61, 65], ["disability", "DISEASE", 67, 77], ["chronic pain", "DISEASE", 120, 132], ["participants", "SPECIES", 156, 168], ["tele", "TEST", 31, 35], ["yoga therapy", "TREATMENT", 36, 48], ["pain", "PROBLEM", 61, 65], ["disability", "PROBLEM", 67, 77], ["psychological symptoms", "PROBLEM", 82, 104], ["chronic pain", "PROBLEM", 120, 132], ["home practices", "TREATMENT", 237, 251], ["chronic", "OBSERVATION_MODIFIER", 120, 127], ["pain", "OBSERVATION", 128, 132]]], ["Average sessions attended with yoga therapist was 11.2 sessions out of 12 over the 6-weeks.", [["yoga therapist", "TREATMENT", 31, 45]]], ["Therapists rated participants as motivated to self-manage pain, showed good understanding of the yoga principles.", [["pain", "DISEASE", 58, 62], ["participants", "SPECIES", 17, 29], ["pain", "PROBLEM", 58, 62]]], ["To our knowledge, this study is the first to deliver a tele-yoga intervention targeting chronic pain condition.DiscussionHome based intervention and the flexibility of time was valued by participants.", [["chronic pain", "DISEASE", 88, 100], ["participants", "SPECIES", 187, 199], ["this study", "TEST", 18, 28], ["a tele-yoga intervention", "TREATMENT", 53, 77], ["chronic pain condition", "PROBLEM", 88, 110], ["Home based intervention", "TREATMENT", 121, 144], ["chronic", "OBSERVATION_MODIFIER", 88, 95]]], ["Change in the pain intensity was observed by 2 nd week (by 4 th session) in most participants (83.3%) and that was the main motivation for continuing their own.", [["pain", "DISEASE", 14, 18], ["participants", "SPECIES", 81, 93], ["Change in the pain intensity", "PROBLEM", 0, 28], ["pain intensity", "OBSERVATION_MODIFIER", 14, 28]]], ["Sixteen participants (88.8%) found selfmanagement feasible and started to make appropriate changes on their own as pain condition changed during the week.", [["pain", "DISEASE", 115, 119], ["participants", "SPECIES", 8, 20], ["pain condition", "PROBLEM", 115, 129]]], ["Overall, technological issues did not affect the intervention and practice sessions.", [["practice sessions", "TREATMENT", 66, 83]]], ["Therapist shared the session outline and video reference to practice at home after each session.DiscussionAlthough our trial was open to chronic pain, most of the participants who enrolled in our study had musculoskeletal pain disorder.", [["chronic pain", "DISEASE", 137, 149], ["musculoskeletal pain disorder", "DISEASE", 206, 235], ["participants", "ORGANISM", 163, 175], ["participants", "SPECIES", 163, 175], ["chronic pain", "PROBLEM", 137, 149], ["our study", "TEST", 192, 201], ["musculoskeletal pain disorder", "PROBLEM", 206, 235], ["chronic", "OBSERVATION_MODIFIER", 137, 144], ["pain", "OBSERVATION", 145, 149], ["musculoskeletal", "ANATOMY", 206, 221], ["pain", "OBSERVATION", 222, 226]]], ["Our findings demonstrate that we were able to recruit, screen, and deliver treatment through telecommunications, including those who had significant impairments in their daily activity participation and psychiatric functioning.DiscussionIn our small sample, we found significant and sustained improvements in primary outcomes of pain intensity and impairment dur to pain.", [["psychiatric", "DISEASE", 203, 214], ["pain", "DISEASE", 329, 333], ["impairment dur", "DISEASE", 348, 362], ["pain", "DISEASE", 366, 370], ["screen", "TEST", 55, 61], ["treatment", "TREATMENT", 75, 84], ["significant impairments", "PROBLEM", 137, 160], ["pain intensity", "PROBLEM", 329, 343], ["impairment dur to pain", "PROBLEM", 348, 370], ["small", "OBSERVATION_MODIFIER", 244, 249], ["significant", "OBSERVATION_MODIFIER", 267, 278], ["sustained", "OBSERVATION_MODIFIER", 283, 292], ["improvements", "OBSERVATION_MODIFIER", 293, 305]]], ["Participants also reported satisfaction with the therapy program.DiscussionTechnology-delivered yoga interventions have previously demonstrated acceptable and appropriate intervention for heart failure and COPD 17 .", [["heart", "ANATOMY", 188, 193], ["heart failure", "DISEASE", 188, 201], ["COPD", "DISEASE", 206, 210], ["heart", "ORGAN", 188, 193], ["Participants", "SPECIES", 0, 12], ["the therapy program", "TREATMENT", 45, 64], ["yoga interventions", "TREATMENT", 96, 114], ["appropriate intervention", "TREATMENT", 159, 183], ["heart failure", "PROBLEM", 188, 201], ["COPD", "PROBLEM", 206, 210], ["heart", "ANATOMY", 188, 193], ["failure", "OBSERVATION", 194, 201], ["COPD", "OBSERVATION", 206, 210]]], ["Technology based primary care management 18 and psychological intervention (CBT) has been found effective for chronic pain 19 , we believe that yoga also had been successfully delivered via technology, and this is an important direction for future research.", [["chronic pain", "DISEASE", 110, 122], ["primary care management", "TREATMENT", 17, 40], ["psychological intervention", "TREATMENT", 48, 74], ["CBT", "TEST", 76, 79], ["chronic pain", "PROBLEM", 110, 122]]], ["Small sample size and no control group are major limitations of the study.", [["Small sample size", "PROBLEM", 0, 17], ["the study", "TEST", 64, 73], ["sample", "OBSERVATION_MODIFIER", 6, 12], ["size", "OBSERVATION_MODIFIER", 13, 17], ["no", "UNCERTAINTY", 22, 24], ["control group", "OBSERVATION_MODIFIER", 25, 38]]], ["Further large clinical trial is needed to confirm the findings.ConclusionsThese preliminary data indicate that tele-yoga therapy was effective with chronic pain and associated disability, anxiety, depression.", [["chronic pain", "DISEASE", 148, 160], ["disability", "DISEASE", 176, 186], ["anxiety", "DISEASE", 188, 195], ["depression", "DISEASE", 197, 207], ["tele", "TEST", 111, 115], ["yoga therapy", "TREATMENT", 116, 128], ["chronic pain", "PROBLEM", 148, 160], ["associated disability", "PROBLEM", 165, 186], ["anxiety", "PROBLEM", 188, 195], ["depression", "PROBLEM", 197, 207], ["large", "OBSERVATION_MODIFIER", 8, 13]]], ["Future randomized controlled trials are needed to test tele-yoga treatment efficacy on chronic pain measure.Acknowledgements:Authors thank all participants who shared their experience in the study.", [["chronic pain", "DISEASE", 87, 99], ["participants", "SPECIES", 143, 155], ["Future randomized controlled trials", "TREATMENT", 0, 35], ["test tele", "TEST", 50, 59], ["yoga treatment", "TREATMENT", 60, 74], ["chronic pain measure", "PROBLEM", 87, 107], ["the study", "TEST", 187, 196]]], ["We also thank community organisation, Hindu Swayamsevak Sangh (UK) and Leicester Ageing Together for their support and participation in executing the study.Acknowledgements:.", [["the study", "TEST", 146, 155]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)Acknowledgements:The copyright holder for this preprint this version posted July 17, 2020. . https://doi.org/10.1101/2020.07.16.20154229 doi: medRxiv preprint", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv", "TREATMENT", 344, 351], ["med", "ANATOMY", 105, 108]]]], "PMC7201197": [["BackgroundOn December 31, 2019 the first case of what is now known as severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2) was reported to the Chinese Center for DiseaseControl and Prevention.", [["SARS-CoV-2", "ORGANISM", 118, 128], ["SARS-CoV-2", "SPECIES", 118, 128], ["severe acute respiratorysyndrome coronavirus", "PROBLEM", 70, 114], ["DiseaseControl and Prevention", "TREATMENT", 169, 198], ["severe", "OBSERVATION_MODIFIER", 70, 76], ["acute", "OBSERVATION_MODIFIER", 77, 82], ["respiratorysyndrome", "OBSERVATION", 83, 102]]], ["In late December 2019, in Wuhan, Hubei Province, China,clusters of patients with pneumonia of unknown cause, linked to a seafood and animalwholesale market there, began to surface.", [["surface", "ANATOMY", 172, 179], ["pneumonia", "DISEASE", 81, 90], ["patients", "ORGANISM", 67, 75], ["surface", "CELLULAR_COMPONENT", 172, 179], ["patients", "SPECIES", 67, 75], ["pneumonia", "PROBLEM", 81, 90], ["pneumonia", "OBSERVATION", 81, 90]]], ["Chinese authorities isolated a novel coronavirus, on January 7, 2020, andshared its genetic sequence on January 12.", [["coronavirus", "DISEASE", 37, 48], ["coronavirus", "ORGANISM", 37, 48], ["a novel coronavirus", "PROBLEM", 29, 48]]], ["Human to human transmission was suggested by January24, and by the 25th it had spread to Australia and France.", [["Human", "ORGANISM", 0, 5], ["human", "ORGANISM", 9, 14], ["Human", "SPECIES", 0, 5], ["human", "SPECIES", 9, 14], ["Human", "SPECIES", 0, 5], ["human", "SPECIES", 9, 14]]], ["On January 30, the World HealthOrganization (WHO) announced that the COVID-19 outbreak was a Public HealthEmergency of International Concern.", [["the COVID", "TEST", 65, 74]]], ["The spread continued, and on March 11 WHOcharacterized COVID-19 as a pandemic, acknowledging the disease\u2019s geographicalspread.", [["the disease\u2019s geographicalspread", "PROBLEM", 93, 125], ["spread", "OBSERVATION_MODIFIER", 4, 10], ["disease", "OBSERVATION", 97, 104]]], ["On March 16, the total number of cases and deaths outside China surpassedthe totals in China.", [["deaths", "DISEASE", 43, 49]]], ["On March 24, 2020, the date of this writing, there are 395,647confirmed cases and 17,240 deaths worldwide (Johns Hopkins University Medicine, 2020).These numbers will certainly be higher at publication.BackgroundThe International Committee on Taxonomy of Viruses (ICTV) announced the name of thisnovel coronavirus as \u201csevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u201don February 11.", [["deaths", "DISEASE", 89, 95], ["coronavirus", "DISEASE", 302, 313], ["acute respiratory syndrome coronavirus", "DISEASE", 325, 363], ["thisnovel coronavirus", "ORGANISM", 292, 313], ["coronavirus", "SPECIES", 302, 313], ["ICTV", "SPECIES", 264, 268], ["thisnovel coronavirus as \u201csevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2", "SPECIES", 292, 377], ["thisnovel coronavirus", "PROBLEM", 292, 313], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 318, 363], ["higher", "OBSERVATION_MODIFIER", 180, 186], ["severe", "OBSERVATION_MODIFIER", 318, 324], ["acute", "OBSERVATION_MODIFIER", 325, 330], ["respiratory syndrome", "OBSERVATION", 331, 351]]], ["This name was chosen because the virus is genetically related, butdifferent, to the coronavirus responsible for the Severe Acute Respiratory Syndrome(SARS) outbreak in 2003 (WorldHealth Organization, 2020b).", [["coronavirus", "DISEASE", 84, 95], ["Acute Respiratory Syndrome", "DISEASE", 123, 149], ["SARS", "DISEASE", 150, 154], ["coronavirus", "ORGANISM", 84, 95], ["Severe Acute Respiratory Syndrome(SARS)", "SPECIES", 116, 155], ["the virus", "PROBLEM", 29, 38], ["the coronavirus", "PROBLEM", 80, 95], ["the Severe Acute Respiratory Syndrome", "PROBLEM", 112, 149], ["virus", "OBSERVATION", 33, 38], ["Severe", "OBSERVATION_MODIFIER", 116, 122], ["Acute", "OBSERVATION_MODIFIER", 123, 128], ["Respiratory Syndrome", "OBSERVATION", 129, 149]]], ["WHO shortened the name coronavirus disease2019 to \u201cCOVID-19.\u201dBackgroundIn addition to the concerns for the general public, there are heightened concerns forthe more at risk populations: the elderly, those with comorbidities, and theimmunosuppressed.", [["coronavirus disease2019", "DISEASE", 23, 46], ["coronavirus", "ORGANISM", 23, 34], ["coronavirus", "SPECIES", 23, 34], ["COVID", "TEST", 51, 56], ["heightened concerns", "PROBLEM", 133, 152], ["comorbidities", "PROBLEM", 210, 223]]], ["Another population of concern is pregnant women.", [["women", "ORGANISM", 42, 47], ["women", "SPECIES", 42, 47]]], ["The other twowell-known coronaviruses, severe acute respiratory syndrome (SARS-CoV) and MiddleEast respiratory syndrome (MERS-CoV) have both been documented as causing severematernal and perinatal complications during pregnancy (Alfaraj et al., 2019; Wong et al., 2004).", [["acute respiratory syndrome (SARS-CoV)", "DISEASE", 46, 83], ["MiddleEast respiratory syndrome", "DISEASE", 88, 119], ["coronaviruses", "ORGANISM", 24, 37], ["SARS-CoV", "ORGANISM", 74, 82], ["MiddleEast respiratory", "ORGANISM", 88, 110], ["MERS-CoV", "ORGANISM", 121, 129], ["SARS-CoV", "SPECIES", 74, 82], ["MiddleEast respiratory syndrome (MERS-CoV", "SPECIES", 88, 129], ["known coronaviruses", "PROBLEM", 18, 37], ["severe acute respiratory syndrome", "PROBLEM", 39, 72], ["SARS-CoV)", "PROBLEM", 74, 83], ["MiddleEast respiratory syndrome", "PROBLEM", 88, 119], ["severematernal and perinatal complications during pregnancy", "PROBLEM", 168, 227], ["coronaviruses", "OBSERVATION", 24, 37], ["severe", "OBSERVATION_MODIFIER", 39, 45], ["acute", "OBSERVATION_MODIFIER", 46, 51], ["respiratory syndrome", "OBSERVATION", 52, 72], ["respiratory syndrome", "OBSERVATION", 99, 119], ["complications", "OBSERVATION", 197, 210]]], ["At this point there aresparse reports of COVID-19 in pregnant women.", [["women", "ORGANISM", 62, 67], ["women", "SPECIES", 62, 67], ["COVID", "TEST", 41, 46]]], ["All nine women deliveredliveborn healthy infants via cesarean deliveries, with no significant complications.Amniotic fluid, cord blood, neonatal throat swabs, and milk samples from six of themothers were tested for SARS-CoV-2, and all samples tested negative for the virus.We will come back to this finding.COVID-19 and Human Milk", [["Amniotic fluid", "ANATOMY", 108, 122], ["cord blood", "ANATOMY", 124, 134], ["throat swabs", "ANATOMY", 145, 157], ["milk samples", "ANATOMY", 163, 175], ["samples", "ANATOMY", 235, 242], ["women", "ORGANISM", 9, 14], ["infants", "ORGANISM", 41, 48], ["Amniotic fluid", "ORGANISM_SUBSTANCE", 108, 122], ["cord blood", "ORGANISM_SUBSTANCE", 124, 134], ["throat swabs", "ORGANISM_SUBSTANCE", 145, 157], ["milk samples", "ORGANISM_SUBSTANCE", 163, 175], ["SARS-CoV-2", "ORGANISM", 215, 225], ["Human", "ORGANISM", 320, 325], ["women", "SPECIES", 9, 14], ["infants", "SPECIES", 41, 48], ["Human", "SPECIES", 320, 325], ["SARS-CoV", "SPECIES", 215, 223], ["Human Milk", "SPECIES", 320, 330], ["cesarean deliveries", "TREATMENT", 53, 72], ["significant complications", "PROBLEM", 82, 107], ["Amniotic fluid", "TEST", 108, 122], ["cord blood", "TEST", 124, 134], ["neonatal throat swabs", "TEST", 136, 157], ["milk samples", "TEST", 163, 175], ["themothers", "TEST", 188, 198], ["SARS", "PROBLEM", 215, 219], ["CoV", "TEST", 220, 223], ["all samples", "TEST", 231, 242], ["the virus", "PROBLEM", 263, 272], ["COVID", "TEST", 307, 312], ["no", "UNCERTAINTY", 79, 81], ["significant", "OBSERVATION_MODIFIER", 82, 93], ["complications", "OBSERVATION", 94, 107], ["fluid", "OBSERVATION", 117, 122], ["cord", "ANATOMY", 124, 128]]]], "PMC7461170": [["This is my second essay focused on the COVID\u201019 pandemic.", [["pandemic", "PROBLEM", 48, 56]]], ["Unlike the first one (Lebow, 2020a), which appeared in our June issue, this one serves as an introduction to an extraordinary special section focused on families, couple and family therapy, and the pandemic.", [["family therapy", "TREATMENT", 174, 188]]], ["I am writing in mid\u2010July 2020 during the remarkable time of COVID\u201019, a time in which there is a pandemic with no vaccine or cure.", [["vaccine", "TREATMENT", 114, 121]]], ["Here, somehow, not wearing a mask to mitigate the spread of COVID\u201019, a widely accepted public health practice, has become a symbol of rebelling against progressive government authority while expressing loyalty to a political leader.", [["COVID", "DISEASE", 60, 65], ["a mask", "TREATMENT", 27, 33]]], ["It also is a time in which profound racial inequality has been brought into societal focus by the murders of several African American young people by police (Anderson, McKenny, & Stevenson, 2019; McDowell, Knudson\u2010Martin, & Bermudez, 2019; Watson, 2019; Watson, Bacigalupe, Daneshpour, Han, & Parra\u2010Cardona, 2020).", [["people", "ORGANISM", 140, 146], ["people", "SPECIES", 140, 146], ["profound", "OBSERVATION_MODIFIER", 27, 35], ["racial", "OBSERVATION_MODIFIER", 36, 42], ["inequality", "OBSERVATION", 43, 53]]], ["And, probably not entirely a coincidence, it is a time marked by the United States\u2019 strongest flirtation with xenophobia and intolerance in memory in the form of the tragicomic but also frightening government of Donald Trump.", [["xenophobia", "DISEASE", 110, 120], ["xenophobia", "PROBLEM", 110, 120], ["intolerance in memory", "PROBLEM", 125, 146], ["probably not entirely", "UNCERTAINTY", 5, 26], ["coincidence", "OBSERVATION", 29, 40]]]], "PMC3927596": [["IntroductionThe recent dread of radioactive leaks near nuclear plants reminds us vividly of the vulnerability of life.", [["radioactive leaks", "PROBLEM", 32, 49], ["radioactive leaks", "OBSERVATION", 32, 49], ["nuclear plants", "OBSERVATION", 55, 69]]], ["\u201cFragile\u201d is an epithet often associated with living organisms, perceived as delicate and easily damaged.", [["Fragile\u201d", "DISEASE", 1, 9], ["living organisms", "PROBLEM", 46, 62], ["Fragile", "OBSERVATION", 1, 8]]], ["What would be the opposite of fragile?", [["fragile", "OBSERVATION", 30, 37]]], ["This property enables finding unexpected solutions, especially when challenged by \u201cnormal accidents\u201d [2], rare deleterious events (in terms of individual probability of occurrence) for which he himself coined the phrase \u201cBlack Swan\u201d events [3].IntroductionA wealth of studies compared economics and biology [4-6].", [["rare deleterious events", "PROBLEM", 106, 129], ["studies", "TEST", 268, 275]]], ["For the lay observer of economics, a point shared by both disciplines is the pervasive presence of tinkering.", [["tinkering", "PROBLEM", 99, 108], ["tinkering", "OBSERVATION", 99, 108]]], ["The biological evolution of unusual structures and processes in response to extreme environments or other types of challenges is ubiquitous.", [["unusual structures", "PROBLEM", 28, 46]]], ["We explore various facets of this notion and see whether it might help us better understand the behavior and evolution of living organisms.", [["living organisms", "PROBLEM", 122, 138]]], ["In this context, tinkering derives from unexpected (undesigned) properties that are put in action under stressful or difficult circumstances.IntroductionOpposing fragility, properties such as \u201crobustness\u201d or \u201cresilience\u201d help make a possibly dynamic entity hard to inactivate or destroy.", [["IntroductionOpposing fragility", "PROBLEM", 141, 171], ["fragility", "OBSERVATION", 162, 171]]], ["The expected fate of the entity is sealed: either it hardens for some time, stays the same or it breaks down.", [["entity", "OBSERVATION", 25, 31], ["sealed", "OBSERVATION_MODIFIER", 35, 41]]], ["More generally, can we identify processes that make an entity stronger (sturdier) through the effect of ageing, shock or stress?IntroductionIn many of its features, life indeed appears to share this property with the Hydra: challenged, it responds by creating new forms of life.", [["shock", "DISEASE", 112, 117], ["shock", "PROBLEM", 112, 117], ["stress", "PROBLEM", 121, 127]]], ["This property is at the root of our models of evolution.", [["root", "OBSERVATION_MODIFIER", 24, 28]]], ["We use dichotomies to construct the Tree of Life.", [["dichotomies", "TREATMENT", 7, 18]]], ["Of course, many (most) branches are cut off forever\u2014and the Greek Hydra is not an immortal animal\u2014but in the succession of generations, antifragile life tends to expand its exploration of the world by generating a systematic creation of novelty.", [["course", "OBSERVATION_MODIFIER", 3, 9], ["branches", "ANATOMY_MODIFIER", 23, 31], ["Greek Hydra", "OBSERVATION", 60, 71]]], ["This is illustrated by the huge number of new life forms that flourish following mass extinctions.", [["mass extinctions", "PROBLEM", 81, 97], ["huge", "OBSERVATION_MODIFIER", 27, 31], ["new", "OBSERVATION_MODIFIER", 42, 45], ["mass", "OBSERVATION", 81, 85]]], ["On shorter time scales, we know well that it takes only a few months before anticancer drugs are defeated by cells trying to become immortal.", [["anticancer", "ANATOMY", 76, 86], ["cells", "ANATOMY", 109, 114], ["anticancer", "CANCER", 76, 86], ["cells", "CELL", 109, 114], ["anticancer drugs", "TREATMENT", 76, 92]]], ["In the same way, resistance to an antibiotic follows shortly after its introduction.", [["an antibiotic", "TREATMENT", 31, 44], ["resistance", "OBSERVATION", 17, 27]]], ["Moreover, resistance does not simply result from horizontal gene transfers, using some hidden form of pre-existing resistance, but, quite often, from the emergence of a completely novel activity.", [["resistance", "OBSERVATION", 115, 125]]], ["For example, while the precursor of Nylon\u00ae never existed before the creation of this man-made polymer, it did not take long to find bacteria that used it as a nitrogen and carbon source [9].", [["Nylon\u00ae", "CHEMICAL", 36, 42], ["nitrogen", "CHEMICAL", 159, 167], ["nitrogen", "CHEMICAL", 159, 167], ["carbon", "CHEMICAL", 172, 178], ["Nylon\u00ae", "SIMPLE_CHEMICAL", 36, 42], ["man", "ORGANISM", 85, 88], ["nitrogen", "SIMPLE_CHEMICAL", 159, 167], ["carbon", "SIMPLE_CHEMICAL", 172, 178], ["man", "SPECIES", 85, 88], ["this man-made polymer", "TREATMENT", 80, 101], ["bacteria", "PROBLEM", 132, 140], ["a nitrogen and carbon source", "TREATMENT", 157, 185]]], ["The enzymes involved have been created de novo from apparently random pieces of DNA [10].", [["DNA", "CELLULAR_COMPONENT", 80, 83], ["enzymes", "PROTEIN", 4, 11], ["The enzymes", "TEST", 0, 11]]], ["In the same way, emerging diseases are often the progeny of pre-existing diseases.", [["emerging diseases", "PROBLEM", 17, 34], ["pre-existing diseases", "PROBLEM", 60, 81], ["diseases", "OBSERVATION", 26, 34], ["diseases", "OBSERVATION", 73, 81]]], ["The SARS coronavirus evolved a novel surface antigen [11], and the Escherichia coli O104:H4 strain assembled traits that were distributed in the environment with a completely different pattern [12].", [["surface", "ANATOMY", 37, 44], ["SARS coronavirus", "DISEASE", 4, 20], ["SARS coronavirus", "ORGANISM", 4, 20], ["Escherichia coli", "ORGANISM", 67, 83], ["O104:H4", "ORGANISM", 84, 91], ["coronavirus", "SPECIES", 9, 20], ["Escherichia coli", "SPECIES", 67, 83], ["SARS coronavirus", "SPECIES", 4, 20], ["Escherichia coli", "SPECIES", 67, 83], ["The SARS coronavirus", "PROBLEM", 0, 20], ["a novel surface antigen", "TEST", 29, 52], ["the Escherichia coli O104", "PROBLEM", 63, 88], ["H4 strain assembled traits", "PROBLEM", 89, 115], ["Escherichia coli", "OBSERVATION", 67, 83]]], ["Antifragility is one such property.", [["Antifragility", "DISEASE", 0, 13], ["one such property", "OBSERVATION_MODIFIER", 17, 34]]], ["It unfolds not only in individual organisms, which age much slower than what could be expected from a fragile entity, but also in the way they generate a progeny.", [["a fragile entity", "PROBLEM", 100, 116], ["not only", "UNCERTAINTY", 11, 19], ["fragile", "OBSERVATION_MODIFIER", 102, 109], ["entity", "OBSERVATION", 110, 116]]], ["Rather than study multicellular organisms, where a variety of cells with complicated hierarchies display the functions of life, possibly hiding important underlying principles, we restrict our views to unicellular organisms, bacteria.", [["cells", "ANATOMY", 62, 67], ["cells", "CELL", 62, 67], ["study multicellular organisms", "TEST", 12, 41], ["a variety of cells", "PROBLEM", 49, 67], ["unicellular organisms", "PROBLEM", 202, 223], ["bacteria", "PROBLEM", 225, 233]]], ["We focus on \u201csteady state\u201d or \u201cstationary\u201d life, which we see as differing from senescence, the continuous degradation of the cell's components as time elapses (in human beings the analogous ageing-before-senescence stage would be roughly between ages 25 and 50).", [["cell", "ANATOMY", 126, 130], ["cell", "CELL", 126, 130], ["human", "ORGANISM", 164, 169], ["human", "SPECIES", 164, 169], ["human", "SPECIES", 164, 169], ["the cell's components", "TREATMENT", 122, 143], ["senescence stage", "PROBLEM", 205, 221]]], ["Choosing among a variety of antifragile processes, we discuss the existence of (literally) flexible proteins and the processes in which they participate.", [["flexible proteins", "PROTEIN", 91, 108]]], ["The final discussion recapitulates the possible roles of these processes in biology at the cellular level, focusing on the stationary regime.The Cell Senses Its Physical State and Exchanges Atoms and Molecules ::: Functions Required to Sustain LifeThe cell's chassis combines management of compartmentalisation (the cell's envelope, appendages, but also its nanomachines such as the ribosome, ATP synthase, the degradosome and many others [19]) and metabolism (flux of interconversion of molecules for the building up, storage, salvage of the cell's building blocks, catalytic centers and energy management).", [["cellular", "ANATOMY", 91, 99], ["Cell", "ANATOMY", 145, 149], ["cell", "ANATOMY", 252, 256], ["cell", "ANATOMY", 316, 320], ["appendages", "ANATOMY", 333, 343], ["cell", "ANATOMY", 543, 547], ["ATP", "CHEMICAL", 393, 396], ["ATP", "CHEMICAL", 393, 396], ["cellular", "CELL", 91, 99], ["Cell", "CELL", 145, 149], ["cell", "CELL", 252, 256], ["cell", "CELL", 316, 320], ["ribosome", "CELLULAR_COMPONENT", 383, 391], ["ATP synthase", "GENE_OR_GENE_PRODUCT", 393, 405], ["cell", "CELL", 543, 547], ["ribosome", "PROTEIN", 383, 391], ["ATP synthase", "PROTEIN", 393, 405], ["the stationary regime", "TREATMENT", 119, 140], ["The cell's chassis", "TREATMENT", 248, 266], ["compartmentalisation", "PROBLEM", 290, 310], ["ATP synthase", "TREATMENT", 393, 405], ["metabolism (flux of interconversion of molecules", "TREATMENT", 449, 497], ["salvage", "TREATMENT", 528, 535], ["the cell's building blocks", "TREATMENT", 539, 565], ["catalytic centers", "TREATMENT", 567, 584], ["energy management", "TREATMENT", 589, 606]]], ["Nutrients are imported and waste products are exported.", [["Nutrients", "TREATMENT", 0, 9]]], ["In parallel, the cell monitors its sensors.", [["cell", "ANATOMY", 17, 21], ["cell", "CELL", 17, 21], ["the cell monitors", "TEST", 13, 30], ["parallel", "OBSERVATION_MODIFIER", 3, 11]]], ["Except in homeothermic organisms, changes of environmental temperature are immediately passed on to the organism.", [["homeothermic organisms", "PROBLEM", 10, 32], ["environmental temperature", "PROBLEM", 45, 70], ["environmental temperature", "OBSERVATION", 45, 70]]], ["Because the effects of temperature on macromolecules are often similar to those of ageing (misfolding is the consequence of both changes), there may be considerable overlap between sensing ageing and sensing temperature variations.", [["temperature on macromolecules", "PROBLEM", 23, 52], ["sensing temperature variations", "PROBLEM", 200, 230], ["may be", "UNCERTAINTY", 145, 151]]], ["Indeed, molecular chaperones have both the role of sensors and of maintenance systems and they belong to the heat shock response [20].", [["shock", "DISEASE", 114, 119], ["molecular chaperones", "PROTEIN", 8, 28]]], ["Hence, because these molecules must act on a large number of substrates, we may assume that functions fulfilled by molecular chaperones are to be executed in priority in stationary life.The Cell Senses Its Physical State and Exchanges Atoms and Molecules ::: Functions Required to Sustain LifeAt the same time, the cell must get a large variety of chemicals from the environment.", [["Cell", "ANATOMY", 190, 194], ["cell", "ANATOMY", 315, 319], ["Cell", "CELL", 190, 194], ["cell", "CELL", 315, 319], ["molecular chaperones", "PROTEIN", 115, 135]]], ["Fortunately, turnover of metabolites and salvage processes minimize the need to resort to the environment for their supply.", [["salvage processes", "TREATMENT", 41, 58]]], ["Salvage is not a heavy-duty process.", [["Salvage", "TREATMENT", 0, 7]]], ["Although necessary, it should not belong to the first-line protection because few functional molecules of the corresponding enzymes are needed in the salvage process (this is akin to the marginal cost of a process in the financial world).", [["enzymes", "PROTEIN", 124, 131], ["the first-line protection", "TREATMENT", 44, 69], ["the corresponding enzymes", "TEST", 106, 131], ["the salvage process", "TREATMENT", 146, 165]]], ["Similarly, the time-dependent decay of most functions involved in transport of chemicals into the cell can be compensated for through considerable redundancy.", [["cell", "ANATOMY", 98, 102], ["cell", "CELL", 98, 102], ["most functions", "OBSERVATION_MODIFIER", 39, 53], ["considerable", "OBSERVATION_MODIFIER", 134, 146], ["redundancy", "OBSERVATION", 147, 157]]], ["The cell only needs to transport a few categories of products: amino acids, simple carbohydrates or dicarboxylates, polyamines, vitamins and ions.", [["cell", "ANATOMY", 4, 8], ["amino acids", "CHEMICAL", 63, 74], ["polyamines", "CHEMICAL", 116, 126], ["amino acids", "CHEMICAL", 63, 74], ["carbohydrates", "CHEMICAL", 83, 96], ["dicarboxylates", "CHEMICAL", 100, 114], ["polyamines", "CHEMICAL", 116, 126], ["vitamins", "CHEMICAL", 128, 136], ["cell", "CELL", 4, 8], ["amino acids", "AMINO_ACID", 63, 74], ["carbohydrates", "SIMPLE_CHEMICAL", 83, 96], ["dicarboxylates", "SIMPLE_CHEMICAL", 100, 114], ["polyamines", "SIMPLE_CHEMICAL", 116, 126], ["vitamins", "SIMPLE_CHEMICAL", 128, 136], ["ions", "SIMPLE_CHEMICAL", 141, 145], ["amino acids", "TREATMENT", 63, 74], ["simple carbohydrates", "TREATMENT", 76, 96], ["dicarboxylates", "TREATMENT", 100, 114], ["polyamines", "TREATMENT", 116, 126], ["vitamins", "TREATMENT", 128, 136], ["ions", "TREATMENT", 141, 145]]], ["This is readily observed in the organisms that can live with a very low number of genes such as Mycoplasma genitalium [21].", [["Mycoplasma genitalium", "ORGANISM", 96, 117], ["Mycoplasma genitalium", "SPECIES", 96, 117], ["Mycoplasma genitalium", "SPECIES", 96, 117], ["Mycoplasma genitalium", "PROBLEM", 96, 117]]], ["Overall, in contrast with the front-line requirement for molecular chaperones, there is no heavy-duty requirement for these functions that may slowly deteriorate over time without dramatic consequences.RNA is Degraded and Re-Synthesized ::: Functions Required to Sustain LifeIn contrast with the situation just described, many components have to be continuously replaced, possibly with a low turnover.", [["molecular chaperones", "PROTEIN", 57, 77], ["RNA", "RNA", 202, 205], ["heavy-duty requirement", "PROBLEM", 91, 113], ["dramatic consequences", "PROBLEM", 180, 201], ["a low turnover", "PROBLEM", 386, 400], ["no", "UNCERTAINTY", 88, 90], ["heavy", "OBSERVATION_MODIFIER", 91, 96]]], ["This requires the continued use of the global biosynthetic capacity of the cell.", [["cell", "ANATOMY", 75, 79], ["cell", "CELL", 75, 79], ["biosynthetic capacity", "OBSERVATION", 46, 67], ["cell", "ANATOMY", 75, 79]]], ["While functions may be ubiquitous, enzyme structures are not [22].", [["enzyme structures", "TEST", 35, 52]]], ["Consider a bacterium after it has entered stationary phase.", [["a bacterium", "PROBLEM", 9, 20]]], ["RNAs are expected to turn over first, as they are seldom repaired (see however [24]).", [["RNAs", "RNA", 0, 4]]], ["The degradosome structure (exosome in Archaea and Eukarya) is highly diverse, being different in gamma-Proteobacteria, alpha-Proteobacteria and Firmicutes, for example [26].", [["exosome", "CELLULAR_COMPONENT", 27, 34], ["gamma-Proteobacteria", "GENE_OR_GENE_PRODUCT", 97, 117], ["alpha-Proteobacteria", "GENE_OR_GENE_PRODUCT", 119, 139], ["Firmicutes", "SIMPLE_CHEMICAL", 144, 154], ["degradosome structure", "PROTEIN", 4, 25], ["exosome", "PROTEIN", 27, 34], ["gamma", "PROTEIN", 97, 102], ["The degradosome structure", "PROBLEM", 0, 25], ["Proteobacteria", "PROBLEM", 125, 139], ["Firmicutes", "TEST", 144, 154], ["diverse", "OBSERVATION_MODIFIER", 69, 76]]], ["It always contains polynucleotide phosphorylase (PNPase) at its core: This enzyme uses phosphorolysis rather than hydrolysis, generating nucleoside diphosphates instead of nucleoside monophosphates as basic building blocks for nucleic acids, followed by the recovery of one quantum of energy [27].", [["nucleoside diphosphates", "CHEMICAL", 137, 160], ["nucleoside monophosphates", "CHEMICAL", 172, 197], ["nucleic acids", "CHEMICAL", 227, 240], ["nucleoside diphosphates", "CHEMICAL", 137, 160], ["nucleoside monophosphates", "CHEMICAL", 172, 197], ["polynucleotide phosphorylase", "GENE_OR_GENE_PRODUCT", 19, 47], ["PNPase", "GENE_OR_GENE_PRODUCT", 49, 55], ["nucleoside diphosphates", "SIMPLE_CHEMICAL", 137, 160], ["nucleoside monophosphates", "SIMPLE_CHEMICAL", 172, 197], ["nucleic acids", "SIMPLE_CHEMICAL", 227, 240], ["polynucleotide phosphorylase", "PROTEIN", 19, 47], ["PNPase", "PROTEIN", 49, 55], ["polynucleotide phosphorylase (PNPase)", "PROBLEM", 19, 56], ["This enzyme", "TEST", 70, 81], ["phosphorolysis", "TREATMENT", 87, 101], ["hydrolysis", "TREATMENT", 114, 124], ["nucleoside diphosphates", "TREATMENT", 137, 160], ["nucleoside monophosphates", "TREATMENT", 172, 197], ["basic building blocks", "TREATMENT", 201, 222], ["nucleic acids", "TREATMENT", 227, 240], ["polynucleotide phosphorylase", "OBSERVATION", 19, 47]]], ["Associated to PNPase we find a variety of ribonucleases of different descent, such as RNase E in gamma-Proteobacteria or RNase J and RNase Y in Firmicutes [28], energy-dependent helicases, as well as core enzymes of the glycolysis/gluconeogenesis pathway [25].", [["PNPase", "GENE_OR_GENE_PRODUCT", 14, 20], ["ribonucleases", "GENE_OR_GENE_PRODUCT", 42, 55], ["RNase E", "GENE_OR_GENE_PRODUCT", 86, 93], ["gamma-Proteobacteria", "GENE_OR_GENE_PRODUCT", 97, 117], ["RNase J", "GENE_OR_GENE_PRODUCT", 121, 128], ["RNase Y", "GENE_OR_GENE_PRODUCT", 133, 140], ["PNPase", "PROTEIN", 14, 20], ["ribonucleases", "PROTEIN", 42, 55], ["RNase E", "PROTEIN", 86, 93], ["gamma-Proteobacteria", "PROTEIN", 97, 117], ["RNase J", "PROTEIN", 121, 128], ["RNase Y", "PROTEIN", 133, 140], ["energy-dependent helicases", "PROTEIN", 161, 187], ["core enzymes", "PROTEIN", 200, 212], ["different descent", "PROBLEM", 59, 76], ["Proteobacteria", "PROBLEM", 103, 117], ["RNase J", "TREATMENT", 121, 128], ["energy-dependent helicases", "PROBLEM", 161, 187], ["core enzymes", "TEST", 200, 212], ["the glycolysis/gluconeogenesis pathway", "TEST", 216, 254]]], ["We also find co-evolving proteins meant to degrade leftovers, such as nanoRNases of various families, depending on the phylogenetic clade [29].RNA is Degraded and Re-Synthesized ::: Functions Required to Sustain LifeA puzzling observation stems out from the composition of the degradosome: Many of its functions are carried out by proteins that are significantly longer than average bacterial proteins (300 residues).", [["nanoRNases", "GENE_OR_GENE_PRODUCT", 70, 80], ["co-evolving proteins", "PROTEIN", 13, 33], ["leftovers", "PROTEIN", 51, 60], ["nanoRNases", "PROTEIN", 70, 80], ["RNA", "RNA", 143, 146], ["bacterial proteins", "PROTEIN", 383, 401], ["co-evolving proteins", "PROBLEM", 13, 33], ["average bacterial proteins", "PROBLEM", 375, 401]]], ["This is counter-intuitive because the synthesis of long proteins is expected to be fragile.", [["long proteins", "PROTEIN", 51, 64], ["the synthesis of long proteins", "PROBLEM", 34, 64], ["fragile", "PROBLEM", 83, 90], ["fragile", "OBSERVATION", 83, 90]]], ["The probability of transcription/translation errors, especially the premature termination of translation, is proportional to the length of the messenger RNA.", [["messenger RNA", "RNA", 143, 156], ["translation errors", "PROBLEM", 33, 51], ["messenger RNA", "OBSERVATION", 143, 156]]], ["Moreover, it is well known that truncated proteins in complexes display a negative-dominant phenotype [30].", [["truncated proteins", "PROTEIN", 32, 50]]], ["RNA turnover implies that the first anabolic function that must be preserved is transcription, because any requirement for re-synthesized macromolecules will first go through this step.", [["RNA turnover", "PROBLEM", 0, 12], ["re-synthesized macromolecules", "TREATMENT", 123, 152]]], ["RNA polymerase is its core component.", [["RNA polymerase", "PROTEIN", 0, 14], ["RNA polymerase", "TEST", 0, 14], ["core", "OBSERVATION_MODIFIER", 22, 26], ["component", "OBSERVATION_MODIFIER", 27, 36]]], ["Surprisingly, it involves two very large subunits (more than 1,300 residues), RpoB and RpoC.", [["RpoB", "GENE_OR_GENE_PRODUCT", 78, 82], ["RpoC", "GENE_OR_GENE_PRODUCT", 87, 91], ["RpoB", "PROTEIN", 78, 82], ["RpoC", "PROTEIN", 87, 91], ["RpoB", "TEST", 78, 82], ["RpoC", "TEST", 87, 91], ["two", "OBSERVATION_MODIFIER", 26, 29], ["very", "OBSERVATION_MODIFIER", 30, 34], ["large", "OBSERVATION_MODIFIER", 35, 40], ["subunits", "OBSERVATION_MODIFIER", 41, 49]]], ["This might have just been a statistical coincidence, but an experiment shows that length is significant.", [["length", "OBSERVATION_MODIFIER", 82, 88], ["significant", "OBSERVATION_MODIFIER", 92, 103]]], ["Bacteria such as Helicobacter pylori, which thrive in difficult environments, fuse RpoB and RpoC into a single gigantic protein.", [["Helicobacter pylori", "ORGANISM", 17, 36], ["RpoB", "GENE_OR_GENE_PRODUCT", 83, 87], ["RpoC", "GENE_OR_GENE_PRODUCT", 92, 96], ["RpoB", "PROTEIN", 83, 87], ["RpoC", "PROTEIN", 92, 96], ["gigantic protein", "PROTEIN", 111, 127], ["Helicobacter pylori", "SPECIES", 17, 36], ["Helicobacter pylori", "SPECIES", 17, 36], ["Bacteria", "PROBLEM", 0, 8], ["Helicobacter pylori", "PROBLEM", 17, 36], ["fuse RpoB", "PROBLEM", 78, 87], ["RpoC", "TREATMENT", 92, 96], ["a single gigantic protein", "PROBLEM", 102, 127], ["Helicobacter pylori", "OBSERVATION", 17, 36]]], ["Splitting it back into two components makes the cell sensitive to the denaturing agent urea, showing that premature termination followed by re-initiation is not an option for recovery [31].", [["cell", "ANATOMY", 48, 52], ["urea", "CHEMICAL", 87, 91], ["urea", "CHEMICAL", 87, 91], ["cell", "CELL", 48, 52], ["urea", "SIMPLE_CHEMICAL", 87, 91], ["the cell", "PROBLEM", 44, 52], ["the denaturing agent urea", "PROBLEM", 66, 91], ["premature termination", "PROBLEM", 106, 127]]], ["Other important components of the machinery are also large, e.g., NusA [32] or the transcription-repair factor Mfd [33].", [["NusA [32]", "GENE_OR_GENE_PRODUCT", 66, 75], ["transcription-repair factor", "PROTEIN", 83, 110], ["Mfd", "PROTEIN", 111, 114], ["the transcription", "TREATMENT", 79, 96], ["large", "OBSERVATION_MODIFIER", 53, 58]]], ["Is there a special property, associated with increased length that could compensate for the fragility of synthesis of long molecules?Proteins also Need to be Replaced ::: Functions Required to Sustain LifeNon-functional proteins can be either repaired [34-36] or refolded, and this costs energy.", [["long molecules", "PROTEIN", 118, 132], ["Sustain LifeNon-functional proteins", "PROTEIN", 193, 228], ["increased length", "PROBLEM", 45, 61], ["the fragility of synthesis of long molecules", "PROBLEM", 88, 132], ["special property", "OBSERVATION_MODIFIER", 11, 27]]], ["Degradation enzymes, often hydrolytic enzymes, are essential at this stage.", [["hydrolytic enzymes", "PROTEIN", 27, 45], ["Degradation enzymes", "TEST", 0, 19], ["often hydrolytic enzymes", "TEST", 21, 45]]], ["Remarkably, while hydrolysis is a highly exothermic process, many degradation enzymes consume energy-an apparent waste.", [["degradation enzymes", "PROTEIN", 66, 85], ["a highly exothermic process", "PROBLEM", 32, 59], ["many degradation enzymes consume energy", "PROBLEM", 61, 100], ["highly", "OBSERVATION_MODIFIER", 34, 40], ["exothermic", "OBSERVATION", 41, 51]]], ["This reminds us of the remark made by Hopfield, that in order to identify important and unexpected functions, we should be exploring \u201cknown reactions which otherwise appear to be useless or deleterious complications [yet] are seen to be essential to the [studied] function\u201d [37].", [["known reactions", "PROBLEM", 134, 149], ["deleterious complications", "PROBLEM", 190, 215]]], ["Antifragility implies improving while ageing, before inevitable senescence.", [["inevitable senescence", "PROBLEM", 53, 74]]], ["Many energy-dependent proteases have been characterized, including Clp, Lon, and FtsH (HflB) in E. coli.", [["Clp", "GENE_OR_GENE_PRODUCT", 67, 70], ["Lon", "GENE_OR_GENE_PRODUCT", 72, 75], ["FtsH", "GENE_OR_GENE_PRODUCT", 81, 85], ["HflB", "GENE_OR_GENE_PRODUCT", 87, 91], ["E. coli", "ORGANISM", 96, 103], ["proteases", "PROTEIN", 22, 31], ["Clp", "PROTEIN", 67, 70], ["Lon", "PROTEIN", 72, 75], ["FtsH", "PROTEIN", 81, 85], ["HflB", "PROTEIN", 87, 91], ["E. coli", "SPECIES", 96, 103], ["E. coli", "SPECIES", 96, 103], ["Many energy-dependent proteases", "PROBLEM", 0, 31], ["Clp", "PROBLEM", 67, 70], ["Lon", "PROBLEM", 72, 75], ["FtsH (HflB)", "PROBLEM", 81, 92], ["E. coli", "PROBLEM", 96, 103], ["dependent proteases", "OBSERVATION_MODIFIER", 12, 31], ["E. coli", "OBSERVATION", 96, 103]]], ["Clp proteases are degradation machines composed of a sensor required for both substrate recognition and ATP-dependent selection for unfolding, and of a peptidase made of multiple subunits, required for substrate hydrolysis (see e.g., [38]).", [["ATP", "CHEMICAL", 104, 107], ["ATP", "CHEMICAL", 104, 107], ["Clp", "GENE_OR_GENE_PRODUCT", 0, 3], ["ATP", "SIMPLE_CHEMICAL", 104, 107], ["Clp proteases", "PROTEIN", 0, 13], ["peptidase", "PROTEIN", 152, 161], ["multiple subunits", "PROTEIN", 170, 187], ["Clp proteases", "TREATMENT", 0, 13], ["degradation machines", "TREATMENT", 18, 38], ["ATP", "TEST", 104, 107], ["unfolding", "PROBLEM", 132, 141], ["a peptidase", "TREATMENT", 150, 161], ["multiple subunits", "TREATMENT", 170, 187], ["substrate hydrolysis", "TREATMENT", 202, 222]]], ["Clp proteases (ClpP) use the ATPase subunits to choose between folded and unfolded substrates.", [["Clp proteases", "GENE_OR_GENE_PRODUCT", 0, 13], ["ClpP", "GENE_OR_GENE_PRODUCT", 15, 19], ["ATPase", "GENE_OR_GENE_PRODUCT", 29, 35], ["Clp proteases", "PROTEIN", 0, 13], ["ClpP", "PROTEIN", 15, 19], ["ATPase subunits", "PROTEIN", 29, 44], ["Clp proteases", "PROBLEM", 0, 13], ["ClpP", "PROBLEM", 15, 19], ["the ATPase subunits", "TREATMENT", 25, 44], ["folded and unfolded substrates", "PROBLEM", 63, 93], ["unfolded substrates", "OBSERVATION", 74, 93]]], ["The importance of choosing (i.e., collecting information on) the substrate to be degraded is illustrated by the unexpected role of a novel class of antibiotics, acyldepsipeptides, that are active against ClpP.", [["acyldepsipeptides", "CHEMICAL", 161, 178], ["acyldepsipeptides", "CHEMICAL", 161, 178], ["acyldepsipeptides", "SIMPLE_CHEMICAL", 161, 178], ["ClpP.", "ORGANISM", 204, 209], ["antibiotics", "TREATMENT", 148, 159], ["acyldepsipeptides", "TREATMENT", 161, 178]]], ["The acyldepsipeptide-activated ClpP core initiates proteolytic degradation without the control exerted by Clp-ATPases.", [["acyldepsipeptide", "CHEMICAL", 4, 20], ["acyldepsipeptide", "CHEMICAL", 4, 20], ["acyldepsipeptide", "SIMPLE_CHEMICAL", 4, 20], ["ClpP", "GENE_OR_GENE_PRODUCT", 31, 35], ["Clp-ATPases", "GENE_OR_GENE_PRODUCT", 106, 117], ["acyldepsipeptide-activated ClpP core", "PROTEIN", 4, 40], ["Clp-ATPases", "PROTEIN", 106, 117], ["The acyldepsipeptide", "TREATMENT", 0, 20], ["activated ClpP core", "TREATMENT", 21, 40], ["proteolytic degradation", "TREATMENT", 51, 74], ["activated ClpP", "OBSERVATION", 21, 35], ["proteolytic degradation", "OBSERVATION", 51, 74]]], ["This unchecked activity, which demonstrates that the energy of ATP is not used in the very process of protein hydrolysis, leads to the inhibition of bacterial cell division and eventually cell death [39].", [["cell", "ANATOMY", 159, 163], ["cell", "ANATOMY", 188, 192], ["ATP", "CHEMICAL", 63, 66], ["death", "DISEASE", 193, 198], ["ATP", "CHEMICAL", 63, 66], ["ATP", "SIMPLE_CHEMICAL", 63, 66], ["cell", "CELL", 159, 163], ["cell", "CELL", 188, 192], ["the energy of ATP", "PROBLEM", 49, 66], ["protein hydrolysis", "PROBLEM", 102, 120], ["bacterial cell division", "PROBLEM", 149, 172], ["eventually cell death", "PROBLEM", 177, 198], ["protein hydrolysis", "OBSERVATION", 102, 120], ["bacterial cell division", "OBSERVATION", 149, 172]]], ["Again, these proteins, essential during stationary life, are long.Proteins also Need to be Replaced ::: Functions Required to Sustain LifeProteolysis makes room in the cell, and relevant feedbacks resynthesise degraded proteins that are important.", [["cell", "ANATOMY", 168, 172], ["cell", "CELL", 168, 172]]], ["To this aim, translation requires utilization of at least part of the population of ribosomes.", [["ribosomes", "ANATOMY", 84, 93], ["ribosomes", "CELLULAR_COMPONENT", 84, 93]]], ["Some ribosomes are clustered together in \u201chibernating\u201d 100S complexes combining two 70S ribosomes and Rmf [40].", [["ribosomes", "ANATOMY", 5, 14], ["ribosomes", "CELLULAR_COMPONENT", 5, 14], ["100S complexes", "PROTEIN", 55, 69], ["70S ribosomes", "PROTEIN", 84, 97], ["Some ribosomes", "PROBLEM", 0, 14]]], ["The available ones must have at least some functional ribosomal proteins (several are somewhat dispensable [41]). tRNA synthetases, initiation and elongation factors are also required in the process.", [["ribosomal", "ANATOMY", 54, 63], ["ribosomal", "CELLULAR_COMPONENT", 54, 63], ["ribosomal proteins", "PROTEIN", 54, 72], ["tRNA synthetases", "PROTEIN", 114, 130], ["elongation factors", "PROTEIN", 147, 165], ["some functional ribosomal proteins", "PROBLEM", 38, 72], ["tRNA synthetases", "TREATMENT", 114, 130], ["elongation factors", "PROBLEM", 147, 165], ["ribosomal proteins", "OBSERVATION", 54, 72]]], ["In contrast to the proteins described previously, ribosomal proteins are short or very short proteins, a feature that could have been selected to minimize errors when they are synthesized.", [["ribosomal", "ANATOMY", 50, 59], ["ribosomal", "CELLULAR_COMPONENT", 50, 59], ["ribosomal proteins", "PROTEIN", 50, 68], ["ribosomal proteins", "PROBLEM", 50, 68], ["short or very short proteins", "PROBLEM", 73, 101], ["short", "OBSERVATION_MODIFIER", 73, 78]]], ["Why such a contrast between the translation nanomachine, and the transcription nanomachine?", [["the translation nanomachine", "TREATMENT", 28, 55]]], ["During stationary life the core functions of energy management (adenylate kinase and nucleoside diphosphokinase in particular) are essential to replenish the energy level of the cell; central intermediary metabolism (with synthesis of phosphoenolpyruvate and acetyl-Coenzyme A) must be present for proper functioning of the cell.", [["cell", "ANATOMY", 178, 182], ["cell", "ANATOMY", 324, 328], ["nucleoside", "CHEMICAL", 85, 95], ["acetyl-Coenzyme A", "CHEMICAL", 259, 276], ["adenylate", "CHEMICAL", 64, 73], ["nucleoside", "CHEMICAL", 85, 95], ["phosphoenolpyruvate", "CHEMICAL", 235, 254], ["acetyl-Coenzyme A", "CHEMICAL", 259, 276], ["adenylate kinase", "GENE_OR_GENE_PRODUCT", 64, 80], ["nucleoside diphosphokinase", "GENE_OR_GENE_PRODUCT", 85, 111], ["cell", "CELL", 178, 182], ["phosphoenolpyruvate", "SIMPLE_CHEMICAL", 235, 254], ["acetyl-Coenzyme A", "SIMPLE_CHEMICAL", 259, 276], ["cell", "CELL", 324, 328], ["adenylate kinase", "PROTEIN", 64, 80], ["nucleoside diphosphokinase", "PROTEIN", 85, 111], ["phosphoenolpyruvate", "PROTEIN", 235, 254], ["energy management", "TREATMENT", 45, 62], ["adenylate kinase", "TEST", 64, 80], ["nucleoside diphosphokinase", "TREATMENT", 85, 111], ["central intermediary metabolism", "PROBLEM", 184, 215], ["synthesis of phosphoenolpyruvate", "TREATMENT", 222, 254], ["acetyl-Coenzyme A", "TREATMENT", 259, 276], ["central", "ANATOMY_MODIFIER", 184, 191], ["intermediary metabolism", "OBSERVATION", 192, 215]]], ["Structural features of the cell's envelope must also be important.", [["cell", "ANATOMY", 27, 31], ["cell", "CELL", 27, 31], ["cell", "ANATOMY", 27, 31]]], ["Also, the murein sacculus (the rigid peptidoglycan structure that gives the cell its shape and protects it against deleterious changes in the environment) is likely to be quite stable and will not require heavy-duty maintenance.", [["cell", "ANATOMY", 76, 80], ["murein sacculus", "GENE_OR_GENE_PRODUCT", 10, 25], ["cell", "CELL", 76, 80], ["the murein sacculus", "PROBLEM", 6, 25], ["the rigid peptidoglycan structure", "PROBLEM", 27, 60], ["heavy-duty maintenance", "TREATMENT", 205, 227], ["murein sacculus", "OBSERVATION", 10, 25], ["likely to be", "UNCERTAINTY", 158, 170], ["stable", "OBSERVATION", 177, 183]]], ["The situation may be somewhat different for membrane phospholipids [42].", [["membrane", "ANATOMY", 44, 52], ["membrane", "CELLULAR_COMPONENT", 44, 52], ["membrane phospholipids", "TEST", 44, 66]]], ["Finally, in line with the fate of macromolecules, altered metabolites are either degraded, recycled or exported to the environment.", [["altered metabolites", "PROBLEM", 50, 69]]], ["Some are repaired (AdoMet via SamT [43], D-amino acids) but this may be optional.", [["AdoMet", "CHEMICAL", 19, 25], ["SamT [43], D-amino acids", "CHEMICAL", 30, 54], ["AdoMet", "CHEMICAL", 19, 25], ["SamT [43], D-amino acids", "CHEMICAL", 30, 54], ["AdoMet", "SIMPLE_CHEMICAL", 19, 25], ["SamT [43]", "SIMPLE_CHEMICAL", 30, 39], ["D-amino acids", "SIMPLE_CHEMICAL", 41, 54], ["D-amino acids", "TEST", 41, 54], ["repaired", "OBSERVATION", 9, 17]]], ["Establishing the list of repaired metabolites should tell us something about their relative importance in the functional hierarchy of the cell under stationary conditions (Table 1).Long and Short Proteins Make up the Stationary Essential Proteome, but Proteins of Average Length do not ::: Functions Required to Sustain LifeThe distribution of the length of the proteins important for stationary survival is compared in Figure 1 to that of all proteins in the E. coli proteome: it displays a remarkable bias both for short and long proteins.Long and Short Proteins Make up the Stationary Essential Proteome, but Proteins of Average Length do not ::: Functions Required to Sustain LifeWhile the presence of short proteins is easy to understand (there is inherent robustness in being short as discussed by Galileo Galilei in his Dialogo sopra i due massimi sistemi del mondo) we need to account for the long ones.", [["cell", "ANATOMY", 138, 142], ["cell", "CELL", 138, 142], ["E. coli", "ORGANISM", 460, 467], ["short and long proteins", "PROTEIN", 517, 540], ["short proteins", "PROTEIN", 706, 720], ["E. coli", "SPECIES", 460, 467], ["E. coli", "SPECIES", 460, 467], ["repaired metabolites", "PROBLEM", 25, 45], ["short and long proteins", "PROBLEM", 517, 540], ["short proteins", "PROBLEM", 706, 720], ["his Dialogo sopra i", "TREATMENT", 823, 842]]], ["We explore now whether this unusual length distribution might suggest a direction to follow.Processes Permitting Stress ManagementDeleterious effects are often perceived as proportional to the amplitude of their causes.", [["Stress ManagementDeleterious effects", "TREATMENT", 113, 149]]], ["However, most biological systems possess some kind of buffering capacity.", [["buffering capacity", "PROBLEM", 54, 72], ["buffering capacity", "OBSERVATION", 54, 72]]], ["Provided a negative effect, a stress for example, is not too pronounced, the system reacts by preserving its homeostasis, displaying no negative change.", [["negative effect", "OBSERVATION_MODIFIER", 11, 26], ["too pronounced", "OBSERVATION_MODIFIER", 57, 71], ["no", "UNCERTAINTY", 133, 135], ["negative", "OBSERVATION", 136, 144]]], ["Some effects, however, are cumulative: exceeding the buffering capacity of the system beyond a certain threshold results in accelerated weathering.", [["accelerated weathering", "PROBLEM", 124, 146], ["accelerated weathering", "OBSERVATION", 124, 146]]], ["In this challenging situation the cell has two choices: either its components will steadily accumulate malfunction, resulting in the error catastrophe [44], or the cell will find a solution where, provided that there are enough representatives of a given particular entity, variants will emerge, some of them ready to provide a relief to the stress induced over time.Processes Permitting Stress ManagementThis parallels antifragility, as proposed by Taleb to create specific detailed scenarios of financial risk management [14].", [["cell", "ANATOMY", 34, 38], ["cell", "ANATOMY", 164, 168], ["cell", "CELL", 34, 38], ["cell", "CELL", 164, 168], ["the error catastrophe", "PROBLEM", 129, 150], ["Stress Management", "TREATMENT", 388, 405], ["financial risk management", "TREATMENT", 497, 522]]], ["Within the collection, one of the entities might fare extremely well, compensating for the collapse of some of the others and even do much better than the bulk, had it remained unchallenged.", [["the collapse", "PROBLEM", 87, 99], ["collection", "OBSERVATION", 11, 21], ["one", "OBSERVATION_MODIFIER", 23, 26], ["collapse", "OBSERVATION", 91, 99], ["unchallenged", "OBSERVATION", 177, 189]]], ["For living organisms this could act at the level of the population of organisms, the population of cells, or the population of intracellular molecules.", [["cells", "ANATOMY", 99, 104], ["intracellular", "ANATOMY", 127, 140], ["cells", "CELL", 99, 104], ["intracellular molecules", "CELLULAR_COMPONENT", 127, 150], ["intracellular molecules", "PROTEIN", 127, 150], ["living organisms", "PROBLEM", 4, 20], ["intracellular molecules", "PROBLEM", 127, 150], ["intracellular molecules", "OBSERVATION", 127, 150]]], ["The number of obvious candidates for antifragile behavior among biological processes is enormous.", [["antifragile behavior", "PROBLEM", 37, 57], ["enormous", "OBSERVATION_MODIFIER", 88, 96]]], ["We choose here to illustrate one of them, protein ageing, using a few specific structural features.Long Proteins have Biased Physico-Chemical Properties ::: Flexible Molecules as Support for Antifragile LearningLong proteins are usually multi-domain proteins connected by flexible links [52].", [["Antifragile LearningLong proteins", "PROTEIN", 191, 224], ["multi-domain proteins", "PROTEIN", 237, 258], ["Flexible Molecules", "TREATMENT", 157, 175], ["Antifragile LearningLong proteins", "TREATMENT", 191, 224], ["Chemical Properties", "OBSERVATION", 133, 152]]], ["However, in addition to being more flexible, long proteins display remarkable structural features.", [["long proteins", "PROTEIN", 45, 58], ["long proteins", "TEST", 45, 58], ["remarkable structural features", "PROBLEM", 67, 97], ["remarkable", "OBSERVATION_MODIFIER", 67, 77], ["structural features", "OBSERVATION", 78, 97]]], ["Longer proteins can fulfill more easily than short ones the requirements for unfolding and misfolding stability, because they have a higher number of native interactions per residue.", [["Longer proteins", "PROBLEM", 0, 15], ["unfolding and misfolding stability", "PROBLEM", 77, 111]]], ["They are also relatively enriched in small amino acid residues.", [["amino acid", "CHEMICAL", 43, 53], ["amino acid", "CHEMICAL", 43, 53], ["amino acid", "AMINO_ACID", 43, 53], ["small amino acid residues", "TREATMENT", 37, 62], ["relatively", "OBSERVATION_MODIFIER", 14, 24], ["enriched", "OBSERVATION_MODIFIER", 25, 33], ["small", "OBSERVATION_MODIFIER", 37, 42], ["amino acid residues", "OBSERVATION", 43, 62]]], ["Furthermore, there is a correlation between the tendency to misfold and protein hydrophobicity, with long proteins being less hydrophobic than short ones [53].", [["the tendency to misfold and protein hydrophobicity", "PROBLEM", 44, 94], ["long proteins", "PROBLEM", 101, 114], ["protein hydrophobicity", "OBSERVATION", 72, 94]]], ["Interestingly, when hydrophobicity is low, long proteins are more resistant to unfolding and misfolding than short proteins [54].", [["long proteins", "PROTEIN", 43, 56], ["hydrophobicity", "TEST", 20, 34], ["long proteins", "PROBLEM", 43, 56], ["unfolding and misfolding than short proteins", "PROBLEM", 79, 123], ["low", "OBSERVATION_MODIFIER", 38, 41], ["more resistant", "OBSERVATION_MODIFIER", 61, 75]]], ["The collapse of unfolded polypeptides, generally believed to be driven by hydrophobic forces, is an early event in the folding of a protein.", [["The collapse of unfolded polypeptides", "PROBLEM", 0, 37], ["collapse", "OBSERVATION", 4, 12], ["unfolded polypeptides", "OBSERVATION", 16, 37], ["hydrophobic forces", "OBSERVATION", 74, 92], ["early", "OBSERVATION_MODIFIER", 100, 105]]], ["Whether hydrogen bonds and side chains play a significant role in the process has been an open question.", [["hydrogen bonds", "CHEMICAL", 8, 22], ["hydrogen", "CHEMICAL", 8, 16], ["hydrogen bonds", "SIMPLE_CHEMICAL", 8, 22], ["hydrogen bonds and side chains", "PROBLEM", 8, 38], ["hydrogen bonds", "OBSERVATION", 8, 22]]], ["Before discussing in more depth the way antifragility may exploit flexibility, we explore some features of flexible regions, which might be a trait selected in proteins that must solve new functional questions while ageing.Long Proteins have Biased Physico-Chemical Properties ::: Flexible Molecules as Support for Antifragile LearningBirth, growth, maturation and senescence are the four ages of all cells.", [["cells", "ANATOMY", 401, 406], ["cells", "CELL", 401, 406], ["some features of flexible regions", "PROBLEM", 90, 123], ["a trait selected in proteins", "PROBLEM", 140, 168], ["Flexible Molecules", "TREATMENT", 281, 299], ["Antifragile LearningBirth", "TREATMENT", 315, 340], ["flexible regions", "OBSERVATION", 107, 123], ["Chemical Properties", "OBSERVATION", 257, 276]]], ["This is true of their components as well.", [["true", "OBSERVATION_MODIFIER", 8, 12], ["components", "OBSERVATION_MODIFIER", 22, 32]]], ["In general the maturation step is ignored: cell's components are viewed as synthesized, used in their final form, then decaying and being either repaired or destroyed.", [["cell", "ANATOMY", 43, 47], ["cell", "CELL", 43, 47], ["cell's components", "PROBLEM", 43, 60]]], ["Maturation and possibly functional improvement during ageing is rarely taken into account.", [["possibly", "UNCERTAINTY", 15, 23], ["functional", "OBSERVATION_MODIFIER", 24, 34], ["improvement", "OBSERVATION_MODIFIER", 35, 46]]], ["Yet, quite a few physico-chemical processes suggests that the state of cell components at any time should be seen as actively browsing through a series of ageing states.", [["cell", "ANATOMY", 71, 75], ["cell", "CELL", 71, 75], ["cell components", "PROBLEM", 71, 86]]], ["In fact, notwithstanding apoptosis (which may be a process to reset the system), most cells harbor a mixture of aged and young components, reflecting the overall history of their divisions (Figure 2).Long Proteins have Biased Physico-Chemical Properties ::: Flexible Molecules as Support for Antifragile LearningFlexibility plays a considerable role here.", [["cells", "ANATOMY", 86, 91], ["cells", "CELL", 86, 91], ["notwithstanding apoptosis", "PROBLEM", 9, 34], ["Flexible Molecules", "TREATMENT", 258, 276], ["apoptosis", "OBSERVATION", 25, 34], ["Chemical Properties", "OBSERVATION", 234, 253]]], ["We explore the notion that, before the deleterious senescence process is triggered, a process of maturation will create a population of molecules that will undergo different fates.", [["the deleterious senescence process", "PROBLEM", 35, 69], ["a population of molecules", "PROBLEM", 120, 145]]], ["Flexible regions in some cases will make the protein prone to be degraded by proteolytic systems.", [["Flexible regions in some cases", "PROBLEM", 0, 30]]], ["Hence the different individuals in a collection of a given gene product may have different fates, and react differently to similar challenges.The Function of Post-Translational Modifications is Disputed ::: Flexible Molecules as Support for Antifragile LearningTwo processes are generally considered important in the maturation of macromolecules: metabolism-driven modifications and intrinsic instabilities.", [["a given gene product", "TREATMENT", 51, 71], ["Flexible Molecules", "TREATMENT", 207, 225], ["intrinsic instabilities", "PROBLEM", 383, 406], ["different", "OBSERVATION_MODIFIER", 10, 19], ["individuals", "OBSERVATION_MODIFIER", 20, 31], ["intrinsic instabilities", "OBSERVATION", 383, 406]]], ["Post-transcriptional and post-translational modifications show that some metabolism-dependent changes are genetically programmed.", [["post-translational modifications", "TREATMENT", 25, 57], ["some metabolism-dependent changes", "PROBLEM", 68, 101], ["dependent", "OBSERVATION_MODIFIER", 84, 93]]], ["At the same time, basal metabolism is required to allow the cell to maintain its activity.", [["cell", "ANATOMY", 60, 64], ["cell", "CELL", 60, 64], ["basal metabolism", "PROBLEM", 18, 34], ["the cell", "TREATMENT", 56, 64], ["basal", "ANATOMY_MODIFIER", 18, 23], ["metabolism", "OBSERVATION", 24, 34]]], ["Many metabolites are not innocuous.", [["metabolites", "OBSERVATION", 5, 16], ["not", "UNCERTAINTY", 21, 24], ["innocuous", "OBSERVATION_MODIFIER", 25, 34]]], ["Some have intrinsic reactivity: dicarbonyls (including reducing carbohydrates) react with accessible amino groups resulting in glycation [56] and respiration produces free radicals or reactive oxygen species (ROS) that modify nucleic acids and proteins.", [["amino", "CHEMICAL", 101, 106], ["oxygen", "CHEMICAL", 193, 199], ["ROS", "CHEMICAL", 209, 212], ["nucleic acids", "CHEMICAL", 226, 239], ["dicarbonyls", "CHEMICAL", 32, 43], ["carbohydrates", "CHEMICAL", 64, 77], ["amino", "CHEMICAL", 101, 106], ["oxygen", "CHEMICAL", 193, 199], ["dicarbonyls", "SIMPLE_CHEMICAL", 32, 43], ["carbohydrates", "SIMPLE_CHEMICAL", 64, 77], ["free radicals", "SIMPLE_CHEMICAL", 167, 180], ["reactive oxygen species", "SIMPLE_CHEMICAL", 184, 207], ["ROS", "SIMPLE_CHEMICAL", 209, 212], ["nucleic acids", "SIMPLE_CHEMICAL", 226, 239], ["dicarbonyls (including reducing carbohydrates)", "TREATMENT", 32, 78], ["accessible amino groups", "TREATMENT", 90, 113], ["free radicals", "PROBLEM", 167, 180], ["reactive oxygen species", "PROBLEM", 184, 207], ["nucleic acids", "TEST", 226, 239], ["reactivity", "OBSERVATION_MODIFIER", 20, 30], ["reactive", "OBSERVATION_MODIFIER", 184, 192], ["oxygen species", "OBSERVATION", 193, 207]]], ["The role of ROS is often perceived as negative.", [["ROS", "CHEMICAL", 12, 15], ["ROS", "SIMPLE_CHEMICAL", 12, 15]]], ["However, in addition to being a potential threat to cellular integrity, ROS are also used in a programmed way by the cell, for example in insects, where ROS-triggered protein alteration is required for the formation of the exoskeleton [57].", [["cellular", "ANATOMY", 52, 60], ["cell", "ANATOMY", 117, 121], ["ROS", "CHEMICAL", 72, 75], ["ROS", "CHEMICAL", 153, 156], ["cellular", "CELL", 52, 60], ["ROS", "SIMPLE_CHEMICAL", 72, 75], ["cell", "CELL", 117, 121], ["ROS", "SIMPLE_CHEMICAL", 153, 156], ["protein alteration", "PROBLEM", 167, 185], ["cellular integrity", "OBSERVATION", 52, 70]]], ["In the same way, laccase is involved in formation of the spore coat defense in Bacillus subtilis [58].", [["laccase", "GENE_OR_GENE_PRODUCT", 17, 24], ["Bacillus subtilis", "ORGANISM", 79, 96], ["laccase", "PROTEIN", 17, 24], ["Bacillus subtilis", "SPECIES", 79, 96], ["Bacillus subtilis", "SPECIES", 79, 96], ["the spore coat defense in Bacillus subtilis", "PROBLEM", 53, 96]]], ["Superoxide is essential for longevity in Caenorhabditis elegans [59] and there is evidence in mice that several oncogenes actively promote a ROS detoxification program that is required for tumour initiation [60].", [["tumour", "ANATOMY", 189, 195], ["Superoxide", "CHEMICAL", 0, 10], ["ROS", "CHEMICAL", 141, 144], ["tumour", "DISEASE", 189, 195], ["Superoxide", "CHEMICAL", 0, 10], ["Superoxide", "SIMPLE_CHEMICAL", 0, 10], ["Caenorhabditis elegans", "ORGANISM", 41, 63], ["mice", "ORGANISM", 94, 98], ["ROS", "SIMPLE_CHEMICAL", 141, 144], ["tumour", "CANCER", 189, 195], ["oncogenes", "DNA", 112, 121], ["Caenorhabditis elegans", "SPECIES", 41, 63], ["mice", "SPECIES", 94, 98], ["Caenorhabditis elegans", "SPECIES", 41, 63], ["mice", "SPECIES", 94, 98], ["Superoxide", "TREATMENT", 0, 10], ["longevity in Caenorhabditis elegans", "PROBLEM", 28, 63], ["a ROS detoxification program", "TREATMENT", 139, 167], ["tumour initiation", "TREATMENT", 189, 206], ["essential for", "UNCERTAINTY", 14, 27], ["longevity", "OBSERVATION_MODIFIER", 28, 37]]], ["This raises questions such as: Is the ROS-dependent modification of a common amino acid, such as methionine oxidation, programmed or accidental [61,62]?", [["ROS", "CHEMICAL", 38, 41], ["amino acid", "CHEMICAL", 77, 87], ["methionine", "CHEMICAL", 97, 107], ["amino acid", "CHEMICAL", 77, 87], ["methionine", "CHEMICAL", 97, 107], ["ROS", "SIMPLE_CHEMICAL", 38, 41], ["amino acid", "AMINO_ACID", 77, 87], ["methionine", "SIMPLE_CHEMICAL", 97, 107], ["the ROS", "PROBLEM", 34, 41], ["a common amino acid", "TREATMENT", 68, 87], ["methionine oxidation", "TREATMENT", 97, 117]]], ["Is an oxidized protein a prelude to senescence or a form of the protein that has evolved specifically with the function of regulation, for example?The Function of Post-Translational Modifications is Disputed ::: Flexible Molecules as Support for Antifragile LearningUnprogrammed modification of macromolecules is often seen as leading to loss of function.", [["oxidized protein", "PROTEIN", 6, 22], ["an oxidized protein", "TREATMENT", 3, 22], ["Flexible Molecules", "TREATMENT", 212, 230], ["Antifragile", "TREATMENT", 246, 257], ["loss of function", "PROBLEM", 338, 354]]], ["This is certainly true of most modifications caused by reactive metabolites such as free radicals, but many modifications are programmed and used as control processes (phosphorylation in particular) or protection processes (methylations or acetylations [63]).", [["free radicals", "SIMPLE_CHEMICAL", 84, 97], ["reactive metabolites", "PROBLEM", 55, 75], ["free radicals", "PROBLEM", 84, 97], ["most modifications", "OBSERVATION_MODIFIER", 26, 44], ["reactive metabolites", "OBSERVATION", 55, 75], ["free radicals", "OBSERVATION", 84, 97]]], ["Some, such as lysine carbamylation [64] or hypusinylation [65], are even essential for activity.", [["lysine", "CHEMICAL", 14, 20], ["lysine", "CHEMICAL", 14, 20], ["lysine carbamylation [64]", "SIMPLE_CHEMICAL", 14, 39], ["hypusinylation [65]", "SIMPLE_CHEMICAL", 43, 62], ["lysine carbamylation", "TREATMENT", 14, 34]]], ["Self-cleavage and formation of a pyruvoyl active center exists in proteins present in the three domains of life [66], inteins are spliced out of ribonucleoside diphosphate reductases [67], reactive centers are made of covalent adducts [68,69]\u2026 One also observes more subtle changes in the backbone of macromolecules such as (deoxy)ribose puckering in nucleic acids [70,71], proline puckering [72], isomerisation of aspartate and asparagine with associated deamidation [73], and there is considerable evidence that this could be functional.The Function of Post-Translational Modifications is Disputed ::: Flexible Molecules as Support for Antifragile LearningInterestingly, the cell's components weather with variable rates (possibly programmed in the very sequence of informational biopolymers [74]), depending on their chemical nature and on their flexibility.", [["cell", "ANATOMY", 677, 681], ["pyruvoyl", "CHEMICAL", 33, 41], ["ribonucleoside diphosphate", "CHEMICAL", 145, 171], ["ribose", "CHEMICAL", 331, 337], ["nucleic acids", "CHEMICAL", 351, 364], ["70,71", "CHEMICAL", 366, 371], ["proline", "CHEMICAL", 374, 381], ["aspartate", "CHEMICAL", 415, 424], ["asparagine", "CHEMICAL", 429, 439], ["pyruvoyl", "CHEMICAL", 33, 41], ["ribonucleoside diphosphate", "CHEMICAL", 145, 171], ["(deoxy)ribose", "CHEMICAL", 324, 337], ["proline", "CHEMICAL", 374, 381], ["aspartate", "CHEMICAL", 415, 424], ["asparagine", "CHEMICAL", 429, 439], ["ribonucleoside diphosphate reductases [67]", "SIMPLE_CHEMICAL", 145, 187], ["(deoxy)ribose", "SIMPLE_CHEMICAL", 324, 337], ["nucleic acids", "SIMPLE_CHEMICAL", 351, 364], ["proline puckering [72]", "SIMPLE_CHEMICAL", 374, 396], ["aspartate", "SIMPLE_CHEMICAL", 415, 424], ["asparagine", "AMINO_ACID", 429, 439], ["cell", "CELL", 677, 681], ["ribonucleoside diphosphate reductases", "PROTEIN", 145, 182], ["a pyruvoyl active center", "TREATMENT", 31, 55], ["ribonucleoside diphosphate reductases", "TEST", 145, 182], ["covalent adducts", "PROBLEM", 218, 234], ["subtle changes in the backbone of macromolecules", "PROBLEM", 267, 315], ["ribose puckering in nucleic acids", "TEST", 331, 364], ["proline puckering", "TEST", 374, 391], ["aspartate and asparagine", "TREATMENT", 415, 439], ["associated deamidation", "PROBLEM", 445, 467], ["Flexible Molecules", "TREATMENT", 604, 622], ["variable rates", "PROBLEM", 708, 722], ["more subtle", "OBSERVATION_MODIFIER", 262, 273]]], ["This process occurs with a definite half-time, specific of the protein sequence.", [["protein sequence", "PROTEIN", 63, 79], ["the protein sequence", "TEST", 59, 79]]], ["This allows the protein to change its interaction with relevant control mediators, at a pre-set time.", [["relevant control mediators", "TREATMENT", 55, 81]]], ["Clocks are central devices in information processing.", [["central devices", "TREATMENT", 11, 26], ["central devices", "OBSERVATION", 11, 26]]], ["Accurate timing requires the presence of a stable clock-an unlikely feature of living cells-but cooperation of many inaccurate clocks may result in defining a proper timing [75], possibly to tell cells that they have to start expressing new regulatory pathways or initiate replication.", [["cells", "ANATOMY", 86, 91], ["cells", "ANATOMY", 196, 201], ["cells", "CELL", 86, 91], ["cells", "CELL", 196, 201], ["living cells", "CELL_TYPE", 79, 91], ["living cells", "PROBLEM", 79, 91]]], ["Because this onset of a variety of behaviors which happens after the protein has been synthesized, under conditions when challenges may be taken into account, this process may promote antifragility.The Function of Post-Translational Modifications is Disputed ::: Flexible Molecules as Support for Antifragile LearningLong proteins such as RNA polymerase subunits have flexible regions and their structure (and sequence) could then change as time elapses.", [["Antifragile LearningLong proteins", "PROTEIN", 297, 330], ["RNA polymerase subunits", "PROTEIN", 339, 362], ["Flexible Molecules", "TREATMENT", 263, 281], ["Antifragile LearningLong proteins", "TREATMENT", 297, 330], ["RNA polymerase subunits", "TREATMENT", 339, 362]]], ["Should not we reinvestigate their structure/function in ageing cells?", [["cells", "ANATOMY", 63, 68], ["cells", "CELL", 63, 68], ["ageing cells", "CELL_TYPE", 56, 68]]], ["In the same way, repair systems are made of long proteins, and these proteins need to avoid the damages of age because they are essential to prevent premature death [76].", [["death", "DISEASE", 159, 164], ["long proteins", "PROTEIN", 44, 57], ["repair systems", "TREATMENT", 17, 31], ["long proteins", "PROBLEM", 44, 57], ["premature death", "PROBLEM", 149, 164], ["repair", "OBSERVATION", 17, 23]]], ["Indeed, for example, large unstructured hydrophilic flexible regions or proteins provide cellular resistance to dehydration [77].Isomerisation of Asparagine and Aspartate Residues Creates Context-Dependent Clocks ::: Flexible Molecules as Support for Antifragile LearningTo illustrate concretely these points, here is a detailed example of a specific time-dependent post- translational molecular mechanism.", [["cellular", "ANATOMY", 89, 97], ["dehydration", "DISEASE", 112, 123], ["Asparagine", "CHEMICAL", 146, 156], ["Aspartate", "CHEMICAL", 161, 170], ["Asparagine", "CHEMICAL", 146, 156], ["Aspartate", "CHEMICAL", 161, 170], ["cellular", "CELL", 89, 97], ["Asparagine", "SIMPLE_CHEMICAL", 146, 156], ["Aspartate Residues", "SIMPLE_CHEMICAL", 161, 179], ["hydrophilic flexible regions", "PROTEIN", 40, 68], ["large unstructured hydrophilic flexible regions", "PROBLEM", 21, 68], ["cellular resistance to dehydration", "PROBLEM", 89, 123], ["Asparagine and Aspartate Residues", "TREATMENT", 146, 179], ["Flexible Molecules", "TREATMENT", 217, 235], ["large", "OBSERVATION_MODIFIER", 21, 26], ["hydrophilic", "OBSERVATION_MODIFIER", 40, 51], ["flexible", "OBSERVATION", 52, 60], ["cellular resistance", "OBSERVATION", 89, 108]]], ["Flexibility favors cyclisation of aspartate and asparagine residues into L-succinimide (Figure 3).Isomerisation of Asparagine and Aspartate Residues Creates Context-Dependent Clocks ::: Flexible Molecules as Support for Antifragile LearningThis process is both fast and frequent, in particular at asparagine-glycine (AsnGly) motifs because of the intrinsic flexibility of glycine [73], with an associated deamidation of asparagine.", [["aspartate", "CHEMICAL", 34, 43], ["asparagine", "CHEMICAL", 48, 58], ["L-succinimide", "CHEMICAL", 73, 86], ["Asparagine", "CHEMICAL", 115, 125], ["Aspartate", "CHEMICAL", 130, 139], ["asparagine-glycine", "CHEMICAL", 297, 315], ["AsnGly", "CHEMICAL", 317, 323], ["glycine", "CHEMICAL", 372, 379], ["asparagine", "CHEMICAL", 420, 430], ["aspartate", "CHEMICAL", 34, 43], ["asparagine", "CHEMICAL", 48, 58], ["L-succinimide", "CHEMICAL", 73, 86], ["Asparagine", "CHEMICAL", 115, 125], ["Aspartate", "CHEMICAL", 130, 139], ["asparagine", "CHEMICAL", 297, 307], ["glycine", "CHEMICAL", 308, 315], ["AsnGly", "CHEMICAL", 317, 323], ["glycine", "CHEMICAL", 372, 379], ["asparagine", "CHEMICAL", 420, 430], ["aspartate", "SIMPLE_CHEMICAL", 34, 43], ["asparagine", "AMINO_ACID", 48, 58], ["L-succinimide", "SIMPLE_CHEMICAL", 73, 86], ["Asparagine", "SIMPLE_CHEMICAL", 115, 125], ["Aspartate Residues", "SIMPLE_CHEMICAL", 130, 148], ["asparagine-glycine", "SIMPLE_CHEMICAL", 297, 315], ["AsnGly", "SIMPLE_CHEMICAL", 317, 323], ["glycine [73]", "SIMPLE_CHEMICAL", 372, 384], ["asparagine", "AMINO_ACID", 420, 430], ["aspartate and asparagine residues into L-succinimide", "TREATMENT", 34, 86], ["Isomerisation of Asparagine and Aspartate Residues", "PROBLEM", 98, 148], ["Flexible Molecules", "TREATMENT", 186, 204], ["asparagine-glycine (AsnGly) motifs", "TREATMENT", 297, 331], ["an associated deamidation of asparagine", "PROBLEM", 391, 430], ["Molecules", "OBSERVATION", 195, 204]]], ["L-succinimide will either hydrolyse into L-isoaspartate spontaneously or after methylation (in 2/3 of the cases), or L-aspartate (in 1/3 of the cases).", [["L-succinimide", "CHEMICAL", 0, 13], ["L-isoaspartate", "CHEMICAL", 41, 55], ["L-aspartate", "CHEMICAL", 117, 128], ["L-succinimide", "CHEMICAL", 0, 13], ["L-isoaspartate", "CHEMICAL", 41, 55], ["L-aspartate", "CHEMICAL", 117, 128], ["L-succinimide", "SIMPLE_CHEMICAL", 0, 13], ["L-isoaspartate", "SIMPLE_CHEMICAL", 41, 55], ["L-aspartate", "SIMPLE_CHEMICAL", 117, 128], ["L-succinimide", "TREATMENT", 0, 13]]], ["Subsequently, L-succinimide will isomerise into D-succinimide at a slow rate, and then lead to formation of D-isoaspartate and D-aspartate residues.", [["L-succinimide", "CHEMICAL", 14, 27], ["D-succinimide", "CHEMICAL", 48, 61], ["D-isoaspartate", "CHEMICAL", 108, 122], ["D-aspartate", "CHEMICAL", 127, 138], ["L-succinimide", "CHEMICAL", 14, 27], ["D-succinimide", "CHEMICAL", 48, 61], ["D-isoaspartate", "CHEMICAL", 108, 122], ["D-aspartate", "CHEMICAL", 127, 138], ["L-succinimide", "SIMPLE_CHEMICAL", 14, 27], ["D-succinimide", "SIMPLE_CHEMICAL", 48, 61], ["D-isoaspartate", "SIMPLE_CHEMICAL", 108, 122], ["D-aspartate", "SIMPLE_CHEMICAL", 127, 138], ["L-succinimide", "TREATMENT", 14, 27], ["succinimide", "TREATMENT", 50, 61], ["a slow rate", "TREATMENT", 65, 76], ["D-isoaspartate and D-aspartate residues", "TREATMENT", 108, 147], ["D-aspartate residues", "OBSERVATION", 127, 147]]], ["As a consequence, proteins with flexible regions containing aspartate or asparagine residues will considerably change over time, leading to multiple states, depending on the past history of the protein.", [["aspartate", "CHEMICAL", 60, 69], ["asparagine", "CHEMICAL", 73, 83], ["aspartate", "CHEMICAL", 60, 69], ["asparagine", "CHEMICAL", 73, 83], ["aspartate", "SIMPLE_CHEMICAL", 60, 69], ["asparagine", "AMINO_ACID", 73, 83], ["flexible regions", "PROTEIN", 32, 48], ["flexible regions containing aspartate or asparagine residues", "PROBLEM", 32, 92], ["asparagine residues", "OBSERVATION", 73, 92]]], ["Remarkably, the beta subunit of RNA polymerase contains conserved AsnGly motifs.", [["beta subunit", "GENE_OR_GENE_PRODUCT", 16, 28], ["AsnGly", "GENE_OR_GENE_PRODUCT", 66, 72], ["beta subunit", "PROTEIN", 16, 28], ["RNA polymerase", "PROTEIN", 32, 46], ["AsnGly motifs", "PROTEIN", 66, 79], ["RNA polymerase", "PROBLEM", 32, 46]]], ["Because of the cost of resynthesising the protein, if destined to become rapidly non-functional after cyclisation-deamidation, these motifs should have been genetically rejected rather than preferred, unless deamidation is of positive biological value.", [["cyclisation", "TEST", 102, 113], ["deamidation", "PROBLEM", 114, 125], ["positive biological value", "PROBLEM", 226, 251]]], ["In the same way, aspartates modified by phosphorylation or methylation are also prone to cyclisation.", [["aspartates", "CHEMICAL", 17, 27], ["aspartates", "CHEMICAL", 17, 27], ["aspartates", "SIMPLE_CHEMICAL", 17, 27], ["phosphorylation or methylation", "TREATMENT", 40, 70]]], ["This may lead to loss of activity, creation of novel functional properties, such as regulatory properties or novel catalytic features (reviewed in [73]).Isomerisation of Asparagine and Aspartate Residues Creates Context-Dependent Clocks ::: Flexible Molecules as Support for Antifragile LearningMany other changes occur as time elapses, in particular during the catalytic cycles in which enzymes perform their functions.", [["Asparagine", "CHEMICAL", 170, 180], ["Aspartate", "CHEMICAL", 185, 194], ["Asparagine", "CHEMICAL", 170, 180], ["Aspartate", "CHEMICAL", 185, 194], ["Asparagine", "SIMPLE_CHEMICAL", 170, 180], ["Aspartate Residues", "SIMPLE_CHEMICAL", 185, 203], ["enzymes", "PROTEIN", 388, 395], ["loss of activity", "PROBLEM", 17, 33], ["novel catalytic features", "PROBLEM", 109, 133], ["Asparagine and Aspartate Residues", "TREATMENT", 170, 203], ["Flexible Molecules", "TREATMENT", 241, 259], ["Antifragile Learning", "TREATMENT", 275, 295], ["the catalytic cycles", "TREATMENT", 358, 378], ["Molecules", "OBSERVATION", 250, 259]]], ["In some cases, once a protein has been modified (e.g., alkylation of a cysteine residue in the Ada enzyme dealkylating DNA [78]), it must be degraded and resynthesized.", [["cysteine", "CHEMICAL", 71, 79], ["DNA", "CELLULAR_COMPONENT", 119, 122], ["Ada enzyme", "PROTEIN", 95, 105], ["a protein", "TREATMENT", 20, 29], ["alkylation", "TREATMENT", 55, 65], ["a cysteine residue", "TREATMENT", 69, 87]]], ["However, this is extremely costly and should be limited to some rare situations when it is better to lose energy than control.", [["some rare situations", "PROBLEM", 59, 79]]], ["This cannot be the rule, and inevitable time-dependent changes in macromolecules provide good reasons to suspect that some have been recruited for being functional in the long run, and even to alter their function in a context-related positive direction, allowing them to display antifragile features.", [["dependent changes in macromolecules", "PROBLEM", 45, 80]]], ["This could account for the bias towards long proteins among those that are needed during stationary ageing, the maturation process preceding deleterious senescence.ConclusionsDrawing an image of the environment is a way to foresee the future.", [["long proteins", "PROTEIN", 40, 53], ["deleterious senescence", "PROBLEM", 141, 163]]], ["We propose that antifragility provides a way to allow the viability of cells and organisms in the long run by providing flexibility in structures and processes so that said cells can learn and implement versatile solutions to the problems posed by a variable environment during stationary life.ConclusionsExtending the concept of induced-fit, we can see antifragile flexible structures and processes as molded on particular ordered structures and processes of the organism.", [["cells", "ANATOMY", 71, 76], ["cells", "ANATOMY", 173, 178], ["cells", "CELL", 71, 76], ["cells", "CELL", 173, 178], ["said cells", "CELL_TYPE", 168, 178], ["the viability of cells", "PROBLEM", 54, 76], ["organisms", "PROBLEM", 81, 90], ["versatile solutions", "TREATMENT", 203, 222], ["induced-fit", "PROBLEM", 330, 341], ["the organism", "PROBLEM", 460, 472]]], ["Antifragility could use pre-set properties selected during evolution, such as the retention of asparagine or aspartate residues at specific positions in proteins, and a context-dependent ability to cyclize.", [["asparagine", "CHEMICAL", 95, 105], ["aspartate", "CHEMICAL", 109, 118], ["asparagine", "CHEMICAL", 95, 105], ["aspartate", "CHEMICAL", 109, 118], ["asparagine", "AMINO_ACID", 95, 105], ["aspartate", "AMINO_ACID", 109, 118], ["the retention of asparagine", "TREATMENT", 78, 105], ["aspartate residues at specific positions in proteins", "PROBLEM", 109, 161]]], ["This way, the cell could learn and memorize a particular moment in its history, and fixate it so that it could be recalled later on when similar conditions appear.", [["cell", "ANATOMY", 14, 18], ["cell", "CELL", 14, 18]]], ["Antifragility would thus be a way to implement a form of epigenetic memory and contribute to the overall mechanisms of network epistasis [50].", [["epigenetic memory", "PROBLEM", 57, 74], ["network epistasis", "PROBLEM", 119, 136]]], ["In the present context it has properties similar to those used in the market of financial derivatives: the cell develops a diverse population of molecules of processes such that, under challenging conditions, one or more will emerge and improve the cell's fate in a much better way than a uniform population would have [14].", [["cell", "ANATOMY", 107, 111], ["cell", "ANATOMY", 249, 253], ["cell", "CELL", 107, 111], ["cell", "CELL", 249, 253], ["financial derivatives", "TREATMENT", 80, 101], ["the cell", "PROBLEM", 103, 111], ["diverse", "OBSERVATION_MODIFIER", 123, 130]]], ["At this point, an aged cell, when facing suddenly a medium where it could reproduce, would initiate a round of replication.", [["cell", "ANATOMY", 23, 27], ["cell", "CELL", 23, 27], ["replication", "TREATMENT", 111, 122]]], ["We did not discuss here the corresponding required processes and functions, which may underlie the widely spread observation of VBNC [18], but the present view should be seen as a pre-requisite to explore this stage of life that represents up to 99% of the bacteria present in the environment.ConclusionsThis population view, with special properties coming from a few individuals, asks for a way to extract a common underlying order that can be memorized.", [["the bacteria", "PROBLEM", 253, 265], ["This population view", "TEST", 304, 324], ["bacteria", "OBSERVATION", 257, 265]]], ["The cell is constantly in the midst of a huge network of interacting partners.", [["cell", "ANATOMY", 4, 8], ["cell", "CELL", 4, 8], ["cell", "OBSERVATION", 4, 8], ["constantly", "OBSERVATION_MODIFIER", 12, 22]]], ["An important feature of large interaction graphs is that they comply with Ramsey's theory, which states that a sufficiently large system, no matter how random, must contain highly organized subsystems [79].", [["large interaction graphs", "PROBLEM", 24, 48], ["a sufficiently large system", "PROBLEM", 109, 136], ["large", "OBSERVATION_MODIFIER", 24, 29], ["interaction", "OBSERVATION", 30, 41], ["no", "UNCERTAINTY", 138, 140]]], ["Antifragility is context- dependent.", [["Antifragility", "DISEASE", 0, 13], ["dependent", "OBSERVATION_MODIFIER", 26, 35]]], ["But there is no means for an antifragile structure to know whether the constraints that made it evolve came from the outside or from the inside.", [["an antifragile structure", "PROBLEM", 26, 50], ["no means for", "UNCERTAINTY", 13, 25]]], ["In this way, once time has taken its toll on the organism, a network of interactions would have been created via antifragile modifications of multiple elements, allowing it to trigger re-synthesis of some components that would fit in place in the graph, because the interaction graph itself would play the role of the original situation that enabled its creation.ConclusionsThis behavior is similar to that of the brain, which both records immediate cues in the environment and anticipates its future behavior without knowing whether the stimuli are endogenous or exogenous.", [["brain", "ANATOMY", 414, 419], ["brain", "ORGAN", 414, 419], ["brain", "ANATOMY", 414, 419]]], ["This is performed via a set of hierarchical functions that combine bottom-up recording (from the senses to the higher levels of the brain) with top-down feedback used to prepare the sensing apparatus to what might soon appear [80].", [["brain", "ANATOMY", 132, 137], ["brain", "ORGAN", 132, 137], ["the sensing apparatus", "TREATMENT", 178, 199], ["brain", "ANATOMY", 132, 137]]], ["An antifragile entity will sense and record \u201con the fly\u201d memories from the bottom up (for example asparagine cyclisation and deamidation will depend on temperature changes, frequency of the involvement of catalytic activity).", [["asparagine", "CHEMICAL", 98, 108], ["asparagine", "CHEMICAL", 98, 108], ["example asparagine cyclisation", "TREATMENT", 90, 120], ["deamidation", "PROBLEM", 125, 136], ["temperature changes", "PROBLEM", 152, 171]]], ["And gene expression will adjust, top- down, the answer of the cell as a whole.ConclusionsWhen accounting for an immediate reaction to challenge, antifragility thus contributes to fitness.", [["cell", "ANATOMY", 62, 66], ["cell", "CELL", 62, 66], ["an immediate reaction", "PROBLEM", 109, 130]]], ["A remarkable property of antifragility is the fact that, by definition, an antifragile entity will react to changes by providing a solution that is not exactly programmed.", [["a solution", "TREATMENT", 129, 139]]]], "PMC7150333": [], "PMC2949546": [["One of the main reasons was the incomplete definition of the proteome due to the lack of comprehensive genomic information, as well as technical limitations for large scale profiling of proteins.", [["large scale profiling of proteins", "PROBLEM", 161, 194], ["main", "OBSERVATION_MODIFIER", 11, 15]]], ["During the past few decades, improved and novel technologies have emerged as powerful tools for proteomic studies including shotgun proteomics by mass spectrometry technology [1] and protein microarray technology [2].", [["proteomic studies", "TEST", 96, 113], ["shotgun proteomics", "TREATMENT", 124, 142], ["protein microarray technology", "TREATMENT", 183, 212]]], ["Mass spectrometry technology, combined with various sample preparation methods, has been used extensively in biological research such as proteome profiling [3], protein\u2013protein interaction mapping [4], [5] and identification of post-translational modification [6], [7], [8].", [["[7]", "SIMPLE_CHEMICAL", 265, 268], ["Mass spectrometry technology", "PROBLEM", 0, 28], ["various sample preparation methods", "TREATMENT", 44, 78], ["proteome profiling", "TEST", 137, 155], ["protein\u2013protein interaction mapping", "TREATMENT", 161, 196]]], ["The greatest advantage of this technology lies in its capability of high throughput protein identification and quantification.", [["greatest", "OBSERVATION_MODIFIER", 4, 12]]], ["Nevertheless, mass spectrometry still has its limitations, such as the undersampling issue (insufficient coverage of the proteome) [9], [10] as well as bias against low abundant proteins [11].", [["mass spectrometry", "PROBLEM", 14, 31], ["low abundant proteins", "PROBLEM", 165, 186], ["mass", "OBSERVATION", 14, 18]]], ["Protein microarray technology, on the other hand, does not have the above limitations for mass spectrometry owing to its particular platform.", [["Protein microarray technology", "TEST", 0, 29], ["mass spectrometry", "PROBLEM", 90, 107]]], ["Protein microarray technology [12], [13] was developed upon the completion of the genome sequence of multiple organisms, including the budding yeast Saccharomyces cerevisiae[14] and humans (Homo sapiens) [15].", [["budding yeast Saccharomyces cerevisiae", "ORGANISM", 135, 173], ["humans", "ORGANISM", 182, 188], ["Homo sapiens", "ORGANISM", 190, 202], ["yeast", "SPECIES", 143, 148], ["Saccharomyces cerevisiae", "SPECIES", 149, 173], ["humans", "SPECIES", 182, 188], ["Homo sapiens", "SPECIES", 190, 202], ["yeast", "SPECIES", 143, 148], ["Saccharomyces cerevisiae", "SPECIES", 149, 173], ["humans", "SPECIES", 182, 188], ["Homo sapiens", "SPECIES", 190, 202], ["Protein microarray technology", "TEST", 0, 29], ["multiple organisms", "PROBLEM", 101, 119], ["the budding yeast Saccharomyces cerevisiae", "TREATMENT", 131, 173], ["humans (Homo sapiens)", "TREATMENT", 182, 203], ["multiple", "OBSERVATION_MODIFIER", 101, 109], ["organisms", "OBSERVATION", 110, 119]]], ["Determination of genomic sequences leads to the annotation of known and predicted open reading frames (ORFs) in these genomes, which makes it possible to express the full or partial proteome with large-scale cloning and gene expression methods [2].IntroductionProtein microarray typically contains hundreds to thousands of proteins that are arrayed in an addressable format.", [["genomic sequences", "DNA", 17, 34], ["open reading frames", "DNA", 82, 101], ["ORFs", "DNA", 103, 107], ["genomic sequences", "PROBLEM", 17, 34], ["large-scale cloning", "TREATMENT", 196, 215], ["IntroductionProtein microarray", "TEST", 248, 278], ["hundreds", "OBSERVATION_MODIFIER", 298, 306]]], ["Protein microarrays are generally one of two types: analytical/diagnostic microarrays and functional microarrays [16], [17].", [["Protein microarrays", "TEST", 0, 19], ["diagnostic microarrays", "TEST", 63, 85], ["functional microarrays", "TEST", 90, 112]]], ["One form of analytical/diagnostic microarrays is the antibody microarray, in which specific antibodies against defined target proteins are arrayed on the surface of a support material (such as glass slides), and are used for the detection and quantification of their specific antigens [18], [19].", [["surface", "ANATOMY", 154, 161], ["surface", "CELLULAR_COMPONENT", 154, 161], ["target proteins", "PROTEIN", 119, 134], ["diagnostic microarrays", "TEST", 23, 45], ["the antibody microarray", "TEST", 49, 72], ["specific antibodies", "TEST", 83, 102], ["the detection", "TEST", 225, 238]]], ["This type of microarray has great potential for clinical diagnosis and clinical research, and its advantages and disadvantages are reviewed in [17], [20], [21].", [["[17], [20]", "SIMPLE_CHEMICAL", 143, 153], ["[21]", "SIMPLE_CHEMICAL", 155, 159]]], ["The other type of protein microarray is the functional microarray.", [["protein microarray", "OBSERVATION", 18, 36]]], ["These arrays usually contain a large number of individually expressed and purified functional, full-length proteins or peptides printed in a high-density format on support surfaces, and can represent the complete or partial proteome of a given organism [22].", [["full-length proteins", "PROTEIN", 95, 115], ["peptides", "PROBLEM", 119, 127], ["support surfaces", "TREATMENT", 164, 180], ["large", "OBSERVATION_MODIFIER", 31, 36], ["number", "OBSERVATION_MODIFIER", 37, 43], ["high-density", "OBSERVATION_MODIFIER", 141, 153]]], ["This type of protein microarray has been used in studies of protein\u2013protein, protein\u2013DNA, and protein\u2013small molecule interactions as well as protein modifications (Fig. 1) [2], [17], [23], [24], [25].", [["[17], [23]", "SIMPLE_CHEMICAL", 177, 187], ["[24]", "SIMPLE_CHEMICAL", 189, 193], ["[25]", "SIMPLE_CHEMICAL", 195, 199], ["protein microarray", "TEST", 13, 31], ["protein\u2013protein", "TEST", 60, 75], ["protein\u2013DNA", "TEST", 77, 88], ["protein\u2013small molecule interactions", "PROBLEM", 94, 129], ["protein modifications", "TEST", 141, 162]]], ["Many of these studies were done in the budding yeast S. cerevisiae, and will be discussed in detail below.", [["budding yeast S. cerevisiae", "ORGANISM", 39, 66], ["yeast", "SPECIES", 47, 52], ["S. cerevisiae", "SPECIES", 53, 66], ["yeast", "SPECIES", 47, 52], ["S. cerevisiae", "SPECIES", 53, 66], ["these studies", "TEST", 8, 21]]], ["Functional protein microarrays containing human proteins have also been widely applied in various clinical studies of cancer, autoimmune diseases and viral infections [26], [27], [28], [29], [30], [31], [32], which will not be covered here.IntroductionIn this article we will review functional protein microarray technologies in yeast.", [["cancer", "ANATOMY", 118, 124], ["cancer", "DISEASE", 118, 124], ["autoimmune diseases", "DISEASE", 126, 145], ["viral infections", "DISEASE", 150, 166], ["human", "ORGANISM", 42, 47], ["cancer", "CANCER", 118, 124], ["[27], [28], [29], [30], [31], [32]", "SIMPLE_CHEMICAL", 173, 207], ["human proteins", "PROTEIN", 42, 56], ["human", "SPECIES", 42, 47], ["yeast", "SPECIES", 329, 334], ["human", "SPECIES", 42, 47], ["yeast", "SPECIES", 329, 334], ["Functional protein microarrays", "TREATMENT", 0, 30], ["human proteins", "TREATMENT", 42, 56], ["cancer", "PROBLEM", 118, 124], ["autoimmune diseases", "PROBLEM", 126, 145], ["viral infections", "PROBLEM", 150, 166], ["functional protein microarray technologies", "TREATMENT", 283, 325], ["cancer", "OBSERVATION", 118, 124]]], ["We cover the various methods for manufacturing of protein microarray, and discuss their applications in studying protein\u2013protein, protein\u2013DNA, protein\u2013small molecule interactions, and protein post-translational modifications (phosphorylation S-nitrosylation and ubiquitination) (Fig. 1).", [["protein\u2013protein, protein\u2013DNA", "PROTEIN", 113, 141], ["manufacturing of protein microarray", "TREATMENT", 33, 68], ["studying protein\u2013protein", "TEST", 104, 128], ["protein\u2013small molecule interactions", "PROBLEM", 143, 178], ["protein post-translational modifications", "TREATMENT", 184, 224], ["phosphorylation S-nitrosylation and ubiquitination)", "TREATMENT", 226, 277]]], ["We will also discuss the advantages and limitations of this technology.Manufacture of high-density protein microarraySince our group generated the first protein microarray covering 5800 ORFs of the budding yeast S. cerevisiae[2], various methods have been developed in protein microarray production.", [["S. cerevisiae", "ORGANISM", 212, 225], ["5800 ORFs", "DNA", 181, 190], ["yeast", "SPECIES", 206, 211], ["S. cerevisiae", "SPECIES", 212, 225], ["yeast", "SPECIES", 206, 211], ["S. cerevisiae", "SPECIES", 212, 225], ["this technology", "TREATMENT", 55, 70], ["the first protein microarray", "TEST", 143, 171], ["various methods", "TREATMENT", 230, 245], ["high-density", "OBSERVATION_MODIFIER", 86, 98], ["protein microarray", "OBSERVATION", 269, 287]]], ["A diagram of the manufacture of protein microarray is shown in Fig. 2.Manufacture of high-density protein microarrayThere are different support surfaces for making protein microarray, including nanowells [33], solid surfaces (such as glass slides) [2], [34], and absorbent surfaces (such as polyacrylamide gel pads) [35].", [["polyacrylamide", "CHEMICAL", 291, 305], ["[34]", "SIMPLE_CHEMICAL", 253, 257], ["protein microarray", "TEST", 32, 50], ["different support surfaces", "TREATMENT", 126, 152], ["protein microarray", "TEST", 164, 182], ["nanowells", "TEST", 194, 203], ["glass slides", "TEST", 234, 246], ["absorbent surfaces", "TREATMENT", 263, 281], ["polyacrylamide gel pads", "TREATMENT", 291, 314], ["high-density", "OBSERVATION_MODIFIER", 85, 97]]], ["The polyacrylamide gel pad technology has not been applied extensively due to cumbersome slide preparation and inconvenient slide handling (e.g. hard to change buffers); similarly, the nanowell surface is less convenient to make and use [17], [36].", [["nanowell surface", "ANATOMY", 185, 201], ["polyacrylamide gel", "CHEMICAL", 4, 22], ["polyacrylamide", "CHEMICAL", 4, 18], ["The polyacrylamide gel pad technology", "TREATMENT", 0, 37], ["cumbersome slide preparation", "TREATMENT", 78, 106]]], ["Currently, the most popular high-density protein microarrays are manufactured on chemically modified or coated glass microscope slides (e.g. nitrocellulose or amino-silane-coated slides) using a standard contact printer [22], [25].", [["amino-silane", "CHEMICAL", 159, 171], ["nitrocellulose", "CHEMICAL", 141, 155], ["amino-silane", "CHEMICAL", 159, 171], ["amino-silane", "SIMPLE_CHEMICAL", 159, 171], ["amino-silane-coated slides", "TREATMENT", 159, 185], ["density protein microarrays", "OBSERVATION", 33, 60]]], ["This format is compatible with many commercial scanners.", [["compatible with", "UNCERTAINTY", 15, 30]]], ["It is noteworthy that, even within this format, different surface chemistries have different attributes in terms of their protein binding ability, protein function/folding and background, and one has to carefully choose the optimal surface that best fits the specific need of the experiment [21].", [["surface", "ANATOMY", 58, 65], ["surface", "ANATOMY", 232, 239], ["different surface chemistries", "PROBLEM", 48, 77]]], ["For example, stronger protein attachment, such as gold-coated glass surface [37] or reactive surfaces with bifunctional cross-linkers [2] can retain the proteins firmly on the surface with covalent cross-linking, but may decrease their activity due to steric hindrance or disruption of proper folding; however, these surfaces will allow detection methods such as Surface Plasmon Resonance or mass spectrometry to study the dynamics of biochemical reactions on these proteins [21].", [["surface", "ANATOMY", 176, 183], ["gold", "CHEMICAL", 50, 54], ["surface", "CELLULAR_COMPONENT", 176, 183], ["stronger protein attachment", "PROBLEM", 13, 40], ["gold-coated glass surface", "TEST", 50, 75], ["bifunctional cross-linkers", "TREATMENT", 107, 133], ["steric hindrance", "PROBLEM", 252, 268], ["proper folding", "PROBLEM", 286, 300], ["detection methods", "TEST", 337, 354], ["Surface Plasmon Resonance", "TREATMENT", 363, 388], ["mass spectrometry", "PROBLEM", 392, 409], ["biochemical reactions", "PROBLEM", 435, 456], ["these proteins", "TEST", 460, 474], ["reactive", "OBSERVATION_MODIFIER", 84, 92], ["surfaces", "OBSERVATION_MODIFIER", 93, 101], ["steric hindrance", "OBSERVATION", 252, 268], ["proper folding", "OBSERVATION", 286, 300]]], ["In addition, we found that amino-silane-coated glass slides provide the highest signal-to-noise ratio in kinase studies [25].Manufacture of high-density protein microarrayProteins for functional microarrays are either produced individually prior to printing [2] or produced in situ by coupling in vitro transcription and translation of DNA that is printed directly on the surface of the array (e.g. the Nucleic Acid Programmable Protein Array, NAPPA) [38].", [["surface", "ANATOMY", 372, 379], ["amino-silane", "CHEMICAL", 27, 39], ["amino-silane", "CHEMICAL", 27, 39], ["amino-silane", "SIMPLE_CHEMICAL", 27, 39], ["DNA", "CELLULAR_COMPONENT", 336, 339], ["surface", "CELLULAR_COMPONENT", 372, 379], ["amino-silane-coated glass slides", "TREATMENT", 27, 59], ["the highest signal", "TEST", 68, 86], ["kinase studies", "TEST", 105, 119], ["functional microarrays", "PROBLEM", 184, 206], ["vitro transcription", "TREATMENT", 297, 316], ["DNA", "PROBLEM", 336, 339], ["high-density", "OBSERVATION_MODIFIER", 140, 152]]], ["Our group has built two collections of full-length yeast genes cloned in expression plasmids that produce either N-terminal GST (glutathione-S-transferase) -tagged or C-terminal TAP (tandem affinity purification) -tagged fusion proteins [39], [40].", [["plasmids", "ANATOMY", 84, 92], ["glutathione", "CHEMICAL", 129, 140], ["N-", "CHEMICAL", 113, 115], ["glutathione", "CHEMICAL", 129, 140], ["S", "CHEMICAL", 141, 142], ["C-", "CHEMICAL", 167, 169], ["GST", "GENE_OR_GENE_PRODUCT", 124, 127], ["glutathione-S-transferase", "GENE_OR_GENE_PRODUCT", 129, 154], ["TAP", "GENE_OR_GENE_PRODUCT", 178, 181], ["full-length yeast genes", "DNA", 39, 62], ["expression plasmids", "DNA", 73, 92], ["N-terminal GST", "PROTEIN", 113, 127], ["glutathione-S-transferase", "PROTEIN", 129, 154], ["C-terminal TAP", "PROTEIN", 167, 181], ["tandem affinity purification) -tagged fusion proteins", "PROTEIN", 183, 236], ["yeast", "SPECIES", 51, 56], ["yeast", "SPECIES", 51, 56], ["full-length yeast genes", "TREATMENT", 39, 62], ["expression plasmids", "TREATMENT", 73, 92], ["N-terminal GST", "TEST", 113, 127], ["glutathione", "TEST", 129, 140], ["C-terminal TAP (tandem affinity purification", "TREATMENT", 167, 211], ["tagged fusion proteins", "TEST", 214, 236]]], ["The recombinant yeast proteins are expressed in individual yeast clones in a 96-well format, and purified using corresponding affinity tags (GST or TAP).", [["clones", "ANATOMY", 65, 71], ["yeast clones", "CELL", 59, 71], ["GST", "GENE_OR_GENE_PRODUCT", 141, 144], ["TAP", "GENE_OR_GENE_PRODUCT", 148, 151], ["recombinant yeast proteins", "PROTEIN", 4, 30], ["yeast clones", "CELL_LINE", 59, 71], ["GST", "PROTEIN", 141, 144], ["TAP", "PROTEIN", 148, 151], ["yeast", "SPECIES", 16, 21], ["yeast", "SPECIES", 59, 64], ["yeast", "SPECIES", 16, 21], ["yeast", "SPECIES", 59, 64], ["The recombinant yeast proteins", "PROBLEM", 0, 30], ["individual yeast clones", "PROBLEM", 48, 71], ["TAP", "TREATMENT", 148, 151], ["yeast proteins", "OBSERVATION", 16, 30], ["yeast clones", "OBSERVATION", 59, 71]]], ["The purified proteins are then arrayed with a 48-pin ESI contact printer on nitrocellulose or amino-silane-coated glass slides in an addressable, high-density format.", [["amino-silane", "CHEMICAL", 94, 106], ["nitrocellulose", "CHEMICAL", 76, 90], ["amino-silane", "CHEMICAL", 94, 106], ["amino-silane", "SIMPLE_CHEMICAL", 94, 106], ["purified proteins", "PROTEIN", 4, 21], ["nitrocellulose", "TREATMENT", 76, 90], ["amino-silane-coated glass slides", "TREATMENT", 94, 126], ["high-density", "OBSERVATION_MODIFIER", 146, 158]]], ["The detailed protein microarray manufacture protocols can be found in references [22], [25].", [["The detailed protein microarray manufacture protocols", "TREATMENT", 0, 53]]], ["In addition to the yeast functional microarrays, we have also produced an Arabidopsis array [41], [42] and a coronavirus array [26].", [["coronavirus", "ORGANISM", 109, 120], ["yeast", "SPECIES", 19, 24], ["yeast", "SPECIES", 19, 24], ["Arabidopsis", "SPECIES", 74, 85], ["the yeast functional microarrays", "PROBLEM", 15, 47], ["an Arabidopsis array", "TEST", 71, 91], ["a coronavirus array", "TEST", 107, 126]]], ["Invitrogen has produced a human protein array which currently contains more than 9000 proteins (expressed individually using Baculovirus/sf9 expression systems).", [["Invitrogen", "CHEMICAL", 0, 10], ["Invitrogen", "GENE_OR_GENE_PRODUCT", 0, 10], ["human", "ORGANISM", 26, 31], ["Baculovirus", "ORGANISM", 125, 136], ["sf9", "GENE_OR_GENE_PRODUCT", 137, 140], ["9000 proteins", "PROTEIN", 81, 94], ["Baculovirus", "PROTEIN", 125, 136], ["sf9", "PROTEIN", 137, 140], ["human", "SPECIES", 26, 31], ["human", "SPECIES", 26, 31], ["a human protein array", "PROBLEM", 24, 45], ["Baculovirus/sf9 expression systems", "TREATMENT", 125, 159]]], ["With a similar method, the group led by Heng Zhu at the Johns Hopkins University also fabricated an Escherichia coli proteome chip containing 4256 proteins encoded by the K12 strain, which is the first reported prokaryotic proteome microarray [43].", [["Escherichia coli", "ORGANISM", 100, 116], ["K12", "GENE_OR_GENE_PRODUCT", 171, 174], ["4256 proteins", "PROTEIN", 142, 155], ["Escherichia coli", "SPECIES", 100, 116], ["Escherichia coli", "SPECIES", 100, 116], ["an Escherichia coli proteome chip", "TREATMENT", 97, 130], ["the K12 strain", "PROBLEM", 167, 181], ["Escherichia coli", "OBSERVATION", 100, 116]]], ["Working with Chuan He's group at the University of Chicago, the authors identified proteins with DNA damage-recognizing activity by probing this array with DNA probes containing a single base-mismatch or an abasic site, which included the known cold-shock DNA-binding protein CspE, and proteins with previous unknown functions, such as YbcN and YbaZ [43].", [["Chuan", "CHEMICAL", 13, 18], ["DNA", "CELLULAR_COMPONENT", 97, 100], ["DNA", "CELLULAR_COMPONENT", 156, 159], ["DNA", "CELLULAR_COMPONENT", 256, 259], ["CspE", "GENE_OR_GENE_PRODUCT", 276, 280], ["YbcN", "GENE_OR_GENE_PRODUCT", 336, 340], ["YbaZ [43]", "GENE_OR_GENE_PRODUCT", 345, 354], ["DNA probes", "DNA", 156, 166], ["abasic site", "DNA", 207, 218], ["cold-shock DNA-binding protein", "PROTEIN", 245, 275], ["CspE", "PROTEIN", 276, 280], ["YbcN", "PROTEIN", 336, 340], ["YbaZ", "PROTEIN", 345, 349], ["Chuan", "SPECIES", 13, 18], ["DNA damage", "PROBLEM", 97, 107], ["DNA probes", "TREATMENT", 156, 166], ["an abasic site", "PROBLEM", 204, 218], ["the known cold-shock DNA", "PROBLEM", 235, 259], ["binding protein CspE", "PROBLEM", 260, 280], ["mismatch", "OBSERVATION", 192, 200], ["abasic site", "OBSERVATION", 207, 218], ["shock DNA", "OBSERVATION", 250, 259]]], ["In this study, the authors further validated the function of YbcN and YbaZ with biochemical analyses, and identified the potential binding partner of YbaZ with the same arrays, demonstrating great potentials of functional protein microarrays.", [["YbcN", "GENE_OR_GENE_PRODUCT", 61, 65], ["YbaZ", "GENE_OR_GENE_PRODUCT", 70, 74], ["YbaZ", "GENE_OR_GENE_PRODUCT", 150, 154], ["YbcN", "PROTEIN", 61, 65], ["YbaZ", "PROTEIN", 70, 74], ["YbaZ", "PROTEIN", 150, 154], ["this study", "TEST", 3, 13], ["YbcN", "TREATMENT", 61, 65], ["biochemical analyses", "TEST", 80, 100], ["functional protein microarrays", "TREATMENT", 211, 241]]], ["The approach of producing proteins and directly spotting them has the following advantages: first of all, in vivo expression of the proteins may help ensure their proper folding and post-translational modifications; second, the individual expression clones allow us to perform single protein quality control, if needed, over the overexpressed collections compared to the coupled transcription-translation method developed by LaBaer et al. [38].", [["the proteins", "TREATMENT", 128, 140], ["single protein quality control", "TREATMENT", 277, 307], ["the overexpressed collections", "PROBLEM", 325, 354], ["the coupled transcription", "TREATMENT", 367, 392], ["translation method", "TREATMENT", 393, 411]]], ["In contrast, the NAPPA method by LaBaer et al. excels in the simplified steps with coupled in vitro, on-slide transcription and translation of the proteins, which saves considerable time and effort [38].Manufacture of high-density protein microarrayVarious detection and data acquisition methods for protein microarray are used to meet different purposes of proteomic studies.", [["the NAPPA method", "TREATMENT", 13, 29], ["protein microarray", "TEST", 300, 318], ["proteomic studies", "TEST", 358, 375], ["high-density", "OBSERVATION_MODIFIER", 218, 230]]], ["For protein\u2013protein, protein\u2013DNA and protein\u2013small molecule interaction studies, these arrays are usually probed with fluorescently labeled molecules and the signals are then acquired with a confocal laser scanner [2], [44], [45].", [["protein\u2013DNA", "SIMPLE_CHEMICAL", 21, 32], ["fluorescently labeled molecules", "PROTEIN", 118, 149], ["protein\u2013protein", "TEST", 4, 19], ["protein\u2013DNA", "TEST", 21, 32], ["protein\u2013small molecule interaction studies", "TEST", 37, 79]]], ["These interactions can also be detected with oligonucleotide-conjugated probes followed by Rolling Circle Amplification [46].", [["oligonucleotide-conjugated probes", "TREATMENT", 45, 78]]], ["For kinase assays, isotope-labeled ATP and autoradiography film exposure are often used for data acquisition [25], [33], [47].Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarrayBecause of its unique features, protein microarrays provide a powerful and convenient platform to study protein\u2013protein, protein\u2013nucleic acid and protein\u2013small molecule interaction networks.", [["ATP", "CHEMICAL", 35, 38], ["protein\u2013nucleic acid", "CHEMICAL", 353, 373], ["ATP", "CHEMICAL", 35, 38], ["ATP", "SIMPLE_CHEMICAL", 35, 38], ["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 156, 167], ["protein\u2013nucleic acid", "SIMPLE_CHEMICAL", 353, 373], ["protein\u2013protein, protein\u2013dna and protein\u2013small molecule", "PROTEIN", 139, 194], ["protein\u2013protein, protein\u2013nucleic acid and protein\u2013small molecule interaction networks", "PROTEIN", 336, 421], ["kinase assays", "TEST", 4, 17], ["isotope-labeled ATP", "TEST", 19, 38], ["autoradiography film exposure", "TEST", 43, 72], ["Detection", "TEST", 126, 135], ["protein\u2013protein", "TEST", 139, 154], ["protein\u2013dna", "TEST", 156, 167], ["protein\u2013small molecule interactions", "PROBLEM", 172, 207], ["protein microarrays", "TEST", 264, 283], ["study protein\u2013protein", "TEST", 330, 351], ["protein\u2013nucleic acid", "TREATMENT", 353, 373], ["protein\u2013small molecule interaction networks", "PROBLEM", 378, 421]]], ["Unlike DNA and RNA, whose functional information depends mainly on the sequence of individual molecules (with the exception of ribozymes), the function and proper regulation of proteins often requires their 3-dimensional conformation and post-translational modifications.", [["DNA", "CELLULAR_COMPONENT", 7, 10], ["Unlike DNA and RNA", "PROBLEM", 0, 18], ["ribozymes", "TREATMENT", 127, 136], ["post-translational modifications", "TREATMENT", 238, 270]]], ["Moreover, the function of proteins also depends heavily on their binding partners in the functional complexes.", [["functional complexes", "PROTEIN", 89, 109]]], ["Therefore, to completely understand the function of a given protein, it is critical to know the information on its interaction to various molecular species in the living cells, whether they are other proteins, nucleic acids, and small molecules.Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarrayMuch of the potential protein\u2013protein interaction information in yeast was obtained by yeast two-hybrid approaches [48], [49], which is very labor-intensive.", [["cells", "ANATOMY", 170, 175], ["nucleic acids", "CHEMICAL", 210, 223], ["cells", "CELL", 170, 175], ["nucleic acids", "SIMPLE_CHEMICAL", 210, 223], ["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 275, 286], ["living cells", "CELL_TYPE", 163, 175], ["protein\u2013dna", "PROTEIN", 275, 286], ["yeast", "SPECIES", 416, 421], ["yeast", "SPECIES", 438, 443], ["yeast", "SPECIES", 416, 421], ["yeast", "SPECIES", 438, 443], ["nucleic acids", "TEST", 210, 223], ["small molecules", "PROBLEM", 229, 244], ["Detection", "TEST", 245, 254], ["protein\u2013protein", "TEST", 258, 273], ["protein\u2013dna", "TEST", 275, 286], ["protein\u2013small molecule interactions", "PROBLEM", 291, 326], ["protein microarrayMuch", "TEST", 333, 355], ["very labor", "PROBLEM", 487, 497], ["small molecules", "OBSERVATION", 229, 244], ["very", "OBSERVATION_MODIFIER", 487, 491], ["labor", "OBSERVATION", 492, 497]]], ["Currently the most comprehensive protein\u2013protein binary interaction data in S. cerevisiae were obtained by Yu et al. [50], by performing high-throughput yeast two-hybrid screening with 3917 bait proteins and 5246 prey proteins, which yielded 1809 interactions among 1278 proteins.", [["S. cerevisiae", "ORGANISM", 76, 89], ["3917 bait proteins", "PROTEIN", 185, 203], ["5246 prey proteins", "PROTEIN", 208, 226], ["1278 proteins", "PROTEIN", 266, 279], ["S. cerevisiae", "SPECIES", 76, 89], ["yeast", "SPECIES", 153, 158], ["S. cerevisiae", "SPECIES", 76, 89], ["hybrid screening", "TEST", 163, 179], ["bait proteins", "TEST", 190, 203], ["prey proteins", "TEST", 213, 226]]], ["Ninety-four randomly chosen interactions were validated with a precision rate of 94\u2013100% in this study.", [["a precision rate", "TEST", 61, 77], ["this study", "TEST", 92, 102]]], ["In addition, a high quality binary protein interaction map was generated in combination with other available data sets including the \u201cUetz-screen\u201d by Uetz et al. [49], the \u201cIto-score\u201d by Ito et al. [51], and high-throughput affinity purification/mass spectrometry data sets by Gavin et al. [4] and Krogan et al. [5].Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarrayProtein microarray has many advantages over the yeast two-hybrid method in studying protein interactions.", [["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 346, 357], ["yeast", "SPECIES", 470, 475], ["yeast", "SPECIES", 470, 475], ["a high quality binary protein interaction map", "PROBLEM", 13, 58], ["et al.", "TEST", 191, 197], ["mass spectrometry data sets", "PROBLEM", 246, 273], ["Detection", "TEST", 316, 325], ["protein\u2013protein", "TEST", 329, 344], ["protein\u2013dna", "TEST", 346, 357], ["protein\u2013small molecule interactions", "PROBLEM", 362, 397], ["protein microarray", "TEST", 404, 422], ["Protein microarray", "TEST", 422, 440]]], ["First, once made, its in vitro nature does not require yeast culture, transformation and mating, which greatly saves time and effort.", [["yeast", "SPECIES", 55, 60], ["yeast", "SPECIES", 55, 60], ["yeast culture", "TEST", 55, 68]]], ["Second, it uses fluorescently labeled probes instead of reporter genes, therefore the interaction signal can be readily quantified with a laser scanner in a matter of minutes, and the relative fluorescence intensity can also reflect the binding strength of the two interacting proteins.", [["reporter genes", "DNA", 56, 70], ["interacting proteins", "PROTEIN", 265, 285], ["a laser scanner", "TREATMENT", 136, 151], ["the relative fluorescence intensity", "PROBLEM", 180, 215]]], ["Moreover, protein microarray also allows many types of molecules to be used as probes (e.g. DNA and small molecules) besides proteins or peptides as compared with the yeast two-hybrid method which only allows detection of protein\u2013protein interactions.Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarraySince its inception, our group has long been interested in pursuing protein\u2013protein and protein\u2013small molecule interaction networks [2].", [["DNA", "CELLULAR_COMPONENT", 92, 95], ["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 281, 292], ["protein\u2013protein, protein\u2013dna and protein\u2013small molecule", "PROTEIN", 264, 319], ["yeast", "SPECIES", 167, 172], ["yeast", "SPECIES", 167, 172], ["protein microarray", "TEST", 10, 28], ["many types of molecules", "PROBLEM", 41, 64], ["probes (e.g. DNA and small molecules", "PROBLEM", 79, 115], ["proteins or peptides", "PROBLEM", 125, 145], ["protein\u2013protein interactions", "PROBLEM", 222, 250], ["Detection", "TEST", 251, 260], ["protein\u2013protein", "TEST", 264, 279], ["protein\u2013dna", "TEST", 281, 292], ["protein\u2013small molecule interactions", "PROBLEM", 297, 332], ["protein microarraySince", "TREATMENT", 339, 362], ["protein\u2013protein", "TREATMENT", 425, 440]]], ["We obtained the binding profile of calmodulin by probing the array with biotinylated calmodulin and Cy3-labeled streptavidin.", [["Cy3", "CHEMICAL", 100, 103], ["calmodulin", "GENE_OR_GENE_PRODUCT", 35, 45], ["calmodulin", "GENE_OR_GENE_PRODUCT", 85, 95], ["Cy3", "SIMPLE_CHEMICAL", 100, 103], ["streptavidin", "GENE_OR_GENE_PRODUCT", 112, 124], ["calmodulin", "PROTEIN", 35, 45], ["calmodulin", "PROTEIN", 85, 95], ["Cy3-labeled streptavidin", "PROTEIN", 100, 124], ["biotinylated calmodulin", "TREATMENT", 72, 95], ["Cy3-labeled streptavidin", "TREATMENT", 100, 124]]], ["Calmodulin is an important calcium binding protein which is highly conserved between species and participates in the regulation of many signaling pathways [52].", [["calcium", "CHEMICAL", 27, 34], ["calcium", "CHEMICAL", 27, 34], ["Calmodulin", "GENE_OR_GENE_PRODUCT", 0, 10], ["calcium", "SIMPLE_CHEMICAL", 27, 34], ["Calmodulin", "PROTEIN", 0, 10], ["calcium binding protein", "PROTEIN", 27, 50], ["Calmodulin", "TREATMENT", 0, 10], ["an important calcium binding protein", "PROBLEM", 14, 50]]], ["With this high throughput method, we identified 33 previously unknown potential binding partners of calmodulin, as well as a novel binding-motif, (I/L)QXXK(K/X)GB for this protein (Fig. 2 in ref.", [["calmodulin", "GENE_OR_GENE_PRODUCT", 100, 110], ["K/X)GB", "GENE_OR_GENE_PRODUCT", 156, 162], ["calmodulin", "PROTEIN", 100, 110], ["novel binding-motif", "PROTEIN", 125, 144], ["Fig. 2", "PROTEIN", 181, 187], ["this protein", "PROBLEM", 167, 179]]], ["Meanwhile, to test the possibility of detecting protein\u2013small molecule interactions, we also probed these arrays with phosphoinositide (PI), a well known secondary messenger lipid.", [["phosphoinositide", "CHEMICAL", 118, 134], ["phosphoinositide", "CHEMICAL", 118, 134], ["phosphoinositide", "SIMPLE_CHEMICAL", 118, 134], ["PI", "SIMPLE_CHEMICAL", 136, 138], ["lipid", "SIMPLE_CHEMICAL", 174, 179], ["protein\u2013small molecule interactions", "PROBLEM", 48, 83], ["phosphoinositide (PI)", "TREATMENT", 118, 139], ["molecule interactions", "OBSERVATION", 62, 83], ["secondary messenger lipid", "OBSERVATION", 154, 179]]], ["We identified 150 novel lipid-binding proteins, which include membrane-associated proteins as well as proteins involved in glucose metabolism [2].", [["membrane", "ANATOMY", 62, 70], ["glucose", "CHEMICAL", 123, 130], ["glucose", "CHEMICAL", 123, 130], ["lipid-binding proteins", "GENE_OR_GENE_PRODUCT", 24, 46], ["membrane", "CELLULAR_COMPONENT", 62, 70], ["glucose", "SIMPLE_CHEMICAL", 123, 130], ["lipid-binding proteins", "PROTEIN", 24, 46], ["membrane-associated proteins", "PROTEIN", 62, 90], ["novel lipid-binding proteins", "TEST", 18, 46], ["membrane-associated proteins", "PROBLEM", 62, 90]]], ["Our study was the first to show the capability of protein microarray technology to pursue protein\u2013protein and protein\u2013small molecule interactions.Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarraySince its first debut a decade ago, protein microarray technology has been used to discover protein interacting partners/networks in a wide range of applications.", [["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 176, 187], ["protein interacting partners", "PROTEIN", 344, 372], ["Our study", "TEST", 0, 9], ["protein microarray technology", "TREATMENT", 50, 79], ["protein\u2013protein", "TREATMENT", 90, 105], ["protein\u2013small molecule interactions", "PROBLEM", 110, 145], ["Detection", "TEST", 146, 155], ["protein\u2013protein", "TEST", 159, 174], ["protein\u2013dna", "TEST", 176, 187], ["protein\u2013small molecule interactions", "PROBLEM", 192, 227], ["protein microarray", "TEST", 234, 252], ["protein microarray technology", "TEST", 288, 317], ["protein\u2013small molecule interactions", "OBSERVATION", 110, 145]]], ["For detecting protein\u2013protein interactions, Hesselberth et al. identified interacting proteins of the WW domain in S. cerevisiae[53].", [["S. cerevisiae", "ORGANISM", 115, 128], ["interacting proteins", "PROTEIN", 74, 94], ["WW domain", "PROTEIN", 102, 111], ["S. cerevisiae", "SPECIES", 115, 128], ["S. cerevisiae", "SPECIES", 115, 128]]], ["The WW domain is a highly conserved domain in many organisms including yeast and human.", [["human", "ORGANISM", 81, 86], ["WW domain", "PROTEIN", 4, 13], ["yeast", "SPECIES", 71, 76], ["human", "SPECIES", 81, 86], ["yeast", "SPECIES", 71, 76], ["human", "SPECIES", 81, 86], ["The WW domain", "PROBLEM", 0, 13], ["yeast", "PROBLEM", 71, 76]]], ["Proteins containing these domains are involved in many cellular processes including cell cycle regulation, targeted protein degradation and transcription activation [54], [55], [56].", [["cellular", "ANATOMY", 55, 63], ["cell", "ANATOMY", 84, 88], ["cellular", "CELL", 55, 63], ["cell", "CELL", 84, 88], ["Proteins containing these domains", "PROBLEM", 0, 33], ["cell cycle regulation", "TEST", 84, 105], ["targeted protein degradation", "PROBLEM", 107, 135], ["transcription activation", "TEST", 140, 164], ["cellular processes", "OBSERVATION", 55, 73], ["cell cycle", "OBSERVATION", 84, 94]]], ["There are 10 WW domain-containing proteins (with 13 WW domains) in S. cerevisiae, including Prp40 which is involved in mRNA splicing, the ubiquitin ligases Rsp5 and SSm4, the histone methyltransferase Set2, the peptidyl-prolyl isomerase Ess1, and proteins with still unknown functions such as YPR152C, Wwm1, Aus1, Vid30 and Alg9 [53].", [["prolyl", "CHEMICAL", 220, 226], ["S. cerevisiae", "ORGANISM", 67, 80], ["Prp40", "GENE_OR_GENE_PRODUCT", 92, 97], ["Rsp5", "GENE_OR_GENE_PRODUCT", 156, 160], ["SSm4", "GENE_OR_GENE_PRODUCT", 165, 169], ["histone methyltransferase", "GENE_OR_GENE_PRODUCT", 175, 200], ["Set2", "GENE_OR_GENE_PRODUCT", 201, 205], ["peptidyl-prolyl isomerase", "GENE_OR_GENE_PRODUCT", 211, 236], ["Ess1", "GENE_OR_GENE_PRODUCT", 237, 241], ["YPR152C", "GENE_OR_GENE_PRODUCT", 293, 300], ["Wwm1", "GENE_OR_GENE_PRODUCT", 302, 306], ["Aus1", "GENE_OR_GENE_PRODUCT", 308, 312], ["Vid30", "GENE_OR_GENE_PRODUCT", 314, 319], ["Alg9 [53]", "GENE_OR_GENE_PRODUCT", 324, 333], ["WW domain-containing proteins", "PROTEIN", 13, 42], ["13 WW domains", "PROTEIN", 49, 62], ["Prp40", "PROTEIN", 92, 97], ["ubiquitin ligases", "PROTEIN", 138, 155], ["Rsp5", "PROTEIN", 156, 160], ["SSm4", "PROTEIN", 165, 169], ["histone methyltransferase", "PROTEIN", 175, 200], ["Set2", "PROTEIN", 201, 205], ["peptidyl-prolyl isomerase", "PROTEIN", 211, 236], ["Ess1", "PROTEIN", 237, 241], ["YPR152C", "PROTEIN", 293, 300], ["Wwm1", "PROTEIN", 302, 306], ["Aus1", "PROTEIN", 308, 312], ["Vid30", "PROTEIN", 314, 319], ["Alg9", "PROTEIN", 324, 328], ["S. cerevisiae", "SPECIES", 67, 80], ["S. cerevisiae", "SPECIES", 67, 80], ["Prp40", "TREATMENT", 92, 97], ["the ubiquitin ligases Rsp5", "TEST", 134, 160], ["SSm4", "TEST", 165, 169], ["the histone methyltransferase", "TEST", 171, 200], ["the peptidyl-prolyl isomerase Ess1", "TEST", 207, 241], ["Aus1", "TEST", 308, 312], ["Vid30", "TEST", 314, 319], ["Alg9", "TEST", 324, 328]]], ["Hesselberth et al. determined the binding partners of 12 of the 13 WW domains by probing them on the yeast protein arrays, and identified 587 high-confidence interactions with 207 proteins [53].", [["13 WW domains", "PROTEIN", 64, 77], ["207 proteins", "PROTEIN", 176, 188], ["yeast", "SPECIES", 101, 106], ["yeast", "SPECIES", 101, 106], ["the yeast protein arrays", "TEST", 97, 121]]], ["These WW-domain interaction proteins are enriched in cofactor metabolism, peroxisome localization, and ER localization with Gene Ontology annotation classifications, suggesting their potential functions.", [["peroxisome", "CELLULAR_COMPONENT", 74, 84], ["ER", "GENE_OR_GENE_PRODUCT", 103, 105], ["WW-domain interaction proteins", "PROTEIN", 6, 36], ["ER", "PROTEIN", 103, 105], ["These WW", "TEST", 0, 8], ["domain interaction proteins", "PROBLEM", 9, 36], ["peroxisome localization", "TEST", 74, 97], ["cofactor metabolism", "OBSERVATION", 53, 72]]], ["They compared their protein microarray findings with yeast two-hybrid and affinity-purification/mass spectrometry data available at that time and identified 19 unreported interacting partners.", [["yeast", "SPECIES", 53, 58], ["yeast", "SPECIES", 53, 58], ["yeast", "TEST", 53, 58], ["purification/mass spectrometry data", "TEST", 83, 118]]], ["Interestingly they also found that some WW-domain containing proteins, such as Rsp5, Alg9, Wwm1 and Ssm4 also have conserved WW-domain binding motifs, which suggested possible multimerization between these proteins.", [["Rsp5", "GENE_OR_GENE_PRODUCT", 79, 83], ["Alg9", "GENE_OR_GENE_PRODUCT", 85, 89], ["Wwm1", "GENE_OR_GENE_PRODUCT", 91, 95], ["Ssm4", "GENE_OR_GENE_PRODUCT", 100, 104], ["WW-domain containing proteins", "PROTEIN", 40, 69], ["Rsp5", "PROTEIN", 79, 83], ["Alg9", "PROTEIN", 85, 89], ["Wwm1", "PROTEIN", 91, 95], ["Ssm4", "PROTEIN", 100, 104], ["WW-domain binding motifs", "PROTEIN", 125, 149], ["some WW-domain containing proteins", "PROBLEM", 35, 69], ["Rsp5", "TEST", 79, 83], ["domain binding motifs", "PROBLEM", 128, 149], ["multimerization between these proteins", "PROBLEM", 176, 214], ["possible", "UNCERTAINTY", 167, 175], ["multimerization", "OBSERVATION", 176, 191]]], ["Using a similar approach, Galindo et al. also identified 4 binding partners for the Aeromonas hydrophila cytotoxic enterotoxin Act in yeast, one of which was the vesicle tethering protein Vsp52, indicating that Act might mediate its function through interfering with vesicle transport of the host cells [57].", [["vesicle", "ANATOMY", 162, 169], ["vesicle", "ANATOMY", 267, 274], ["cells", "ANATOMY", 297, 302], ["Aeromonas hydrophila", "ORGANISM", 84, 104], ["enterotoxin", "GENE_OR_GENE_PRODUCT", 115, 126], ["vesicle", "CELLULAR_COMPONENT", 162, 169], ["Vsp52", "GENE_OR_GENE_PRODUCT", 188, 193], ["vesicle", "CELLULAR_COMPONENT", 267, 274], ["cells", "CELL", 297, 302], ["Aeromonas hydrophila cytotoxic enterotoxin", "PROTEIN", 84, 126], ["vesicle tethering protein", "PROTEIN", 162, 187], ["Vsp52", "PROTEIN", 188, 193], ["Act", "PROTEIN", 211, 214], ["host cells", "CELL_TYPE", 292, 302], ["Aeromonas hydrophila", "SPECIES", 84, 104], ["yeast", "SPECIES", 134, 139], ["Aeromonas hydrophila", "SPECIES", 84, 104], ["yeast", "SPECIES", 134, 139], ["a similar approach", "TREATMENT", 6, 24], ["Galindo et al", "TREATMENT", 26, 39], ["the Aeromonas hydrophila cytotoxic enterotoxin", "TREATMENT", 80, 126]]], ["Protein microarray technology can also be used for specific protein quantification.", [["Protein microarray technology", "TEST", 0, 29], ["specific protein quantification", "TEST", 51, 82]]], ["Park et al. fabricated an antibody protein microarray (named by the authors as \u201creverse-phase protein microarray\u201d), and quantified the protein N-myc Downstream Regulated Gene 2 (NDRG2) in hepatocellular carcinoma patients and normal controls and observed significant lower expression of this protein in cancerous tissues [58].Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarrayProtein microarrays have also been used to identify protein-nucleic acid interactions.", [["hepatocellular carcinoma", "ANATOMY", 188, 212], ["cancerous tissues", "ANATOMY", 303, 320], ["hepatocellular carcinoma", "DISEASE", 188, 212], ["N-myc Downstream Regulated Gene 2", "GENE_OR_GENE_PRODUCT", 143, 176], ["NDRG2", "GENE_OR_GENE_PRODUCT", 178, 183], ["hepatocellular carcinoma", "CANCER", 188, 212], ["patients", "ORGANISM", 213, 221], ["cancerous tissues", "TISSUE", 303, 320], ["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 356, 367], ["nucleic acid", "SIMPLE_CHEMICAL", 492, 504], ["antibody protein", "PROTEIN", 26, 42], ["protein N-myc Downstream Regulated Gene 2", "PROTEIN", 135, 176], ["NDRG2", "DNA", 178, 183], ["patients", "SPECIES", 213, 221], ["an antibody protein microarray", "TEST", 23, 53], ["the protein N", "TEST", 131, 144], ["myc Downstream", "TEST", 145, 159], ["hepatocellular carcinoma", "PROBLEM", 188, 212], ["this protein in cancerous tissues", "PROBLEM", 287, 320], ["Detection", "TEST", 326, 335], ["protein\u2013protein", "TEST", 339, 354], ["protein\u2013dna", "TEST", 356, 367], ["protein\u2013small molecule interactions", "PROBLEM", 372, 407], ["protein microarray", "TEST", 414, 432], ["Protein microarrays", "TEST", 432, 451], ["protein", "TEST", 484, 491], ["nucleic acid interactions", "PROBLEM", 492, 517], ["hepatocellular", "ANATOMY", 188, 202], ["carcinoma", "OBSERVATION", 203, 212], ["significant", "OBSERVATION_MODIFIER", 255, 266], ["lower expression", "OBSERVATION_MODIFIER", 267, 283], ["cancerous tissues", "OBSERVATION", 303, 320]]], ["Our group probed the yeast protein microarray with Cy3-labeled single-stranded (ssDNA) or double-stranded (dsDNA) yeast genomic DNA and identified 84 ssDNA-binding, 58 dsDNA binding, and 131 ssDNA and dsDNA-binding proteins (schematic design shown in Fig. 1 as well as Fig. 1 in ref.", [["Cy3", "CHEMICAL", 51, 54], ["Cy3", "SIMPLE_CHEMICAL", 51, 54], ["DNA", "CELLULAR_COMPONENT", 128, 131], ["Cy3-labeled single-stranded (ssDNA) or double-stranded (dsDNA) yeast genomic DNA", "DNA", 51, 131], ["dsDNA-binding proteins", "PROTEIN", 201, 223], ["yeast", "SPECIES", 21, 26], ["yeast", "SPECIES", 114, 119], ["yeast", "SPECIES", 21, 26], ["yeast", "SPECIES", 114, 119], ["the yeast protein microarray", "TEST", 17, 45], ["Cy3", "TEST", 51, 54], ["double-stranded (dsDNA) yeast genomic DNA", "PROBLEM", 90, 131], ["ssDNA", "TEST", 150, 155], ["dsDNA binding", "TEST", 168, 181], ["ssDNA", "TEST", 191, 196], ["dsDNA", "TEST", 201, 206], ["binding proteins", "TEST", 207, 223], ["Fig", "OBSERVATION", 269, 272]]], ["We chose 8 proteins previously unreported for their DNA-binding activity for further validation, and 3 proteins were confirmed by Chromatin-Immunoprecipitation followed by probing genomic DNA microarrays (ChIP-Chip; [60]).", [["DNA", "CELLULAR_COMPONENT", 52, 55], ["Chromatin", "CELLULAR_COMPONENT", 130, 139], ["DNA", "CELLULAR_COMPONENT", 188, 191], ["further validation", "TEST", 77, 95], ["genomic DNA microarrays (ChIP-Chip", "TREATMENT", 180, 214]]], ["Of the 3 validated proteins, Arg5,6 was found to bind both mitochondrial (15 S ribosomal DNA, COX1, COX3, and COB1) and nuclear genes (PUF4, PHO23 and THI13), and participate in both transcription elongation and RNA-processing.", [["mitochondrial", "ANATOMY", 59, 72], ["nuclear", "ANATOMY", 120, 127], ["Arg5,6", "GENE_OR_GENE_PRODUCT", 29, 35], ["mitochondrial", "CELLULAR_COMPONENT", 59, 72], ["ribosomal", "CELLULAR_COMPONENT", 79, 88], ["DNA", "CELLULAR_COMPONENT", 89, 92], ["COX1", "GENE_OR_GENE_PRODUCT", 94, 98], ["COX3", "GENE_OR_GENE_PRODUCT", 100, 104], ["COB1", "GENE_OR_GENE_PRODUCT", 110, 114], ["nuclear", "CELLULAR_COMPONENT", 120, 127], ["PUF4", "GENE_OR_GENE_PRODUCT", 135, 139], ["PHO23", "GENE_OR_GENE_PRODUCT", 141, 146], ["THI13", "GENE_OR_GENE_PRODUCT", 151, 156], ["Arg5,6", "PROTEIN", 29, 35], ["mitochondrial (15 S ribosomal DNA", "DNA", 59, 92], ["COX1", "DNA", 94, 98], ["COX3", "DNA", 100, 104], ["COB1", "DNA", 110, 114], ["nuclear genes", "DNA", 120, 133], ["PUF4", "DNA", 135, 139], ["PHO23", "DNA", 141, 146], ["THI13", "DNA", 151, 156], ["S ribosomal DNA", "TEST", 77, 92], ["COX1", "TEST", 94, 98], ["COX3", "TEST", 100, 104], ["PHO23", "TEST", 141, 146], ["elongation", "OBSERVATION_MODIFIER", 197, 207]]], ["Using a similar approach, Hu et al. identified conserved DNA motif-binding proteins using a protein microarray containing 4191 human proteins [61].", [["DNA", "CELLULAR_COMPONENT", 57, 60], ["human", "ORGANISM", 127, 132], ["conserved DNA motif-binding proteins", "PROTEIN", 47, 83], ["4191 human proteins", "PROTEIN", 122, 141], ["human", "SPECIES", 127, 132], ["human", "SPECIES", 127, 132], ["a similar approach", "TREATMENT", 6, 24], ["a protein microarray", "TEST", 90, 110], ["human proteins", "TEST", 127, 141]]], ["Interestingly, besides known transcription factors, they also identified over 300 previously unknown or unexpected DNA-binding proteins, including ERK2, a multifaceted mitogen-activated protein kinase [62], which also acts as a transcription repressor in the interferon gamma signaling pathway.", [["DNA", "CELLULAR_COMPONENT", 115, 118], ["ERK2", "GENE_OR_GENE_PRODUCT", 147, 151], ["mitogen-activated protein kinase [62", "GENE_OR_GENE_PRODUCT", 168, 204], ["interferon gamma", "GENE_OR_GENE_PRODUCT", 259, 275], ["transcription factors", "PROTEIN", 29, 50], ["DNA-binding proteins", "PROTEIN", 115, 135], ["ERK2", "PROTEIN", 147, 151], ["multifaceted mitogen-activated protein kinase", "PROTEIN", 155, 200], ["transcription repressor", "PROTEIN", 228, 251], ["interferon gamma", "PROTEIN", 259, 275], ["known transcription factors", "PROBLEM", 23, 50], ["unexpected DNA-binding proteins", "PROBLEM", 104, 135], ["ERK2", "TEST", 147, 151], ["a multifaceted mitogen", "TEST", 153, 175], ["activated protein kinase", "TEST", 176, 200], ["a transcription repressor", "TREATMENT", 226, 251], ["the interferon gamma signaling pathway", "TREATMENT", 255, 293], ["transcription factors", "OBSERVATION", 29, 50]]], ["Another interesting study was reported by Zhu et al. on the identification and validation of binding proteins to the clamped adenine motif (CAM) of Brome mosaic virus (BMV), a model positive-strand RNA plant virus [63].", [["adenine", "CHEMICAL", 125, 132], ["adenine", "CHEMICAL", 125, 132], ["adenine", "SIMPLE_CHEMICAL", 125, 132], ["CAM", "MULTI-TISSUE_STRUCTURE", 140, 143], ["Brome mosaic virus", "ORGANISM", 148, 166], ["BMV", "ORGANISM", 168, 171], ["binding proteins", "PROTEIN", 93, 109], ["clamped adenine motif", "DNA", 117, 138], ["Brome mosaic virus", "SPECIES", 148, 166], ["BMV", "SPECIES", 168, 171], ["Another interesting study", "TEST", 0, 25], ["the identification", "TEST", 56, 74], ["binding proteins", "TREATMENT", 93, 109], ["the clamped adenine motif (CAM", "TREATMENT", 113, 143], ["Brome mosaic virus", "PROBLEM", 148, 166], ["a model positive-strand RNA plant virus", "PROBLEM", 174, 213]]], ["As BMV can also replicate in S. cerevisiae, the authors probed the yeast proteome array (containing ~ 5000 purified proteins) with both Cy3-labeled CAM-containing RNA and a Cy5-labeled control, and identified 12 hits that showed equal or stronger signals than BMV's own capsid protein (CP).", [["BMV", "ORGANISM", 3, 6], ["S. cerevisiae", "ORGANISM", 29, 42], ["Cy3", "SIMPLE_CHEMICAL", 136, 139], ["CAM", "MULTI-TISSUE_STRUCTURE", 148, 151], ["Cy5", "SIMPLE_CHEMICAL", 173, 176], ["BMV's own capsid protein", "GENE_OR_GENE_PRODUCT", 260, 284], ["purified proteins", "PROTEIN", 107, 124], ["Cy3-labeled CAM-containing RNA", "RNA", 136, 166], ["capsid protein", "PROTEIN", 270, 284], ["CP", "PROTEIN", 286, 288], ["S. cerevisiae", "SPECIES", 29, 42], ["yeast", "SPECIES", 67, 72], ["BMV", "SPECIES", 3, 6], ["S. cerevisiae", "SPECIES", 29, 42], ["yeast", "SPECIES", 67, 72], ["BMV", "SPECIES", 260, 263], ["Cy3-labeled CAM", "TREATMENT", 136, 151], ["RNA", "TREATMENT", 163, 166], ["a Cy5-labeled control", "TREATMENT", 171, 192]]], ["The authors focused on 2 of the 3 strongest binders, Pus4 and App1, and found that they could also inhibit positive-strand RNA accumulation and systemic viral infection in vivo.", [["viral infection", "DISEASE", 153, 168], ["Pus4", "GENE_OR_GENE_PRODUCT", 53, 57], ["App1", "GENE_OR_GENE_PRODUCT", 62, 66], ["Pus4", "PROTEIN", 53, 57], ["App1", "PROTEIN", 62, 66], ["positive-strand RNA accumulation", "PROBLEM", 107, 139], ["systemic viral infection in vivo", "PROBLEM", 144, 176], ["strand RNA accumulation", "OBSERVATION", 116, 139], ["systemic", "OBSERVATION_MODIFIER", 144, 152], ["viral infection", "OBSERVATION", 153, 168]]], ["Their further investigation demonstrated that Pus4 inhibited in vivo viral systemic spread by affecting virion formation through a direct competition with CP.", [["virion", "ANATOMY", 104, 110], ["Pus4", "CHEMICAL", 46, 50], ["Pus4", "CHEMICAL", 46, 50], ["Pus4", "SIMPLE_CHEMICAL", 46, 50], ["virion", "CELLULAR_COMPONENT", 104, 110], ["Their further investigation", "TEST", 0, 27], ["Pus4", "PROBLEM", 46, 50], ["vivo viral systemic spread", "PROBLEM", 64, 90], ["CP", "PROBLEM", 155, 157], ["virion formation", "OBSERVATION", 104, 120]]], ["This study shows a good example of the capability of functional protein microarray in the discovery of interactions of in vivo physiological importance, and in this case, components involved in antiviral response.Detection of protein\u2013protein, protein\u2013dna and protein\u2013small molecule interactions using protein microarrayBesides protein\u2013protein and protein\u2013DNA/RNA discoveries, protein microarrays were also used to identify protein\u2013small molecule interactions.", [["protein\u2013dna", "GENE_OR_GENE_PRODUCT", 243, 254], ["This study", "TEST", 0, 10], ["functional protein microarray", "PROBLEM", 53, 82], ["Detection", "TEST", 213, 222], ["protein\u2013protein", "TEST", 226, 241], ["protein\u2013dna", "TEST", 243, 254], ["protein\u2013small molecule interactions", "PROBLEM", 259, 294], ["protein microarray", "TEST", 301, 319], ["protein\u2013protein", "TEST", 327, 342], ["protein\u2013DNA", "TEST", 347, 358], ["protein microarrays", "TEST", 376, 395], ["protein\u2013small molecule interactions", "PROBLEM", 423, 458], ["antiviral response", "OBSERVATION", 194, 212]]], ["Rapamycin is a small molecule drug that can induce starvation response and inhibit cell growth through its target TOR (Target of Rapamycin), a highly conserved kinase regulating cell proliferation and metabolism, in yeast and humans [64].", [["cell", "ANATOMY", 83, 87], ["cell", "ANATOMY", 178, 182], ["Rapamycin", "CHEMICAL", 0, 9], ["Rapamycin", "CHEMICAL", 129, 138], ["Rapamycin", "CHEMICAL", 0, 9], ["Rapamycin", "CHEMICAL", 129, 138], ["Rapamycin", "SIMPLE_CHEMICAL", 0, 9], ["cell", "CELL", 83, 87], ["TOR", "GENE_OR_GENE_PRODUCT", 114, 117], ["Target of Rapamycin", "GENE_OR_GENE_PRODUCT", 119, 138], ["cell", "CELL", 178, 182], ["humans", "ORGANISM", 226, 232], ["TOR", "PROTEIN", 114, 117], ["Target of Rapamycin", "PROTEIN", 119, 138], ["yeast", "SPECIES", 216, 221], ["humans", "SPECIES", 226, 232], ["yeast", "SPECIES", 216, 221], ["humans", "SPECIES", 226, 232], ["Rapamycin", "TREATMENT", 0, 9], ["a small molecule drug", "TREATMENT", 13, 34], ["starvation response", "PROBLEM", 51, 70], ["inhibit cell growth", "PROBLEM", 75, 94], ["Rapamycin", "TREATMENT", 129, 138], ["a highly conserved kinase regulating cell proliferation", "PROBLEM", 141, 196], ["kinase regulating cell proliferation", "OBSERVATION", 160, 196]]], ["Rapamycin analogs are promising chemotherapeutic drugs to treat cancer [65].", [["cancer", "ANATOMY", 64, 70], ["Rapamycin", "CHEMICAL", 0, 9], ["cancer", "DISEASE", 64, 70], ["Rapamycin", "CHEMICAL", 0, 9], ["Rapamycin", "SIMPLE_CHEMICAL", 0, 9], ["cancer", "CANCER", 64, 70], ["Rapamycin analogs", "TREATMENT", 0, 17], ["chemotherapeutic drugs", "TREATMENT", 32, 54], ["cancer", "PROBLEM", 64, 70]]], ["Jiang et al. identified small molecules that could enhance (small-molecule enhancers of rapamycin, or SMERs) or inhibit (small-molecule inhibitors of rapamycin, or SMIRs) rapamycin effects in yeast, and discovered intracellular protein targets of two SMIRs, SMIR3 and SMIR4, by probing the yeast protein microarray with biotinylated SMIRs [66].", [["intracellular", "ANATOMY", 214, 227], ["rapamycin", "CHEMICAL", 88, 97], ["rapamycin", "CHEMICAL", 150, 159], ["rapamycin", "CHEMICAL", 171, 180], ["rapamycin", "CHEMICAL", 88, 97], ["rapamycin", "CHEMICAL", 150, 159], ["rapamycin", "CHEMICAL", 171, 180], ["rapamycin", "SIMPLE_CHEMICAL", 88, 97], ["SMERs", "SIMPLE_CHEMICAL", 102, 107], ["rapamycin", "SIMPLE_CHEMICAL", 150, 159], ["SMIRs", "GENE_OR_GENE_PRODUCT", 164, 169], ["rapamycin", "SIMPLE_CHEMICAL", 171, 180], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 214, 227], ["SMIRs", "GENE_OR_GENE_PRODUCT", 251, 256], ["SMIR3", "GENE_OR_GENE_PRODUCT", 258, 263], ["SMIR4", "GENE_OR_GENE_PRODUCT", 268, 273], ["SMIRs", "PROTEIN", 251, 256], ["SMIR3", "PROTEIN", 258, 263], ["SMIR4", "PROTEIN", 268, 273], ["yeast", "SPECIES", 192, 197], ["yeast", "SPECIES", 290, 295], ["yeast", "SPECIES", 192, 197], ["yeast", "SPECIES", 290, 295], ["small molecules", "PROBLEM", 24, 39], ["small-molecule enhancers", "PROBLEM", 60, 84], ["rapamycin", "TREATMENT", 88, 97], ["SMERs", "PROBLEM", 102, 107], ["small-molecule inhibitors", "TREATMENT", 121, 146], ["rapamycin", "TREATMENT", 150, 159], ["SMIRs", "TREATMENT", 164, 169], ["rapamycin effects in yeast", "PROBLEM", 171, 197], ["SMIR4", "TREATMENT", 268, 273], ["the yeast protein microarray", "TEST", 286, 314], ["biotinylated SMIRs", "TEST", 320, 338], ["small", "OBSERVATION_MODIFIER", 24, 29], ["molecules", "OBSERVATION", 30, 39], ["small", "OBSERVATION_MODIFIER", 60, 65], ["small", "OBSERVATION_MODIFIER", 121, 126]]], ["Among the strongest protein targets identified in this study, two proteins, Tep1p and Nir1p, were shown to be components of the TOR signaling pathway, suggesting that the protein array method is capable of detecting specific protein\u2013small molecule interactions.", [["Tep1p", "GENE_OR_GENE_PRODUCT", 76, 81], ["Nir1p", "GENE_OR_GENE_PRODUCT", 86, 91], ["TOR", "GENE_OR_GENE_PRODUCT", 128, 131], ["Tep1p", "PROTEIN", 76, 81], ["Nir1p", "PROTEIN", 86, 91], ["TOR", "PROTEIN", 128, 131], ["this study", "TEST", 50, 60], ["Tep1p", "TEST", 76, 81], ["Nir1p", "TREATMENT", 86, 91], ["the protein array method", "TEST", 167, 191], ["protein\u2013small molecule interactions", "OBSERVATION", 225, 260]]], ["By probing the protein arrays with biotinylated polyanions (two proteins, two compounds, and DNA) Salamat-Miller et al. also identified a total of 893 polyanion-binding proteins in S. cerevisiae[67].", [["DNA", "CELLULAR_COMPONENT", 93, 96], ["S. cerevisiae", "ORGANISM", 181, 194], ["893 polyanion-binding proteins", "PROTEIN", 147, 177], ["S. cerevisiae", "SPECIES", 181, 194], ["S. cerevisiae", "SPECIES", 181, 194], ["the protein arrays", "TREATMENT", 11, 29], ["biotinylated polyanions (two proteins", "TREATMENT", 35, 72]]], ["Interestingly, the polyanions and their binding proteins are found to form a network that is involved in maintaining the structure and activity of the yeast cells.Detection of post-translational modifications using protein microarrayThe proteome ultimately carries out most cellular functions, and is regulated by many different types of post-translational modifications.", [["yeast cells", "ANATOMY", 151, 162], ["cellular", "ANATOMY", 274, 282], ["yeast cells", "CELL", 151, 162], ["cellular", "CELL", 274, 282], ["binding proteins", "PROTEIN", 40, 56], ["yeast cells", "CELL_TYPE", 151, 162], ["yeast", "SPECIES", 151, 156], ["yeast", "SPECIES", 151, 156], ["the polyanions and their binding proteins", "PROBLEM", 15, 56], ["post-translational modifications", "TREATMENT", 176, 208], ["protein microarray", "TEST", 215, 233], ["post-translational modifications", "TREATMENT", 338, 370], ["yeast cells", "OBSERVATION", 151, 162], ["out most", "OBSERVATION_MODIFIER", 265, 273], ["cellular functions", "OBSERVATION", 274, 292], ["many", "OBSERVATION_MODIFIER", 314, 318], ["different types", "OBSERVATION_MODIFIER", 319, 334], ["post-translational modifications", "OBSERVATION", 338, 370]]], ["These modifications include phosphorylation, glycosylation, acetylation, ubiquitination, SUMOylation, and S-nitrilation [68], [69], [70].", [["S-nitrilation [68]", "SIMPLE_CHEMICAL", 106, 124], ["phosphorylation, glycosylation", "TREATMENT", 28, 58], ["acetylation", "TREATMENT", 60, 71], ["ubiquitination", "TREATMENT", 73, 87], ["SUMOylation", "TREATMENT", 89, 100]]], ["Therefore, the status of post-translational modification of the proteome is a snapshot of the dynamic activities of the living cell.Detection of post-translational modifications using protein microarrayThe specific platform of protein microarray makes it ideal to identify proteome-wide potential targets for protein post-translational modification enzymes.", [["cell", "ANATOMY", 127, 131], ["cell", "CELL", 127, 131], ["protein post-translational modification enzymes", "PROTEIN", 309, 356], ["post-translational modifications", "TREATMENT", 145, 177], ["protein microarray", "TEST", 184, 202], ["protein microarray", "TEST", 227, 245], ["protein", "TEST", 309, 316], ["translational modification enzymes", "TEST", 322, 356], ["living cell", "OBSERVATION", 120, 131]]], ["The high throughput format enables screening of potential substrates in the whole or partial proteome in a single assay, and its in vitro nature allows fine and accurate controls over the assay conditions.Detection of post-translational modifications using protein microarrayOf all post-translational modifications, phosphorylation is the most studied.", [["the assay conditions", "TEST", 184, 204], ["post-translational modifications", "TREATMENT", 218, 250], ["protein microarrayOf", "TREATMENT", 257, 277], ["translational modifications", "TREATMENT", 287, 314], ["phosphorylation", "TREATMENT", 316, 331], ["high", "OBSERVATION_MODIFIER", 4, 8]]], ["The kinome, or collection of all kinases in the cell, is responsible for the dynamic phosphorylation of proteins and controls many different cellular processes.", [["cell", "ANATOMY", 48, 52], ["cellular", "ANATOMY", 141, 149], ["cell", "CELL", 48, 52], ["cellular", "CELL", 141, 149], ["kinases", "PROTEIN", 33, 40], ["all kinases in the cell", "PROBLEM", 29, 52], ["the dynamic phosphorylation of proteins", "PROBLEM", 73, 112], ["many different cellular processes", "PROBLEM", 126, 159], ["kinome", "OBSERVATION_MODIFIER", 4, 10], ["all", "OBSERVATION_MODIFIER", 29, 32], ["kinases", "OBSERVATION_MODIFIER", 33, 40], ["cell", "ANATOMY", 48, 52], ["responsible for", "UNCERTAINTY", 57, 72], ["cellular processes", "OBSERVATION", 141, 159]]], ["Levels of kinase activities are likely to be very tightly controlled; indeed Sopko et al. examined the influence of individual overexpression of more than 80% of all yeast genes and observed enrichment of kinases and phosphatases in the list of \u201ctoxic gene set\u201d; a set of genes whose overexpression significantly slowed yeast growth [71].", [["yeast genes", "DNA", 166, 177], ["kinases", "PROTEIN", 205, 212], ["phosphatases", "PROTEIN", 217, 229], ["yeast", "SPECIES", 166, 171], ["yeast", "SPECIES", 320, 325], ["yeast", "SPECIES", 166, 171], ["yeast", "SPECIES", 320, 325], ["Levels of kinase activities", "TEST", 0, 27], ["all yeast genes", "PROBLEM", 162, 177], ["kinases", "TEST", 205, 212], ["phosphatases", "TEST", 217, 229], ["yeast growth", "PROBLEM", 320, 332], ["yeast genes", "OBSERVATION", 166, 177]]], ["Several groups including ours have carried out large-scale studies to identify the substrates of yeast kinases at the proteomic level.", [["yeast kinases", "GENE_OR_GENE_PRODUCT", 97, 110], ["yeast kinases", "PROTEIN", 97, 110], ["yeast", "SPECIES", 97, 102], ["yeast", "SPECIES", 97, 102], ["large-scale studies", "TEST", 47, 66], ["yeast kinases", "PROBLEM", 97, 110], ["yeast kinases", "OBSERVATION", 97, 110]]], ["In 2000 our group screened 119 of the 122 yeast kinases with 17 different substrates (including the kinases themselves for monitoring autophosphorylation) on a prototype of protein microarray [33].", [["122 yeast kinases", "PROTEIN", 38, 55], ["kinases", "PROTEIN", 100, 107], ["yeast", "SPECIES", 42, 47], ["yeast", "SPECIES", 42, 47], ["yeast kinases", "TEST", 42, 55], ["17 different substrates", "PROBLEM", 61, 84], ["the kinases themselves", "TREATMENT", 96, 118], ["monitoring autophosphorylation", "TEST", 123, 153], ["a prototype of protein microarray", "TREATMENT", 158, 191]]], ["The substrates were immobilized onto nanowell protein chips and phosphorylation events were identified by adding 33P-\u03b3-ATP and a specific yeast kinase and exposing the chip to a phosphoimager.", [["33P-\u03b3-ATP", "CHEMICAL", 113, 122], ["33P-\u03b3-ATP", "CHEMICAL", 113, 122], ["33P-\u03b3-ATP", "SIMPLE_CHEMICAL", 113, 122], ["33P", "PROTEIN", 113, 116], ["yeast kinase", "PROTEIN", 138, 150], ["yeast", "SPECIES", 138, 143], ["yeast", "SPECIES", 138, 143], ["The substrates", "TREATMENT", 0, 14], ["nanowell protein chips", "TREATMENT", 37, 59], ["phosphorylation events", "PROBLEM", 64, 86], ["a phosphoimager", "TREATMENT", 176, 191]]], ["We discovered that more than 60% of the kinases autophosphorylated themselves, and 94% of the tested kinases had at least one substrate in vitro, with 32 of them specifically phosphorylating one or two substrates.", [["kinases", "PROTEIN", 40, 47], ["kinases", "PROTEIN", 101, 108], ["the kinases autophosphorylated themselves", "TEST", 36, 77], ["the tested kinases", "TEST", 90, 108]]], ["Twenty-seven kinases were found to phosphorylate poly(Tyr-Glu), which quadrupled the number of identified tyrosine kinases (seven) reported at that time.", [["poly(Tyr-Glu", "CHEMICAL", 49, 61], ["tyrosine", "CHEMICAL", 106, 114], ["poly(Tyr-Glu)", "CHEMICAL", 49, 62], ["tyrosine", "CHEMICAL", 106, 114], ["Tyr-Glu", "SIMPLE_CHEMICAL", 54, 61], ["kinases", "PROTEIN", 13, 20], ["tyrosine kinases", "PROTEIN", 106, 122], ["phosphorylate poly", "TEST", 35, 53], ["tyrosine kinases", "TEST", 106, 122], ["tyrosine kinases", "OBSERVATION", 106, 122]]], ["Moreover, these tyrosine kinases preferentially contain 3 conserved lysines and one conserved methionine near the catalytic region, indicating their potential roles in substrate selection.", [["tyrosine", "CHEMICAL", 16, 24], ["methionine", "CHEMICAL", 94, 104], ["tyrosine", "CHEMICAL", 16, 24], ["lysines", "CHEMICAL", 68, 75], ["methionine", "CHEMICAL", 94, 104], ["methionine", "AMINO_ACID", 94, 104], ["tyrosine kinases", "PROTEIN", 16, 32], ["catalytic region", "PROTEIN", 114, 130], ["these tyrosine kinases", "TREATMENT", 10, 32], ["catalytic", "ANATOMY", 114, 123], ["region", "ANATOMY_MODIFIER", 124, 130], ["substrate selection", "OBSERVATION", 168, 187]]], ["The same method was later used to identify Hrr25p as a kinase for the zinc-finger transcription factor Crz1, which turned out to negatively regulate Crz1 activity and nuclear localization by phosphorylation in vivo [72].", [["nuclear", "ANATOMY", 167, 174], ["zinc", "CHEMICAL", 70, 74], ["Hrr25p", "GENE_OR_GENE_PRODUCT", 43, 49], ["Crz1", "GENE_OR_GENE_PRODUCT", 103, 107], ["Crz1", "GENE_OR_GENE_PRODUCT", 149, 153], ["nuclear", "CELLULAR_COMPONENT", 167, 174], ["Hrr25p", "PROTEIN", 43, 49], ["zinc-finger transcription factor", "PROTEIN", 70, 102], ["Crz1", "PROTEIN", 103, 107], ["Crz1", "PROTEIN", 149, 153], ["the zinc-finger transcription", "TREATMENT", 66, 95], ["nuclear localization", "TEST", 167, 187]]], ["Our group later expanded the study to search for the substrates of 87 different S. cerevisiae kinases in a large set of more than 4400 full-length, functional yeast proteins with a yeast protein microarray containing 4400 yeast proteins [47].", [["S. cerevisiae", "ORGANISM", 80, 93], ["S. cerevisiae kinases", "PROTEIN", 80, 101], ["functional yeast proteins", "PROTEIN", 148, 173], ["4400 yeast proteins", "PROTEIN", 217, 236], ["S. cerevisiae", "SPECIES", 80, 93], ["yeast", "SPECIES", 159, 164], ["yeast", "SPECIES", 181, 186], ["yeast", "SPECIES", 222, 227], ["S. cerevisiae", "SPECIES", 80, 93], ["yeast", "SPECIES", 159, 164], ["yeast", "SPECIES", 181, 186], ["yeast", "SPECIES", 222, 227], ["the study", "TEST", 25, 34], ["the substrates", "TEST", 49, 63], ["cerevisiae kinases", "TEST", 83, 101], ["functional yeast proteins", "PROBLEM", 148, 173], ["a yeast protein microarray", "TEST", 179, 205], ["yeast proteins", "TEST", 222, 236]]], ["In this study we discovered about 4200 phosphorylation events affecting 1325 proteins and generated the first version of the phosphorylation network in yeast (schematic design shown in Fig. 3).", [["1325 proteins", "PROTEIN", 72, 85], ["yeast", "SPECIES", 152, 157], ["yeast", "SPECIES", 152, 157], ["this study", "TEST", 3, 13], ["4200 phosphorylation events", "PROBLEM", 34, 61], ["the phosphorylation network", "TREATMENT", 121, 148]]], ["We found that each kinase had a unique substrate profile and most phosphorylation substrates were recognized by 3 or fewer kinases.", [["kinases", "PROTEIN", 123, 130], ["a unique substrate profile", "PROBLEM", 30, 56], ["most phosphorylation substrates", "PROBLEM", 61, 92]]], ["Even within closely related kinases such as Tpk1, Tpk2 and Tpk3, there seem to be a low overlap between their substrate profiles (only 12.3% of all their identified substrates could be recognized by more than one of the three kinases).", [["Tpk1", "GENE_OR_GENE_PRODUCT", 44, 48], ["Tpk2", "GENE_OR_GENE_PRODUCT", 50, 54], ["Tpk3", "GENE_OR_GENE_PRODUCT", 59, 63], ["kinases", "PROTEIN", 28, 35], ["Tpk1", "PROTEIN", 44, 48], ["Tpk2", "PROTEIN", 50, 54], ["Tpk3", "PROTEIN", 59, 63], ["kinases", "PROTEIN", 226, 233], ["Tpk1", "TEST", 44, 48], ["Tpk2", "TEST", 50, 54], ["Tpk3", "TEST", 59, 63], ["a low overlap between their substrate profiles", "PROBLEM", 82, 128], ["low", "OBSERVATION", 84, 87]]], ["Moreover, we also found that kinases might display distinct substrate preferences when they form complexes with different proteins.", [["kinases", "PROTEIN", 29, 36], ["different proteins", "PROBLEM", 112, 130]]], ["We determined the consensus motifs for 11 kinases in this study using a method developed by Jonassen et al. [73], and further investigated this in a larger scale in a separate study with a rapid peptide screening approach (schematic design shown in Fig. 3), in which we determined the consensus phosphorylation motifs for 61 kinases [74].", [["consensus motifs", "DNA", 18, 34], ["kinases", "PROTEIN", 42, 49], ["consensus phosphorylation motifs", "PROTEIN", 285, 317], ["61 kinases", "PROTEIN", 322, 332], ["this study", "TEST", 53, 63], ["a method", "TREATMENT", 70, 78], ["a separate study", "TEST", 165, 181], ["a rapid peptide screening approach", "TREATMENT", 187, 221]]], ["Lastly, by combining our profiling data with available transcription factor binding and protein interaction data sets [49], [51], [75], [76], [77], [78], [79], we discovered 8 regulatory modules in the phosphorylation network.", [["[51], [75], [76], [77], [78]", "SIMPLE_CHEMICAL", 124, 152], ["[79]", "SIMPLE_CHEMICAL", 154, 158], ["transcription factor", "PROTEIN", 55, 75], ["protein interaction data sets", "TEST", 88, 117]]], ["All of the above indicated that kinases have evolved to have their unique, specific roles in carrying out molecular and cellular functions in the eukaryotic cells.Detection of post-translational modifications using protein microarrayBesides protein microarrays, large-scale profiling of the protein phosphorylation networks was also approached with other methods.", [["cellular", "ANATOMY", 120, 128], ["cells", "ANATOMY", 157, 162], ["cellular", "CELL", 120, 128], ["cells", "CELL", 157, 162], ["kinases", "PROTEIN", 32, 39], ["eukaryotic cells", "CELL_TYPE", 146, 162], ["protein phosphorylation networks", "PROTEIN", 291, 323], ["post-translational modifications", "TREATMENT", 176, 208], ["protein microarray", "TEST", 215, 233], ["protein microarrays", "TEST", 241, 260], ["the protein phosphorylation networks", "PROBLEM", 287, 323], ["cellular functions", "OBSERVATION", 120, 138], ["eukaryotic cells", "OBSERVATION", 146, 162], ["large", "OBSERVATION_MODIFIER", 262, 267]]], ["Instead of direct proteomic approaches, Fiedler et al. determined the epistasis of binary interactions between all yeast kinases, phosphatases and key cellular regulators by building an epistatic miniarray profile (E-MAP) through the generation of double mutants [80].", [["cellular", "ANATOMY", 151, 159], ["cellular", "CELL", 151, 159], ["E-MAP", "GENE_OR_GENE_PRODUCT", 215, 220], ["yeast kinases", "PROTEIN", 115, 128], ["phosphatases", "PROTEIN", 130, 142], ["cellular regulators", "PROTEIN", 151, 170], ["yeast", "SPECIES", 115, 120], ["yeast", "SPECIES", 115, 120], ["direct proteomic approaches", "TREATMENT", 11, 38], ["the epistasis of binary interactions", "PROBLEM", 66, 102], ["all yeast kinases", "TEST", 111, 128], ["phosphatases", "TEST", 130, 142], ["an epistatic miniarray profile", "TEST", 183, 213], ["double mutants", "PROBLEM", 248, 262], ["epistasis", "OBSERVATION", 70, 79]]], ["In this study, by analyzing \u201cTriplet Genetic Motifs\u201d, the authors detected both known (such as Cak1 and its substrates Ctk1 and Smk1) and previously undiscovered (e.g. involvement of Cak1 and Fus3 in the Set2/Rpd3C(S) pathway) interactions with this method.", [["Cak1", "GENE_OR_GENE_PRODUCT", 95, 99], ["Ctk1", "GENE_OR_GENE_PRODUCT", 119, 123], ["Smk1", "GENE_OR_GENE_PRODUCT", 128, 132], ["Cak1", "GENE_OR_GENE_PRODUCT", 183, 187], ["Fus3", "GENE_OR_GENE_PRODUCT", 192, 196], ["Set2", "GENE_OR_GENE_PRODUCT", 204, 208], ["Rpd3C(S)", "GENE_OR_GENE_PRODUCT", 209, 217], ["Cak1", "PROTEIN", 95, 99], ["Ctk1", "PROTEIN", 119, 123], ["Smk1", "PROTEIN", 128, 132], ["Cak1", "PROTEIN", 183, 187], ["Fus3", "PROTEIN", 192, 196], ["Set2", "PROTEIN", 204, 208], ["this study", "TEST", 3, 13], ["Cak1", "TEST", 183, 187], ["Fus3", "TEST", 192, 196], ["this method", "TREATMENT", 245, 256]]], ["Moreover, Korf et al. generated an antibody-based protein microarray, which can be used to monitor time-dependent quantitative changes in the phosphorylation states of individual kinases [81].", [["an antibody", "TEST", 32, 43], ["protein microarray", "TEST", 50, 68], ["dependent quantitative changes", "PROBLEM", 104, 134], ["individual kinases", "TEST", 168, 186]]], ["This method could be applied potentially to monitor many targets at the same time; however, like other antibody protein microarrays, this method significantly depends on the quality and specificity of the antibody pairs for each protein [21].", [["antibody pairs", "PROTEIN", 205, 219], ["This method", "TREATMENT", 0, 11], ["other antibody protein microarrays", "TEST", 97, 131], ["this method", "TEST", 133, 144], ["the antibody pairs", "TEST", 201, 219], ["each protein", "TEST", 224, 236]]], ["Alternatively, the phospho-proteome can also be profiled with quantitative mass spectrometry [82], [83].", [["quantitative mass spectrometry", "TEST", 62, 92]]], ["Soufi et al. identified 5534 unique phospho-peptides associated with the osmotic response of S. cerevisiae with a quantitative high-resolution mass spectrometry of their phospho-proteome, and observed that greater than 15% of these changes occured within 5 min after the start of the treatment, suggesting that phosphorylation of a group of specific proteins is part of the early response to osmotic changes [82].Detection of post-translational modifications using protein microarrayOther post-translational modifications have also been investigated with protein microarray technology.", [["phospho", "CHEMICAL", 36, 43], ["phospho", "CHEMICAL", 170, 177], ["phospho-peptides", "GENE_OR_GENE_PRODUCT", 36, 52], ["S. cerevisiae", "ORGANISM", 93, 106], ["phospho", "PROTEIN", 170, 177], ["S. cerevisiae", "SPECIES", 93, 106], ["S. cerevisiae", "SPECIES", 93, 106], ["unique phospho-peptides", "TREATMENT", 29, 52], ["the treatment", "TREATMENT", 280, 293], ["phosphorylation of a group of specific proteins", "PROBLEM", 311, 358], ["osmotic changes", "PROBLEM", 392, 407], ["post-translational modifications", "TREATMENT", 426, 458], ["protein microarrayOther", "TREATMENT", 465, 488], ["translational modifications", "TREATMENT", 494, 521], ["protein microarray technology", "TREATMENT", 555, 584], ["greater", "OBSERVATION_MODIFIER", 206, 213]]], ["By probing the yeast protein microarray with Concanavalin A or Wheat-Germ Agglutinin, both of which are lectins that bind glycans on proteins, Kung et al. identified 534 glycosylated yeast proteins including 30 mitochondrial proteins and a number of nuclear proteins; 406 of the glycosylated protein were unreported previously [84].", [["mitochondrial", "ANATOMY", 211, 224], ["nuclear", "ANATOMY", 250, 257], ["Concanavalin A", "GENE_OR_GENE_PRODUCT", 45, 59], ["Wheat-Germ Agglutinin", "GENE_OR_GENE_PRODUCT", 63, 84], ["mitochondrial", "CELLULAR_COMPONENT", 211, 224], ["nuclear", "CELLULAR_COMPONENT", 250, 257], ["534 glycosylated yeast proteins", "PROTEIN", 166, 197], ["mitochondrial proteins", "PROTEIN", 211, 233], ["nuclear proteins", "PROTEIN", 250, 266], ["glycosylated protein", "PROTEIN", 279, 299], ["yeast", "SPECIES", 15, 20], ["yeast", "SPECIES", 183, 188], ["yeast", "SPECIES", 15, 20], ["yeast", "SPECIES", 183, 188], ["the yeast protein microarray", "TEST", 11, 39], ["Concanavalin A", "TREATMENT", 45, 59], ["Germ Agglutinin", "PROBLEM", 69, 84], ["glycosylated yeast proteins", "TEST", 170, 197], ["mitochondrial proteins", "TEST", 211, 233], ["nuclear proteins", "TEST", 250, 266], ["the glycosylated protein", "TEST", 275, 299], ["yeast proteins", "OBSERVATION", 183, 197]]], ["Interestingly, they also found that inhibition of glycosylation by N-linked glycosylation inhibitor tunicamycin affected the localization of some mitochondrial proteins, such as Ydr065wp and Lpe10p, which suggests that proper protein glycosylation is important for their normal localization and function.", [["mitochondrial", "ANATOMY", 146, 159], ["tunicamycin", "CHEMICAL", 100, 111], ["N", "CHEMICAL", 67, 68], ["tunicamycin", "CHEMICAL", 100, 111], ["tunicamycin", "SIMPLE_CHEMICAL", 100, 111], ["mitochondrial", "CELLULAR_COMPONENT", 146, 159], ["Ydr065wp", "GENE_OR_GENE_PRODUCT", 178, 186], ["Lpe10p", "GENE_OR_GENE_PRODUCT", 191, 197], ["mitochondrial proteins", "PROTEIN", 146, 168], ["Ydr065wp", "PROTEIN", 178, 186], ["Lpe10p", "PROTEIN", 191, 197], ["glycosylation", "TREATMENT", 50, 63], ["N-linked glycosylation inhibitor tunicamycin", "TREATMENT", 67, 111], ["some mitochondrial proteins", "PROBLEM", 141, 168], ["proper protein glycosylation", "PROBLEM", 219, 247], ["mitochondrial proteins", "OBSERVATION", 146, 168], ["protein glycosylation", "OBSERVATION", 226, 247]]], ["In addition to glycosylation, Tao et al. used an analogous approach to examine poly(ADP-ribosyl)ation in yeast with protein microarray [85].", [["poly(ADP-ribosyl", "CHEMICAL", 79, 95], ["poly(ADP-ribosyl)", "CHEMICAL", 79, 96], ["poly(ADP-ribosyl)", "GENE_OR_GENE_PRODUCT", 79, 96], ["yeast", "SPECIES", 105, 110], ["yeast", "SPECIES", 105, 110], ["glycosylation", "TREATMENT", 15, 28], ["Tao et al", "TREATMENT", 30, 39], ["an analogous approach", "TREATMENT", 46, 67], ["poly(ADP-ribosyl)ation", "TREATMENT", 79, 101], ["protein microarray", "TEST", 116, 134]]], ["Poly(ADP-ribosyl)ation of proteins is usually carried out by the enzyme poly(ADP-ribose) polymerase-1 (PARP-1), a pluripotent enzyme involved in both DNA damage sensing mechanism and regulation of gene expression [86], [87].", [["Poly", "CHEMICAL", 0, 4], ["ADP", "CHEMICAL", 5, 8], ["poly(ADP-ribose", "CHEMICAL", 72, 87], ["Poly(ADP-ribosyl)", "CHEMICAL", 0, 17], ["poly(ADP-ribose)", "CHEMICAL", 72, 88], ["Poly(ADP-ribosyl)", "GENE_OR_GENE_PRODUCT", 0, 17], ["poly(ADP-ribose) polymerase-1", "GENE_OR_GENE_PRODUCT", 72, 101], ["PARP-1", "GENE_OR_GENE_PRODUCT", 103, 109], ["DNA", "CELLULAR_COMPONENT", 150, 153], ["poly(ADP-ribose) polymerase-1 (PARP-1", "PROTEIN", 72, 109], ["pluripotent enzyme", "PROTEIN", 114, 132], ["Poly(ADP-ribosyl)ation of proteins", "TREATMENT", 0, 34], ["the enzyme poly", "TEST", 61, 76], ["ADP-ribose) polymerase", "TEST", 77, 99], ["PARP", "TEST", 103, 107], ["a pluripotent enzyme", "TEST", 112, 132], ["gene expression", "TEST", 197, 212]]], ["The authors identified 33 PARP-1 substrates in this study, including six proteins involved in ribosome biogenesis, indicating that poly(ADP-ribosyl)ation may be required for the normal biogenesis process of the ribosomes.Detection of post-translational modifications using protein microarrayAcetylation and deacetylation of the lysine residues in proteins, especially histones are important events in regulating chromatin-related processes and gene expression, although not much was known for the non-chromatin-associated substrates of these histone acetyltransferases and deacetylases [88], [89].", [["ribosome", "ANATOMY", 94, 102], ["ribosomes", "ANATOMY", 211, 220], ["chromatin", "ANATOMY", 412, 421], ["poly(ADP-ribosyl", "CHEMICAL", 131, 147], ["lysine", "CHEMICAL", 328, 334], ["poly(ADP-ribosyl)", "CHEMICAL", 131, 148], ["lysine", "CHEMICAL", 328, 334], ["PARP-1", "GENE_OR_GENE_PRODUCT", 26, 32], ["ribosome", "CELLULAR_COMPONENT", 94, 102], ["poly(ADP-ribosyl)ation", "GENE_OR_GENE_PRODUCT", 131, 153], ["ribosomes", "CELLULAR_COMPONENT", 211, 220], ["histones", "GENE_OR_GENE_PRODUCT", 368, 376], ["chromatin", "CELLULAR_COMPONENT", 412, 421], ["histone acetyltransferases", "GENE_OR_GENE_PRODUCT", 542, 568], ["PARP", "PROTEIN", 26, 30], ["histones", "PROTEIN", 368, 376], ["chromatin", "DNA", 412, 421], ["histone acetyltransferases", "PROTEIN", 542, 568], ["deacetylases", "PROTEIN", 573, 585], ["this study", "TEST", 47, 57], ["poly(ADP-ribosyl)ation", "TREATMENT", 131, 153], ["post-translational modifications", "TREATMENT", 234, 266], ["protein microarrayAcetylation", "TREATMENT", 273, 302], ["deacetylation", "TREATMENT", 307, 320], ["the lysine residues in proteins", "TREATMENT", 324, 355], ["especially histones", "PROBLEM", 357, 376], ["gene expression", "PROBLEM", 444, 459], ["these histone acetyltransferases", "TREATMENT", 536, 568], ["deacetylases", "TEST", 573, 585], ["ribosome biogenesis", "OBSERVATION", 94, 113], ["post-translational modifications", "OBSERVATION", 234, 266]]], ["Of the many different histone acetyltransferases, only the catalytic enzyme Esa1p in the essential nucleosome acetyltransferase of H4 (NuA4) complex was found required for the viability of the cells, indicating this complex may have additional roles beyond gene expression regulation [90].", [["cells", "ANATOMY", 193, 198], ["histone acetyltransferases", "GENE_OR_GENE_PRODUCT", 22, 48], ["Esa1p", "GENE_OR_GENE_PRODUCT", 76, 81], ["nucleosome", "CELLULAR_COMPONENT", 99, 109], ["acetyltransferase of H4", "GENE_OR_GENE_PRODUCT", 110, 133], ["NuA4", "GENE_OR_GENE_PRODUCT", 135, 139], ["cells", "CELL", 193, 198], ["histone acetyltransferases", "PROTEIN", 22, 48], ["catalytic enzyme", "PROTEIN", 59, 75], ["Esa1p", "PROTEIN", 76, 81], ["essential nucleosome acetyltransferase", "PROTEIN", 89, 127], ["H4 (NuA4) complex", "PROTEIN", 131, 148], ["the catalytic enzyme", "TEST", 55, 75], ["histone acetyltransferases", "OBSERVATION", 22, 48], ["nucleosome acetyltransferase", "OBSERVATION", 99, 127]]], ["By incubating the NuA4 complex with yeast proteome microarrays in the presence of 14C labeled Acetyl-CoA, Lin et al. discovered a large number of novel non-histone substrates for NuA4 and confirmed 13 of them with standard in vitro activity assays [88]; and more importantly, the authors also validated these substrates with in vivo experiments [91]: the levels of acetylated substrates were found decreased dramatically in ESA1 Ts (esa1-531) mutant cells when they were grown at the nonpermissive temperature, which proved that these proteins are real in vivo targets of Esa1p.", [["cells", "ANATOMY", 450, 455], ["14C", "CHEMICAL", 82, 85], ["Acetyl-CoA", "CHEMICAL", 94, 104], ["14C", "CHEMICAL", 82, 85], ["Acetyl-CoA", "CHEMICAL", 94, 104], ["NuA4", "GENE_OR_GENE_PRODUCT", 18, 22], ["14C", "SIMPLE_CHEMICAL", 82, 85], ["Acetyl-CoA", "SIMPLE_CHEMICAL", 94, 104], ["NuA4", "GENE_OR_GENE_PRODUCT", 179, 183], ["esa1-531", "GENE_OR_GENE_PRODUCT", 433, 441], ["Esa1p", "GENE_OR_GENE_PRODUCT", 572, 577], ["NuA4 complex", "PROTEIN", 18, 30], ["non-histone substrates", "PROTEIN", 152, 174], ["NuA4", "PROTEIN", 179, 183], ["ESA1 Ts (esa1-531) mutant cells", "CELL_LINE", 424, 455], ["Esa1p", "PROTEIN", 572, 577], ["yeast", "SPECIES", 36, 41], ["yeast", "SPECIES", 36, 41], ["yeast proteome microarrays", "TREATMENT", 36, 62], ["novel non-histone substrates", "TREATMENT", 146, 174], ["NuA4", "TEST", 179, 183], ["standard in vitro activity assays", "TEST", 214, 247], ["acetylated substrates", "PROBLEM", 365, 386], ["esa1", "TEST", 433, 437], ["mutant cells", "PROBLEM", 443, 455], ["these proteins", "PROBLEM", 529, 543], ["CoA", "ANATOMY", 101, 104], ["large", "OBSERVATION_MODIFIER", 130, 135], ["decreased", "OBSERVATION_MODIFIER", 398, 407], ["nonpermissive temperature", "OBSERVATION_MODIFIER", 484, 509]]], ["The authors then focused on Pck1p (phosphoenolpyruvate carboxykinase), a metabolic enzyme involved in gluconeogenesis, and found that the acetylation of Pck1p is essential for its enzymatic activity and the life span of yeast.", [["phosphoenolpyruvate", "CHEMICAL", 35, 54], ["Pck1p", "GENE_OR_GENE_PRODUCT", 28, 33], ["phosphoenolpyruvate carboxykinase", "GENE_OR_GENE_PRODUCT", 35, 68], ["Pck1p", "GENE_OR_GENE_PRODUCT", 153, 158], ["Pck1p", "PROTEIN", 28, 33], ["phosphoenolpyruvate carboxykinase", "PROTEIN", 35, 68], ["metabolic enzyme", "PROTEIN", 73, 89], ["Pck1p", "PROTEIN", 153, 158], ["yeast", "SPECIES", 220, 225], ["yeast", "SPECIES", 220, 225], ["Pck1p (phosphoenolpyruvate carboxykinase", "TREATMENT", 28, 68], ["a metabolic enzyme", "TEST", 71, 89], ["the acetylation of Pck1p", "PROBLEM", 134, 158], ["its enzymatic activity", "PROBLEM", 176, 198], ["yeast", "PROBLEM", 220, 225]]], ["This study is one of the first to examine an important acetyltransferase complex for non-histone-related regulatory functions in the cell and suggests that histone acetyltransferases and deacetylases may also have other important cellular roles besides chromatin-related processes.", [["cell", "ANATOMY", 133, 137], ["cellular", "ANATOMY", 230, 238], ["chromatin", "ANATOMY", 253, 262], ["acetyltransferase complex", "GENE_OR_GENE_PRODUCT", 55, 80], ["cell", "CELL", 133, 137], ["histone acetyltransferases", "GENE_OR_GENE_PRODUCT", 156, 182], ["cellular", "CELL", 230, 238], ["chromatin", "CELLULAR_COMPONENT", 253, 262], ["acetyltransferase complex", "PROTEIN", 55, 80], ["histone acetyltransferases", "PROTEIN", 156, 182], ["deacetylases", "PROTEIN", 187, 199], ["chromatin", "DNA", 253, 262], ["This study", "TEST", 0, 10], ["histone acetyltransferases", "TREATMENT", 156, 182], ["deacetylases", "TREATMENT", 187, 199], ["histone acetyltransferases", "OBSERVATION", 156, 182]]], ["Moreover, in vivo validation of the acetylation targets of the NuA4 complex suggested that using enzyme complexes instead of individual proteins in protein microarray studies may help identify substrates that are more physiologically relevant.Detection of post-translational modifications using protein microarrayUbiquitination is another critical post-translational modification involved in various cellular processes.", [["cellular", "ANATOMY", 400, 408], ["NuA4", "GENE_OR_GENE_PRODUCT", 63, 67], ["cellular", "CELL", 400, 408], ["NuA4 complex", "PROTEIN", 63, 75], ["enzyme complexes", "PROTEIN", 97, 113], ["enzyme complexes", "TEST", 97, 113], ["protein microarray studies", "TEST", 148, 174], ["post-translational modifications", "PROBLEM", 256, 288], ["protein microarrayUbiquitination", "TREATMENT", 295, 327], ["post-translational modifications", "OBSERVATION", 256, 288], ["cellular processes", "OBSERVATION", 400, 418]]], ["It facilitates proteosome-mediated protein degradation/recycling [92] as well as activation of cell signaling molecules [93].", [["cell", "ANATOMY", 95, 99], ["proteosome", "GENE_OR_GENE_PRODUCT", 15, 25], ["cell", "CELL", 95, 99], ["proteosome", "PROTEIN", 15, 25], ["cell signaling molecules", "PROTEIN", 95, 119], ["mediated protein degradation", "PROBLEM", 26, 54], ["cell signaling molecules", "TEST", 95, 119]]], ["Gupta et al. identified the substrates of Rsp5, a ubiquitin-protein ligase (E3) in yeast by both in vitro ubiquitination and protein interaction assays [94].", [["Rsp5", "GENE_OR_GENE_PRODUCT", 42, 46], ["E3", "GENE_OR_GENE_PRODUCT", 76, 78], ["Rsp5", "PROTEIN", 42, 46], ["ubiquitin-protein ligase", "PROTEIN", 50, 74], ["E3", "PROTEIN", 76, 78], ["yeast", "SPECIES", 83, 88], ["yeast", "SPECIES", 83, 88], ["Rsp5", "TEST", 42, 46], ["a ubiquitin-protein ligase", "TEST", 48, 74], ["protein interaction assays", "TEST", 125, 151]]], ["To identify substrates that could be ubiquitinated by Rsp5, the authors incubated the yeast protein microarrays with Rsp5 and FITC-labeled ubiquitin; alternatively, the arrays were probed with Alexa Fluor 647-labeled Rsp5 to identify interacting proteins.", [["FITC", "CHEMICAL", 126, 130], ["Alexa Fluor 647", "CHEMICAL", 193, 208], ["Rsp5", "GENE_OR_GENE_PRODUCT", 54, 58], ["Rsp5", "GENE_OR_GENE_PRODUCT", 117, 121], ["FITC", "GENE_OR_GENE_PRODUCT", 126, 130], ["ubiquitin", "GENE_OR_GENE_PRODUCT", 139, 148], ["Alexa Fluor 647", "SIMPLE_CHEMICAL", 193, 208], ["Rsp5", "GENE_OR_GENE_PRODUCT", 217, 221], ["Rsp5", "PROTEIN", 54, 58], ["Rsp5", "PROTEIN", 117, 121], ["FITC-labeled ubiquitin", "PROTEIN", 126, 148], ["Alexa Fluor 647-labeled Rsp5", "PROTEIN", 193, 221], ["interacting proteins", "PROTEIN", 234, 254], ["yeast", "SPECIES", 86, 91], ["yeast", "SPECIES", 86, 91], ["the yeast protein microarrays", "TEST", 82, 111], ["Rsp5", "TEST", 117, 121], ["FITC", "TEST", 126, 130], ["Alexa Fluor", "TEST", 193, 204], ["interacting proteins", "PROBLEM", 234, 254]]], ["One hundred and fifty proteins were identified in the ubiquitination assay and 155 in the interaction assay, of which 64 proteins were identified in both sets of experiments.", [["fifty proteins", "TEST", 16, 30], ["the ubiquitination assay", "TEST", 50, 74], ["the interaction assay", "TEST", 86, 107], ["ubiquitination assay", "OBSERVATION", 54, 74]]], ["Of these identified substrates, the authors discovered more details of the known PY motif for Rsp5 binding.", [["Rsp5", "GENE_OR_GENE_PRODUCT", 94, 98], ["PY motif", "PROTEIN", 81, 89], ["Rsp5", "PROTEIN", 94, 98], ["Rsp5 binding", "PROBLEM", 94, 106]]], ["They found that Prolines, Serines and Alanines were enriched in the (L/P)PxY motif (at position x) which may also contribute to substrate specificity.Detection of post-translational modifications using protein microarrayProtein microarray technology was also used for the discovery of other protein post-translational modifications such as S-nitrosylation [95].", [["Prolines", "CHEMICAL", 16, 24], ["Serines", "CHEMICAL", 26, 33], ["Alanines", "CHEMICAL", 38, 46], ["Prolines", "CHEMICAL", 16, 24], ["Serines", "CHEMICAL", 26, 33], ["Alanines", "CHEMICAL", 38, 46], ["Prolines", "SIMPLE_CHEMICAL", 16, 24], ["Serines", "SIMPLE_CHEMICAL", 26, 33], ["Alanines", "SIMPLE_CHEMICAL", 38, 46], ["Serines and Alanines", "TREATMENT", 26, 46], ["the (L/P)PxY motif (at position x)", "TREATMENT", 64, 98], ["post-translational modifications", "TREATMENT", 163, 195], ["protein microarray", "TEST", 202, 220], ["Protein microarray technology", "TEST", 220, 249], ["other protein", "PROBLEM", 285, 298], ["translational modifications", "TREATMENT", 304, 331]]], ["This type of post-translational modification plays an important role in nitric oxide (NO) and endogenous S-nitrosothiol (SNO) signaling, abnormal regulation of which is associated with diseases such as neurological dysfunction and cancer [95], [96], [97].", [["neurological", "ANATOMY", 202, 214], ["cancer", "ANATOMY", 231, 237], ["nitric oxide", "CHEMICAL", 72, 84], ["NO", "CHEMICAL", 86, 88], ["S-nitrosothiol", "CHEMICAL", 105, 119], ["SNO", "CHEMICAL", 121, 124], ["neurological dysfunction", "DISEASE", 202, 226], ["cancer", "DISEASE", 231, 237], ["nitric oxide", "CHEMICAL", 72, 84], ["NO", "CHEMICAL", 86, 88], ["S-nitrosothiol", "CHEMICAL", 105, 119], ["SNO", "CHEMICAL", 121, 124], ["nitric oxide", "SIMPLE_CHEMICAL", 72, 84], ["NO", "SIMPLE_CHEMICAL", 86, 88], ["S-nitrosothiol", "SIMPLE_CHEMICAL", 105, 119], ["SNO", "SIMPLE_CHEMICAL", 121, 124], ["cancer", "CANCER", 231, 237], ["post-translational modification", "TREATMENT", 13, 44], ["nitric oxide", "TREATMENT", 72, 84], ["endogenous S-nitrosothiol (SNO)", "TREATMENT", 94, 125], ["abnormal regulation", "PROBLEM", 137, 156], ["diseases", "PROBLEM", 185, 193], ["neurological dysfunction", "PROBLEM", 202, 226], ["cancer", "PROBLEM", 231, 237], ["post-translational modification", "OBSERVATION", 13, 44]]], ["Using a biotin switch technique that converts SNO to S-biotinylated Cys [98], which is then readily detectable with anti-biotin antibody, Foster et al. identified several hundred SNO-proteins after S-nitrosocysteine treatment of the yeast protein microarrays [95].", [["biotin", "CHEMICAL", 8, 14], ["SNO", "CHEMICAL", 46, 49], ["S-biotinylated Cys", "CHEMICAL", 53, 71], ["S-nitrosocysteine", "CHEMICAL", 198, 215], ["biotin", "CHEMICAL", 8, 14], ["SNO", "CHEMICAL", 46, 49], ["Cys", "CHEMICAL", 68, 71], ["anti-biotin", "CHEMICAL", 116, 127], ["S-nitrosocysteine", "CHEMICAL", 198, 215], ["biotin", "SIMPLE_CHEMICAL", 8, 14], ["SNO", "SIMPLE_CHEMICAL", 46, 49], ["S-biotinylated Cys [98]", "SIMPLE_CHEMICAL", 53, 76], ["anti-biotin", "SIMPLE_CHEMICAL", 116, 127], ["S-nitrosocysteine", "SIMPLE_CHEMICAL", 198, 215], ["anti-biotin antibody", "PROTEIN", 116, 136], ["hundred SNO-proteins", "PROTEIN", 171, 191], ["yeast", "SPECIES", 233, 238], ["yeast", "SPECIES", 233, 238], ["a biotin switch technique", "TREATMENT", 6, 31], ["S-biotinylated Cys", "TEST", 53, 71], ["anti-biotin antibody", "PROBLEM", 116, 136], ["S-nitrosocysteine treatment", "TREATMENT", 198, 225], ["the yeast protein microarrays", "TEST", 229, 258], ["several", "OBSERVATION_MODIFIER", 163, 170], ["hundred SNO", "OBSERVATION_MODIFIER", 171, 182]]], ["These proteins were enriched with proteins with active-site Cys thiols, however, neither secondary structures nor Cys thiol nucleophilicity could explain substrate specificity.", [["Cys thiol", "CHEMICAL", 114, 123], ["Cys", "CHEMICAL", 60, 63], ["thiols", "CHEMICAL", 64, 70], ["Cys", "CHEMICAL", 114, 117], ["thiol", "CHEMICAL", 118, 123], ["Cys thiols", "SIMPLE_CHEMICAL", 60, 70], ["Cys thiol nucleophilicity", "SIMPLE_CHEMICAL", 114, 139], ["These proteins", "TEST", 0, 14], ["Cys thiol nucleophilicity", "PROBLEM", 114, 139], ["thiol nucleophilicity", "OBSERVATION", 118, 139]]], ["The authors then found out that S-nitrosylation efficiency might depend on the stereochemistry and structure of the NO-donor as well as allosteric effectors.Advantages and limitations of protein microarray technologyAs reviewed above, protein microarray technology serves as a powerful and convenient tool in a large-scale, high-throughput manner for proteomic studies such as protein interactions and modifications.", [["NO", "CHEMICAL", 116, 118], ["NO", "CHEMICAL", 116, 118], ["NO", "SIMPLE_CHEMICAL", 116, 118], ["allosteric effectors", "PROTEIN", 136, 156], ["S-nitrosylation efficiency", "PROBLEM", 32, 58], ["protein microarray technology", "TREATMENT", 187, 216], ["proteomic studies", "TEST", 351, 368], ["protein interactions", "TREATMENT", 377, 397], ["S-nitrosylation efficiency", "OBSERVATION", 32, 58], ["allosteric effectors", "OBSERVATION", 136, 156]]], ["The advantages of the protein microarray technology are (also refer to review by Zhu et al. [17]): its convenient and straightforward probing using a wide variety of standard detection platforms, the ability to control and fine-tune experimental conditions, and its unbiased protein target selection (regardless of their endogenous cellular abundance) due to its particular fashion of manufacture.", [["cellular", "ANATOMY", 332, 340], ["cellular", "CELL", 332, 340], ["manufacture", "OBSERVATION", 385, 396]]], ["The latter enables the inclusion of normally underrepresented proteins such as low abundant proteins, membrane and secreted proteins, and conditionally expressed proteins.Advantages and limitations of protein microarray technologyProtein microarray technology also have limitations.", [["membrane", "ANATOMY", 102, 110], ["membrane", "CELLULAR_COMPONENT", 102, 110], ["low abundant proteins", "PROTEIN", 79, 100], ["membrane and secreted proteins", "PROTEIN", 102, 132], ["conditionally expressed proteins", "PROTEIN", 138, 170], ["low abundant proteins", "PROBLEM", 79, 100], ["membrane and secreted proteins", "PROBLEM", 102, 132], ["protein microarray technology", "TREATMENT", 201, 230], ["Protein microarray technology", "TEST", 230, 259]]], ["First, the scope of protein microarray relies heavily on the availability of genomic information of the specific organisms.", [["protein microarray", "TEST", 20, 38]]], ["Therefore, this technology is not capable of covering unknown ORFs/splicing variants, and is unavailable for organisms whose genome information is unknown.", [["ORFs", "DNA", 62, 66], ["splicing variants", "DNA", 67, 84], ["unknown ORFs/splicing variants", "PROBLEM", 54, 84], ["organisms", "PROBLEM", 109, 118], ["splicing variants", "OBSERVATION", 67, 84]]], ["Second, as proteins are purified from the cells, they may contain mixed post-translational modifications or even co-purified interacting proteins, which may interfere with the protein binding, kinase assays and post-translational modification detection.", [["cells", "ANATOMY", 42, 47], ["cells", "CELL", 42, 47], ["co-purified interacting proteins", "PROTEIN", 113, 145], ["mixed post-translational modifications", "PROBLEM", 66, 104], ["co-purified interacting proteins", "PROBLEM", 113, 145], ["the protein binding", "TEST", 172, 191], ["kinase assays", "TEST", 193, 206], ["post-translational modification detection", "TEST", 211, 252], ["mixed", "OBSERVATION_MODIFIER", 66, 71]]], ["In vitro expression methods may avoid contamination from other tightly interacting proteins; however, proteins produced this way may not be properly folded or modified.", [["tightly interacting proteins", "PROTEIN", 63, 91], ["contamination", "PROBLEM", 38, 51], ["other tightly interacting proteins", "PROBLEM", 57, 91]]], ["Third, as protein microarray-based studies are in vitro studies, off-target interactions and modifications that do not normally happen in cell may also occur.", [["cell", "ANATOMY", 138, 142], ["cell", "CELL", 138, 142], ["protein microarray", "TEST", 10, 28], ["based studies", "TEST", 29, 42], ["vitro studies", "TEST", 50, 63]]], ["For this reason protein microarray findings should be validated with more direct methods such as immunoprecipitation, immunoblotting and in vitro and in vivo activity assays.", [["protein microarray findings", "PROBLEM", 16, 43], ["immunoprecipitation", "TREATMENT", 97, 116], ["immunoblotting", "TREATMENT", 118, 132]]], ["Furthermore, as the cost for manufacturing protein microarrays is still high, it can be expensive to study large proteomes such as the human proteome.", [["human", "ORGANISM", 135, 140], ["human", "SPECIES", 135, 140], ["human", "SPECIES", 135, 140], ["manufacturing protein microarrays", "TEST", 29, 62]]], ["Lastly, the specific platform of protein microarray usually allows only one or two probes/enzymes per each assay on a single proteome array, which, with the cost of manufacturing the protein microarrays, limits researchers to investigate only one or a few probes/enzymes at a time.", [["enzymes", "PROTEIN", 90, 97], ["enzymes", "PROTEIN", 263, 270], ["protein microarray", "TEST", 33, 51], ["enzymes", "TEST", 90, 97], ["manufacturing the protein microarrays", "TREATMENT", 165, 202]]], ["This limitation will be significantly alleviated, however, with the drop of manufacturing cost as well as improvements in multiplexing technologies.Closing remarksSince its debut a decade ago, protein microarray technology has evolved into a powerful tool in proteomic studies.", [["manufacturing cost", "TREATMENT", 76, 94], ["protein microarray technology", "TEST", 193, 222], ["proteomic studies", "TEST", 259, 276]]], ["Application of this technology in the model organism S. cerevisiae has led to numerous significant scientific findings at the proteomic level, including protein\u2013protein, protein\u2013DNA and protein\u2013small molecule interactions as well as post-translational modifications.", [["S. cerevisiae", "ORGANISM", 53, 66], ["S. cerevisiae", "SPECIES", 53, 66], ["S. cerevisiae", "SPECIES", 53, 66], ["this technology", "TREATMENT", 15, 30], ["protein\u2013protein", "TEST", 153, 168], ["protein\u2013DNA", "TREATMENT", 170, 181], ["protein\u2013small molecule interactions", "PROBLEM", 186, 221], ["numerous", "OBSERVATION_MODIFIER", 78, 86], ["significant", "OBSERVATION_MODIFIER", 87, 98], ["protein\u2013small molecule interactions", "OBSERVATION", 186, 221], ["post-translational modifications", "OBSERVATION", 233, 265]]], ["Since many of these mechanisms are conserved through evolution, some of these findings are expected to be relevant to those occurring in other organisms, such as plant and human [99].", [["human", "ORGANISM", 172, 177], ["human", "SPECIES", 172, 177], ["human", "SPECIES", 172, 177]]], ["In fact, multiple studies mentioned above have already confirmed the counterparts of their findings in humans [57], [85], [88].Closing remarksThe proteome is only a part of the complex network in a living organism.", [["humans", "ORGANISM", 103, 109], ["humans", "SPECIES", 103, 109], ["humans", "SPECIES", 103, 109], ["multiple studies", "TEST", 9, 25]]], ["It coordinates with the other systems including the genome, the transcriptome, and the metabolome, to carry out complex cellular functions and intercellular communication [100].", [["cellular", "ANATOMY", 120, 128], ["intercellular", "ANATOMY", 143, 156], ["cellular", "CELL", 120, 128]]], ["With the emergence of new high throughput technologies such as next generation high-throughput sequencing [101] and improved mass spectrometry technologies [1], it becomes possible to simultaneously generate integrated networks at the systems level from the same sample sets in a time dependent manner, if desired.", [["new high throughput technologies", "TREATMENT", 22, 54], ["improved mass spectrometry technologies", "PROBLEM", 116, 155]]], ["Time-resolved global networks generated from quantitative data sets of the proteome, the genome, the methylome, the transcriptome and the metabolome, with environmental factors such as the microbiome (Fig. 4), will enable a comprehensive view of miscellaneous biological processes, as well as their roles in natural courses such as development and aging, and in pathogenesis of human diseases such as cancer.", [["cancer", "ANATOMY", 401, 407], ["cancer", "DISEASE", 401, 407], ["human", "ORGANISM", 378, 383], ["cancer", "CANCER", 401, 407], ["human", "SPECIES", 378, 383], ["human", "SPECIES", 378, 383], ["environmental factors", "TREATMENT", 155, 176], ["human diseases", "PROBLEM", 378, 392], ["cancer", "PROBLEM", 401, 407], ["cancer", "OBSERVATION", 401, 407]]]], "5306d1e54bdb040fea797ee3edbefe867ac400f5": [["Human adenoviruses (HAdVs) are highly contagious pathogens with more than 60 serotypes which have been recognized and divided into seven species (A-G) 1 .", [["Human", "ORGANISM", 0, 5], ["adenoviruses", "ORGANISM", 6, 18], ["HAdVs", "GENE_OR_GENE_PRODUCT", 20, 25], ["A-G) 1", "GENE_OR_GENE_PRODUCT", 146, 152], ["Human", "SPECIES", 0, 5], ["Human adenoviruses", "SPECIES", 0, 18], ["HAdVs", "SPECIES", 20, 25], ["Human adenoviruses (HAdVs", "TREATMENT", 0, 25], ["highly contagious pathogens", "PROBLEM", 31, 58], ["contagious", "OBSERVATION_MODIFIER", 38, 48]]], ["At present, human adenovirus infection is mainly characterized by acute respiratory infections, gastrointestinal diseases, ophthalmic infection and genitourinary system illness [2] [3] [4] .", [["respiratory", "ANATOMY", 72, 83], ["gastrointestinal", "ANATOMY", 96, 112], ["genitourinary system", "ANATOMY", 148, 168], ["adenovirus infection", "DISEASE", 18, 38], ["acute respiratory infections", "DISEASE", 66, 94], ["gastrointestinal diseases", "DISEASE", 96, 121], ["ophthalmic infection", "DISEASE", 123, 143], ["genitourinary system illness", "DISEASE", 148, 176], ["human", "ORGANISM", 12, 17], ["adenovirus", "ORGANISM", 18, 28], ["gastrointestinal", "ORGAN", 96, 112], ["human", "SPECIES", 12, 17], ["human adenovirus", "SPECIES", 12, 28], ["human adenovirus infection", "PROBLEM", 12, 38], ["acute respiratory infections", "PROBLEM", 66, 94], ["gastrointestinal diseases", "PROBLEM", 96, 121], ["ophthalmic infection", "PROBLEM", 123, 143], ["genitourinary system illness", "PROBLEM", 148, 176], ["infection", "OBSERVATION", 29, 38], ["acute", "OBSERVATION_MODIFIER", 66, 71], ["respiratory", "ANATOMY", 72, 83], ["infections", "OBSERVATION", 84, 94], ["gastrointestinal", "ANATOMY", 96, 112], ["infection", "OBSERVATION", 134, 143]]], ["Of the HAdV pathogens associated with respiratory disease, HAdV-B (HAdV-3, HAdV-7) and HAdV-C (HAdV-1, HAdV-2, HAdV-5 and HAdV-6) are among the most commonly reported and associated with severe acute respiratory infection (SARI) 5, 6 .", [["respiratory", "ANATOMY", 38, 49], ["respiratory", "ANATOMY", 200, 211], ["HAdV pathogens", "DISEASE", 7, 21], ["respiratory disease", "DISEASE", 38, 57], ["acute respiratory infection", "DISEASE", 194, 221], ["SARI", "DISEASE", 223, 227], ["HAdV", "ORGANISM", 7, 11], ["HAdV-B", "ORGANISM", 59, 65], ["HAdV-3", "ORGANISM", 67, 73], ["HAdV-7", "ORGANISM", 75, 81], ["HAdV-C", "ORGANISM", 87, 93], ["HAdV-1", "ORGANISM", 95, 101], ["HAdV-2", "ORGANISM", 103, 109], ["HAdV-5", "ORGANISM", 111, 117], ["HAdV-6", "ORGANISM", 122, 128], ["HAdV-1", "SPECIES", 95, 101], ["HAdV-B", "SPECIES", 59, 65], ["HAdV-C", "SPECIES", 87, 93], ["HAdV-1", "SPECIES", 95, 101], ["HAdV-5", "SPECIES", 111, 117], ["the HAdV pathogens", "PROBLEM", 3, 21], ["respiratory disease", "PROBLEM", 38, 57], ["HAdV", "PROBLEM", 59, 63], ["HAdV", "TEST", 67, 71], ["HAdV", "TEST", 75, 79], ["HAdV", "PROBLEM", 87, 91], ["HAdV", "TEST", 95, 99], ["HAdV", "PROBLEM", 103, 107], ["HAdV", "PROBLEM", 111, 115], ["HAdV", "PROBLEM", 122, 126], ["severe acute respiratory infection", "PROBLEM", 187, 221], ["HAdV pathogens", "OBSERVATION", 7, 21], ["respiratory disease", "OBSERVATION", 38, 57], ["severe", "OBSERVATION_MODIFIER", 187, 193], ["acute", "OBSERVATION_MODIFIER", 194, 199], ["respiratory", "ANATOMY", 200, 211], ["infection", "OBSERVATION", 212, 221]]]], "57aa2506f588fe98f8288101667810c4a2c3ad13": [["INTRODUCTIONBefore and immediately after hatch, turkey poults are dependent on the lipids and proteins of the egg yolk as main sources of nutrients.", [["egg yolk", "ANATOMY", 110, 118], ["lipids", "SIMPLE_CHEMICAL", 83, 89], ["egg yolk", "ORGAN", 110, 118], ["turkey", "SPECIES", 48, 54], ["poults", "SPECIES", 55, 61], ["turkey", "SPECIES", 48, 54], ["the lipids", "TREATMENT", 79, 89], ["the egg yolk", "TREATMENT", 106, 118]]], ["The yolk is usually depleted within 5 to 6 d posthatch .", [["yolk", "ANATOMY", 4, 8], ["yolk", "ORGANISM_SUBSTANCE", 4, 8], ["usually", "OBSERVATION_MODIFIER", 12, 19], ["depleted", "OBSERVATION", 20, 28]]], ["Thus, progress in the physical and functional development of the gastrointestinal tract (GIT) is necessary to enable newly hatched poults to efficiently utilize nutrients supplied by the diet.", [["gastrointestinal tract", "ANATOMY", 65, 87], ["GIT", "ANATOMY", 89, 92], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 65, 87], ["GIT", "ANATOMICAL_SYSTEM", 89, 92], ["poults", "ORGANISM", 131, 137], ["poults", "SPECIES", 131, 137], ["gastrointestinal tract", "ANATOMY", 65, 87]]], ["Because of distances of shipment or delays in shipment, poults are often subjected to delayed access to feed and water, which may retard the development of the GIT, limiting nutrient utilization and performance of the turkey.", [["GIT", "ANATOMY", 160, 163], ["poults", "ORGANISM", 56, 62], ["GIT", "ORGANISM_SUBDIVISION", 160, 163], ["turkey", "ORGANISM", 218, 224], ["poults", "SPECIES", 56, 62], ["turkey", "SPECIES", 218, 224], ["poults", "SPECIES", 56, 62], ["turkey", "SPECIES", 218, 224], ["GIT", "ANATOMY", 160, 163]]], ["Early access to feed and water after hatch has been shown to be an important factor for subsequent performance (Moran, 1990) .", [["Early access to feed", "TREATMENT", 0, 20]]], ["Moran (1978) reported that depriving poults of feed and water for 24 h posthatch led to reduced BW through 14 wk of age.", [["poults", "ORGANISM", 37, 43], ["poults", "SPECIES", 37, 43]]], ["Uni et al. (1998) reported that withholding feed from chicks for 36 h posthatch resulted initially in retarded growth of all segments of the small intestine.", [["small intestine", "ANATOMY", 141, 156], ["small intestine", "ORGAN", 141, 156], ["growth", "OBSERVATION_MODIFIER", 111, 117], ["all segments", "ANATOMY_MODIFIER", 121, 133], ["small intestine", "ANATOMY", 141, 156]]], ["Murakami et al. (1992) found that delaying access to feed and water slowed the growth of the small intestine and proventriculus in broiler chicks.", [["small intestine", "ANATOMY", 93, 108], ["proventriculus", "ANATOMY", 113, 127], ["small intestine", "ORGAN", 93, 108], ["proventriculus", "ORGAN", 113, 127], ["chicks", "SPECIES", 139, 145], ["small intestine", "ANATOMY", 93, 108], ["proventriculus", "ANATOMY", 113, 127], ["broiler chicks", "OBSERVATION", 131, 145]]], ["Donaldson and Christensen (1991) reported that poults deprived of feed 24 h posthatch had significantly lighter liver weights than fed poults.", [["liver", "ANATOMY", 112, 117], ["poults", "ORGANISM", 47, 53], ["liver", "ORGAN", 112, 117], ["poults", "SPECIES", 47, 53], ["poults", "SPECIES", 135, 141], ["liver", "ANATOMY", 112, 117]]], ["Noy and Sklan (1997) concluded that one effect of delayed placement on both chicks and poults was that the organs of the GIT (crop, small intestine, and large intestine) grew less by 48 h posthatch than did organs of poults or chicks placed immediately on feed and water.", [["organs", "ANATOMY", 107, 113], ["GIT", "ANATOMY", 121, 124], ["small intestine", "ANATOMY", 132, 147], ["intestine", "ANATOMY", 159, 168], ["organs", "ANATOMY", 207, 213], ["poults", "ORGANISM", 87, 93], ["organs", "ORGAN", 107, 113], ["GIT", "ORGANISM_SUBDIVISION", 121, 124], ["small intestine", "ORGAN", 132, 147], ["intestine", "ORGAN", 159, 168], ["organs", "ORGAN", 207, 213], ["poults", "ORGANISM", 217, 223], ["chicks", "SPECIES", 76, 82], ["poults", "SPECIES", 87, 93], ["poults", "SPECIES", 217, 223], ["chicks", "SPECIES", 227, 233], ["poults", "SPECIES", 217, 223], ["delayed placement", "TREATMENT", 50, 67], ["GIT", "ANATOMY", 121, 124], ["small intestine", "ANATOMY", 132, 147], ["intestine", "ANATOMY", 159, 168]]], ["Depriving poults of feed for 48 h posthatch led to reduced uptake of residual yolk and greater yolk weights than was observed with poults given immediate access to feed and water (Moran and Reinhart, 1980; Moran, 1989; Pinchasov and Noy, 1993) .", [["yolk", "ANATOMY", 78, 82], ["yolk", "ANATOMY", 95, 99], ["poults", "ORGANISM", 10, 16], ["yolk", "ORGAN", 78, 82], ["yolk", "ORGANISM_SUBDIVISION", 95, 99], ["poults", "SPECIES", 10, 16], ["poults", "SPECIES", 131, 137], ["poults", "SPECIES", 131, 137], ["reduced uptake of residual yolk", "PROBLEM", 51, 82], ["greater yolk weights", "PROBLEM", 87, 107], ["residual yolk", "OBSERVATION", 69, 82]]], ["Murakami et al. (1992) reported yolk weight decreases of 48 and 41%/d for fed and feed-deprived broiler chicks, respectively.", [["yolk", "ANATOMY", 32, 36], ["yolk", "ORGANISM_SUBDIVISION", 32, 36], ["chicks", "ORGANISM", 104, 110], ["chicks", "SPECIES", 104, 110], ["yolk weight", "TEST", 32, 43], ["decreases", "OBSERVATION_MODIFIER", 44, 53]]], ["Experimentally determined ME n values of diets fed to poults were lowest between 4 and 7 d of age (Sell, 1996) .", [["poults", "ORGANISM", 54, 60], ["poults", "SPECIES", 54, 60], ["poults", "SPECIES", 54, 60]]], ["Weights of the GIT increase more rapidly than BW in young turkeys until 6 d of age.", [["GIT", "ANATOMY", 15, 18], ["GIT", "ORGANISM_SUBDIVISION", 15, 18], ["turkeys", "SPECIES", 58, 65], ["turkeys", "SPECIES", 58, 65], ["Weights", "TEST", 0, 7], ["increase", "OBSERVATION_MODIFIER", 19, 27]]], ["Total activities of pancreatic enzymes increase substantially after hatching, mainly because of increased pancreas weight .", [["pancreatic", "ANATOMY", 20, 30], ["pancreas", "ANATOMY", 106, 114], ["pancreatic", "ORGAN", 20, 30], ["pancreas", "ORGAN", 106, 114], ["pancreatic enzymes", "PROTEIN", 20, 38], ["pancreatic enzymes", "TEST", 20, 38], ["increased pancreas weight", "PROBLEM", 96, 121], ["pancreatic", "ANATOMY", 20, 30], ["pancreas", "ANATOMY", 106, 114]]], ["Absorption of nutrients from the GIT is dependent on digestion, mainly by pancreatic enzyme activity.", [["GIT", "ANATOMY", 33, 36], ["pancreatic", "ANATOMY", 74, 84], ["GIT", "ORGANISM_SUBDIVISION", 33, 36], ["pancreatic", "ORGAN", 74, 84], ["pancreatic", "ANATOMY", 74, 84]]], ["Lack of pancreatic enzymic hydrolysis in the intestinal lumen decreases the apparent digestibility of dietary components (Corring and Bourdon, 1977) .", [["pancreatic", "ANATOMY", 8, 18], ["intestinal lumen", "ANATOMY", 45, 61], ["pancreatic", "ORGAN", 8, 18], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 45, 61], ["pancreatic enzymic hydrolysis in the intestinal lumen", "PROBLEM", 8, 61], ["pancreatic", "ANATOMY", 8, 18], ["enzymic hydrolysis", "OBSERVATION", 19, 37], ["intestinal lumen", "ANATOMY", 45, 61], ["digestibility", "OBSERVATION_MODIFIER", 85, 98], ["dietary", "OBSERVATION_MODIFIER", 102, 109], ["components", "OBSERVATION_MODIFIER", 110, 120]]], ["Siddons (1972) reported that by 16 d of age, chickens deprived of feed for 72 h posthatch had lower total activities of all disaccharidases (maltase, sucrase, isomaltase, and palatinase) in the small intestine than chickens deprived of feed for 24 h posthatch.", [["small intestine", "ANATOMY", 194, 209], ["palatinase", "CHEMICAL", 175, 185], ["chickens", "ORGANISM", 45, 53], ["disaccharidases", "SIMPLE_CHEMICAL", 124, 139], ["maltase", "GENE_OR_GENE_PRODUCT", 141, 148], ["sucrase", "GENE_OR_GENE_PRODUCT", 150, 157], ["isomaltase", "SIMPLE_CHEMICAL", 159, 169], ["palatinase", "SIMPLE_CHEMICAL", 175, 185], ["small intestine", "ORGAN", 194, 209], ["chickens", "ORGANISM", 215, 223], ["disaccharidases", "PROTEIN", 124, 139], ["maltase", "PROTEIN", 141, 148], ["sucrase", "PROTEIN", 150, 157], ["chickens", "SPECIES", 45, 53], ["chickens", "SPECIES", 215, 223], ["chickens", "SPECIES", 45, 53], ["chickens", "SPECIES", 215, 223], ["all disaccharidases", "TREATMENT", 120, 139], ["maltase, sucrase", "TREATMENT", 141, 157], ["isomaltase", "TREATMENT", 159, 169], ["palatinase", "TREATMENT", 175, 185], ["small intestine", "ANATOMY", 194, 209]]], ["The ability of young poultry to utilize certain dietary fats is especially limited for the first few days after hatch, possibly due to limited pancreatic lipase activity (Krogdahl and Sell, 1989) .", [["dietary fats", "ANATOMY", 48, 60], ["pancreatic", "ANATOMY", 143, 153], ["pancreatic", "ORGAN", 143, 153], ["lipase", "GENE_OR_GENE_PRODUCT", 154, 160], ["pancreatic lipase", "PROTEIN", 143, 160], ["limited pancreatic lipase activity", "PROBLEM", 135, 169], ["pancreatic", "ANATOMY", 143, 153], ["lipase", "OBSERVATION", 154, 160]]], ["The production and secretion of digestive enzymes in the posthatch chick could be limiting factors in digestion and subsequently in feed intake and growth (Nitsan et al., 1991) .INTRODUCTIONThe results described above reflect the importance of the supply organs (e.g., intestine, pancreas, and liver) immediately after hatch, demonstrating that the development of the GIT and associated digestive enzyme production may be the limiting factors in posthatch growth.", [["digestive", "ANATOMY", 32, 41], ["organs", "ANATOMY", 255, 261], ["intestine", "ANATOMY", 269, 278], ["pancreas", "ANATOMY", 280, 288], ["liver", "ANATOMY", 294, 299], ["GIT", "ANATOMY", 368, 371], ["digestive", "ANATOMY", 387, 396], ["digestive", "ORGAN", 32, 41], ["chick", "ORGANISM", 67, 72], ["organs", "ORGAN", 255, 261], ["intestine", "ORGAN", 269, 278], ["pancreas", "ORGAN", 280, 288], ["liver", "ORGAN", 294, 299], ["GIT", "ORGAN", 368, 371], ["digestive", "ORGAN", 387, 396], ["digestive enzymes", "PROTEIN", 32, 49], ["chick", "SPECIES", 67, 72], ["secretion of digestive enzymes", "PROBLEM", 19, 49], ["the supply organs (e.g., intestine, pancreas, and liver", "PROBLEM", 244, 299], ["the GIT and associated digestive enzyme production", "PROBLEM", 364, 414], ["intestine", "ANATOMY", 269, 278], ["pancreas", "ANATOMY", 280, 288], ["liver", "ANATOMY", 294, 299], ["GIT", "ANATOMY", 368, 371]]], ["Moreover, limited research has been done to determine the effects of delaying access to feed and water on the development of the GIT of poults.", [["GIT", "ANATOMY", 129, 132], ["GIT", "ORGANISM_SUBDIVISION", 129, 132], ["poults", "ORGANISM", 136, 142], ["poults", "SPECIES", 136, 142], ["delaying access to feed", "TREATMENT", 69, 92]]], ["On the basis of previous research, it was hypothesized that delayed access to feed and water would retard development of the GIT, impairing nutrient utilization and resulting in reduced growth.", [["GIT", "ANATOMY", 125, 128], ["GIT", "ORGAN", 125, 128], ["the GIT", "PROBLEM", 121, 128], ["reduced growth", "PROBLEM", 178, 192], ["GIT", "ANATOMY", 125, 128], ["reduced", "OBSERVATION_MODIFIER", 178, 185], ["growth", "OBSERVATION_MODIFIER", 186, 192]]], ["Two experiments examined the changes in the GIT, digestive enzymes, and BW, and the third experiment evaluated the changes in utilization of dietary energy.Experimental DesignThree experiments were conducted with turkey poults obtained from a commercial hatchery.", [["GIT", "ANATOMY", 44, 47], ["digestive", "ANATOMY", 49, 58], ["GIT", "ORGANISM_SUBDIVISION", 44, 47], ["turkey", "ORGANISM", 213, 219], ["poults", "ORGANISM", 220, 226], ["digestive enzymes", "PROTEIN", 49, 66], ["turkey", "SPECIES", 213, 219], ["poults", "SPECIES", 220, 226], ["turkey", "SPECIES", 213, 219], ["digestive enzymes", "TEST", 49, 66], ["GIT", "ANATOMY", 44, 47]]], ["Poults arrived at the experimental farm approximately 6 h after removal from the hatcher.", [["removal", "TREATMENT", 64, 71]]], ["These placement times were 6, 30, and 54 h after removal of poults from the hatcher (referred to hereafter as posthatch), and these times were when the poults were allowed access to feed and water.", [["poults", "ORGANISM", 60, 66], ["poults", "ORGANISM", 152, 158], ["poults", "SPECIES", 60, 66], ["poults", "SPECIES", 152, 158], ["poults", "SPECIES", 152, 158], ["removal", "TREATMENT", 49, 56], ["poults", "TREATMENT", 60, 66]]], ["Poults of the delayed placement groups (30 and 54 h) were held in shipping boxes until given access to feed and water.", [["the delayed placement groups", "TREATMENT", 10, 38]]], ["At the appropriate times, poults were placed in floor pens (1.2 m 2 ) equipped for brooding (Experiments 1 and 2) or in electrically heated brooder batteries 4 (Experiment 3).", [["poults", "ORGANISM", 26, 32], ["poults", "SPECIES", 26, 32], ["electrically heated brooder batteries", "TREATMENT", 120, 157]]], ["After placement, poults were provided feed and water for ad libitum consumption.", [["poults", "ORGANISM", 17, 23], ["poults", "SPECIES", 17, 23], ["placement", "TREATMENT", 6, 15]]], ["All poults were fed a cornsoybean meal diet formulated to meet or exceed nutrient concentrations recommended by the NRC (1994) ( Table 1) .", [["poults", "ORGANISM", 4, 10], ["poults", "SPECIES", 4, 10], ["All poults", "TREATMENT", 0, 10], ["a cornsoybean meal diet", "TREATMENT", 20, 43], ["nutrient concentrations", "TREATMENT", 73, 96]]], ["The diet fed in Experiments 2 and 3 contained Celite 5 (acid insoluble ash) as an indigestible marker.", [["Celite 5 (acid insoluble ash", "CHEMICAL", 46, 74], ["ash", "SIMPLE_CHEMICAL", 71, 74], ["Celite 5 (acid insoluble ash", "TREATMENT", 46, 74], ["an indigestible marker", "TREATMENT", 79, 101]]], ["One hundred and ninety-two male turkey poults were divided into three groups of 64 poults, such that group weights were similar.", [["turkey", "ORGANISM", 32, 38], ["poults", "ORGANISM", 39, 45], ["poults", "ORGANISM", 83, 89], ["turkey", "SPECIES", 32, 38], ["poults", "SPECIES", 39, 45], ["poults", "SPECIES", 83, 89], ["turkey", "SPECIES", 32, 38]]], ["Room temperatures ranged between 25 to 27 C and poults had access to 35 C under brooder heat lamps for the first 7 d and 32 C for the remaining 3 d of the experiment.", [["poults", "SPECIES", 48, 54], ["Room temperatures", "TEST", 0, 17], ["brooder heat lamps", "TREATMENT", 80, 98]]], ["Weight gain and feed consumption were determined when poults were 1, 2, 3, 4, 5, 6, 8, and 10 d of age.Experimental DesignExperiment 2.", [["Weight gain", "DISEASE", 0, 11], ["poults", "SPECIES", 54, 60], ["Weight gain", "TEST", 0, 11]]], ["Female turkey poults were obtained from a commercial hatchery and 22 poults were placed in each of 18 floor pens (six pens per treatment).", [["turkey", "ORGANISM", 7, 13], ["poults", "ORGANISM", 14, 20], ["poults", "ORGANISM", 69, 75], ["turkey", "SPECIES", 7, 13], ["poults", "SPECIES", 14, 20], ["poults", "SPECIES", 69, 75], ["turkey", "SPECIES", 7, 13], ["poults", "SPECIES", 69, 75], ["a commercial hatchery", "TREATMENT", 40, 61]]], ["Room temperatures ranged between 25 and 29 C, and poults had 6 Halocarbon Laboratories Incorporated, North Augusta, SC 29841.", [["poults", "ORGANISM", 50, 56], ["poults", "SPECIES", 50, 56], ["Room temperatures", "TEST", 0, 17]]], ["7 Kinematica PT 10-35, Brinkman Instruments, Westbury, NY 11590.", [["Kinematica PT", "TEST", 2, 15]]], ["8 Parr Instruments Co., Moline, IL 61265. access to 35, 32, and 29 C under brooder heat lamps for the 1st, 2nd, and 3rd wk, respectively.", [["brooder heat lamps", "TREATMENT", 75, 93]]], ["Weight gain and feed consumption were determined when poults were 7, 14, 21, and 28 d of age.", [["Weight gain", "DISEASE", 0, 11], ["poults", "SPECIES", 54, 60], ["Weight gain", "TEST", 0, 11]]], ["Seventy-two female turkey poults were obtained from a commercial hatchery and randomly assigned to 12 pens (4 pens per treatment, 6 poults per pen).", [["turkey", "ORGANISM", 19, 25], ["poults", "ORGANISM", 26, 32], ["turkey", "SPECIES", 19, 25], ["poults", "SPECIES", 26, 32], ["poults", "SPECIES", 132, 138], ["turkey", "SPECIES", 19, 25]]], ["Room temperatures ranged between 25 and 29 C, and the brooder temperatures were kept at 35 and 32 C for the 1st and 2nd wk, respectively.", [["Room temperatures", "TEST", 0, 17], ["the brooder temperatures", "TEST", 50, 74]]], ["Weight gain and feed consumption were determined when poults were 7 and 14 d of age.", [["Weight gain", "DISEASE", 0, 11], ["poults", "ORGANISM", 54, 60], ["poults", "SPECIES", 54, 60], ["poults", "SPECIES", 54, 60], ["Weight gain", "TEST", 0, 11]]], ["Feed efficiency was calculated as the feed intake to BW gain ratio.SamplingIn Experiments 1 and 2 five poults were sampled at 6 h posthatch for baseline measurements.", [["poults", "ORGANISM", 103, 109], ["poults", "SPECIES", 103, 109], ["SamplingIn Experiments", "TREATMENT", 67, 89]]], ["In Experiment 1, six poults per placement time were selected randomly for sampling when poults were 1, 2, 3, 4, 5, 6, 8, and 10 d of age.", [["poults", "ORGANISM", 21, 27], ["poults", "ORGANISM", 88, 94], ["poults", "SPECIES", 21, 27], ["poults", "SPECIES", 88, 94], ["poults", "SPECIES", 88, 94]]], ["In Experiment 2, 2 poults per pen (12 per treatment) were selected randomly for sampling when poults were 1, 2, 3, 4, 5, 10, 15, and 28 d of age.", [["poults", "ORGANISM", 19, 25], ["poults", "ORGANISM", 94, 100], ["poults", "SPECIES", 19, 25], ["poults", "SPECIES", 94, 100], ["poults", "SPECIES", 94, 100]]], ["The average of two poults per pen was treated as an experimental unit.", [["poults", "ORGANISM", 19, 25], ["poults", "SPECIES", 19, 25], ["average", "OBSERVATION_MODIFIER", 4, 11]]], ["In Experiments 1 and 2, poults were weighed, killed by inhalation of Halothane , 6 and the abdominal cavity opened.", [["abdominal cavity", "ANATOMY", 91, 107], ["Halothane", "CHEMICAL", 69, 78], ["Halothane", "CHEMICAL", 69, 78], ["poults", "ORGANISM", 24, 30], ["Halothane", "SIMPLE_CHEMICAL", 69, 78], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 91, 107], ["poults", "SPECIES", 24, 30], ["Halothane", "TREATMENT", 69, 78], ["abdominal cavity", "ANATOMY", 91, 107]]], ["The residual yolk (with yolk sac) was removed from the GIT and weighed.", [["yolk", "ANATOMY", 13, 17], ["yolk sac", "ANATOMY", 24, 32], ["GIT", "ANATOMY", 55, 58], ["yolk", "ORGAN", 13, 17], ["yolk sac", "ORGAN", 24, 32], ["GIT", "ORGANISM_SUBDIVISION", 55, 58], ["The residual yolk (with yolk sac", "PROBLEM", 0, 32], ["residual yolk", "OBSERVATION", 4, 17], ["yolk sac", "OBSERVATION_MODIFIER", 24, 32], ["GIT", "ANATOMY", 55, 58]]], ["The proventriculus, gizzard, and small intestine were separated, and weights of the proventriculus and gizzard were recorded after ingesta were removed.", [["proventriculus", "ANATOMY", 4, 18], ["gizzard", "ANATOMY", 20, 27], ["small intestine", "ANATOMY", 33, 48], ["proventriculus", "ANATOMY", 84, 98], ["gizzard", "ANATOMY", 103, 110], ["proventriculus", "ORGAN", 4, 18], ["gizzard", "ORGAN", 20, 27], ["small intestine", "ORGAN", 33, 48], ["proventriculus", "ORGAN", 84, 98], ["gizzard", "ORGAN", 103, 110], ["proventriculus", "ANATOMY", 4, 18], ["gizzard", "ANATOMY", 20, 27], ["small intestine", "ANATOMY", 33, 48], ["proventriculus", "ANATOMY", 84, 98]]], ["In Experiment 1, the spleen, heart, and liver were excised and weighed.", [["spleen", "ANATOMY", 21, 27], ["heart", "ANATOMY", 29, 34], ["liver", "ANATOMY", 40, 45], ["spleen", "ORGAN", 21, 27], ["heart", "ORGAN", 29, 34], ["liver", "ORGAN", 40, 45], ["spleen", "ANATOMY", 21, 27], ["heart", "ANATOMY", 29, 34], ["liver", "ANATOMY", 40, 45], ["excised", "OBSERVATION", 51, 58]]], ["In Experiment 2, the bursa of Fabricius was excised and weighed.", [["bursa", "ANATOMY", 21, 26], ["bursa", "ORGAN", 21, 26], ["Fabricius", "ORGAN", 30, 39], ["bursa", "ANATOMY", 21, 26], ["Fabricius", "ANATOMY", 30, 39]]], ["The small intestine with the pancreas was suspended vertically with a weight of 3.5 or 10 g (varying with age) attached to the lower end to apply uniform tension for length measurements.", [["small intestine", "ANATOMY", 4, 19], ["pancreas", "ANATOMY", 29, 37], ["small intestine", "ORGAN", 4, 19], ["pancreas", "ORGAN", 29, 37], ["length measurements", "TEST", 166, 185], ["small intestine", "ANATOMY", 4, 19], ["pancreas", "ANATOMY", 29, 37], ["lower", "ANATOMY_MODIFIER", 127, 132], ["uniform", "OBSERVATION_MODIFIER", 146, 153], ["tension", "OBSERVATION", 154, 161]]], ["For length and weight measurements, the small intestine was divided into three segments: duodenum (from gizzard to entry of the bile and pancreatic ducts), jejunum (from entry of the ducts to yolk stalk), and ileum (from yolk stalk to ileocecal junction).", [["small intestine", "ANATOMY", 40, 55], ["duodenum", "ANATOMY", 89, 97], ["gizzard", "ANATOMY", 104, 111], ["bile", "ANATOMY", 128, 132], ["pancreatic ducts", "ANATOMY", 137, 153], ["jejunum", "ANATOMY", 156, 163], ["ducts", "ANATOMY", 183, 188], ["yolk stalk", "ANATOMY", 192, 202], ["ileum", "ANATOMY", 209, 214], ["yolk stalk", "ANATOMY", 221, 231], ["ileocecal junction", "ANATOMY", 235, 253], ["small intestine", "ORGAN", 40, 55], ["duodenum", "ORGAN", 89, 97], ["gizzard", "ORGANISM_SUBDIVISION", 104, 111], ["bile", "MULTI-TISSUE_STRUCTURE", 128, 132], ["pancreatic ducts", "MULTI-TISSUE_STRUCTURE", 137, 153], ["jejunum", "MULTI-TISSUE_STRUCTURE", 156, 163], ["ducts", "MULTI-TISSUE_STRUCTURE", 183, 188], ["yolk stalk", "MULTI-TISSUE_STRUCTURE", 192, 202], ["ileum", "ORGAN", 209, 214], ["yolk stalk", "MULTI-TISSUE_STRUCTURE", 221, 231], ["ileocecal junction", "MULTI-TISSUE_STRUCTURE", 235, 253], ["length and weight measurements", "TEST", 4, 34], ["small intestine", "ANATOMY", 40, 55], ["duodenum", "ANATOMY", 89, 97], ["bile", "ANATOMY", 128, 132], ["pancreatic ducts", "ANATOMY", 137, 153], ["jejunum", "ANATOMY", 156, 163], ["ducts", "ANATOMY", 183, 188], ["ileum", "ANATOMY", 209, 214], ["ileocecal junction", "ANATOMY", 235, 253]]], ["The pancreas was removed from the duodenal loop, placed in preweighed vials, and immediately frozen in liquid nitrogen.", [["pancreas", "ANATOMY", 4, 12], ["duodenal", "ANATOMY", 34, 42], ["nitrogen", "CHEMICAL", 110, 118], ["pancreas", "ORGAN", 4, 12], ["duodenal loop", "MULTI-TISSUE_STRUCTURE", 34, 47], ["pancreas", "ANATOMY", 4, 12], ["removed", "OBSERVATION", 17, 24], ["duodenal loop", "ANATOMY", 34, 47]]], ["The duodenum and ileum were flushed with 10 to 20 mL of deionized water, and the empty weight recorded.", [["duodenum", "ANATOMY", 4, 12], ["ileum", "ANATOMY", 17, 22], ["duodenum", "MULTI-TISSUE_STRUCTURE", 4, 12], ["ileum", "ORGAN", 17, 22], ["duodenum", "ANATOMY", 4, 12], ["ileum", "ANATOMY", 17, 22], ["flushed", "OBSERVATION", 28, 35]]], ["Because maltase activity of the jejunum was to be determined, this segment was flushed with 10 to 20 mL of saline solution, and the empty weight recorded.", [["jejunum", "ANATOMY", 32, 39], ["maltase", "GENE_OR_GENE_PRODUCT", 8, 15], ["jejunum", "ORGAN", 32, 39], ["saline", "SIMPLE_CHEMICAL", 107, 113], ["maltase", "PROTEIN", 8, 15], ["maltase activity of the jejunum", "PROBLEM", 8, 39], ["saline solution", "TREATMENT", 107, 122], ["jejunum", "ANATOMY", 32, 39]]], ["Approximately 10 cm of the middle portion of the jejunum was placed in preweighed vials and immediately frozen in liquid nitrogen.", [["middle portion", "ANATOMY", 27, 41], ["jejunum", "ANATOMY", 49, 56], ["nitrogen", "CHEMICAL", 121, 129], ["jejunum", "ORGAN", 49, 56], ["liquid nitrogen", "TREATMENT", 114, 129], ["10 cm", "OBSERVATION_MODIFIER", 14, 19], ["middle", "ANATOMY_MODIFIER", 27, 33], ["portion", "ANATOMY_MODIFIER", 34, 41], ["jejunum", "ANATOMY", 49, 56]]], ["Jejunal and pancreatic samples were stored at -20 C until prepared for further analysis.Determination of Enzyme ActivitiesAfter their weights were determined, jejunal and pancreas samples were thawed and homogenized with a Polytron homogenizer 7 at a speed setting of 4 (low to moderate) for 45 s with sufficient cold deionized water to result in a concentration of 50 mg tissue/mL of homogenate.", [["Jejunal", "ANATOMY", 0, 7], ["pancreatic samples", "ANATOMY", 12, 30], ["jejunal", "ANATOMY", 159, 166], ["pancreas samples", "ANATOMY", 171, 187], ["tissue", "ANATOMY", 372, 378], ["homogenate", "ANATOMY", 385, 395], ["Jejunal", "MULTI-TISSUE_STRUCTURE", 0, 7], ["pancreatic samples", "CANCER", 12, 30], ["jejunal", "MULTI-TISSUE_STRUCTURE", 159, 166], ["pancreas samples", "CANCER", 171, 187], ["tissue", "TISSUE", 372, 378], ["Jejunal and pancreatic samples", "TEST", 0, 30], ["further analysis", "TEST", 71, 87], ["Enzyme Activities", "TEST", 105, 122], ["a Polytron homogenizer", "TREATMENT", 221, 243], ["sufficient cold deionized water", "TREATMENT", 302, 333], ["pancreatic", "ANATOMY", 12, 22], ["jejunal", "ANATOMY", 159, 166], ["pancreas", "ANATOMY", 171, 179]]], ["Aliquots of the homogenates were taken for determination of protein concentration (Lowry et al., 1951) and enzyme assays.", [["Aliquots", "ANATOMY", 0, 8], ["homogenates", "ANATOMY", 16, 27], ["the homogenates", "TREATMENT", 12, 27], ["protein concentration", "TEST", 60, 81], ["enzyme assays", "TEST", 107, 120]]], ["Jejuna were assayed for maltase (EC 3.3.1.20) activity by using maltose as a substrate (Dahlquist, 1964) .", [["maltose", "CHEMICAL", 64, 71], ["maltose", "CHEMICAL", 64, 71], ["Jejuna", "SIMPLE_CHEMICAL", 0, 6], ["maltase", "GENE_OR_GENE_PRODUCT", 24, 31], ["maltose", "SIMPLE_CHEMICAL", 64, 71], ["maltase", "PROTEIN", 24, 31], ["Jejuna", "TEST", 0, 6], ["maltase (EC", "TEST", 24, 35]]], ["Pancreas homogenates were analyzed for amylase (EC 3.2.1.1) by using the Phadebas blue starch procedure (Ceska et al., 1969) .", [["Pancreas homogenates", "ANATOMY", 0, 20], ["Pancreas homogenates", "CANCER", 0, 20], ["amylase", "GENE_OR_GENE_PRODUCT", 39, 46], ["amylase", "PROTEIN", 39, 46], ["Pancreas homogenates", "TEST", 0, 20], ["amylase", "TEST", 39, 46], ["EC", "TEST", 48, 50], ["the Phadebas blue starch procedure", "TREATMENT", 69, 103]]], ["Trypsin activity in the pancreas was determined by the method of Erlanger et al. (1966) .", [["pancreas", "ANATOMY", 24, 32], ["Trypsin", "GENE_OR_GENE_PRODUCT", 0, 7], ["pancreas", "ORGAN", 24, 32], ["Trypsin", "PROTEIN", 0, 7], ["Trypsin activity in the pancreas", "PROBLEM", 0, 32], ["pancreas", "ANATOMY", 24, 32]]], ["Amylase, maltase, and trypsin specific activities were expressed as micromoles of substrate hydrolyzed hourly per milligram of tissue protein.", [["tissue", "ANATOMY", 127, 133], ["Amylase", "GENE_OR_GENE_PRODUCT", 0, 7], ["maltase", "GENE_OR_GENE_PRODUCT", 9, 16], ["trypsin", "GENE_OR_GENE_PRODUCT", 22, 29], ["tissue", "TISSUE", 127, 133], ["Amylase", "PROTEIN", 0, 7], ["maltase", "PROTEIN", 9, 16], ["trypsin", "PROTEIN", 22, 29], ["tissue protein", "PROTEIN", 127, 141], ["Amylase", "TEST", 0, 7], ["maltase", "TEST", 9, 16]]], ["Pancreatic lipase activity was determined by the procedure of Nitsan et al. (1974) as modified by Palo (1994) , and specific activities are expressed as milligrams of naphthol released in 60 min at 37 C/g of protein.Determination of Nitrogen-Correcrted Metabolizable EnergyIn Experiment 3, ME n was determined when poults were 4, 7, and 14 d of age.", [["Pancreatic", "ANATOMY", 0, 10], ["naphthol", "CHEMICAL", 167, 175], ["Nitrogen", "CHEMICAL", 233, 241], ["naphthol", "CHEMICAL", 167, 175], ["Nitrogen", "CHEMICAL", 233, 241], ["Pancreatic", "ORGAN", 0, 10], ["lipase", "GENE_OR_GENE_PRODUCT", 11, 17], ["naphthol", "SIMPLE_CHEMICAL", 167, 175], ["Nitrogen", "SIMPLE_CHEMICAL", 233, 241], ["lipase", "PROTEIN", 11, 17], ["poults", "SPECIES", 315, 321], ["Pancreatic lipase activity", "PROBLEM", 0, 26], ["naphthol", "TREATMENT", 167, 175], ["Nitrogen", "TREATMENT", 233, 241], ["lipase activity", "OBSERVATION", 11, 26]]], ["After preliminary drying, feed and excreta samples were ground to pass through a 0.5-mm mesh sieve.", [["excreta samples", "ANATOMY", 35, 50], ["excreta samples", "ORGANISM_SUBSTANCE", 35, 50], ["preliminary drying", "TREATMENT", 6, 24], ["excreta samples", "TEST", 35, 50], ["a 0.5-mm mesh sieve", "TREATMENT", 79, 98]]], ["Dry matter of the feed and excreta was determined by drying the samples in a forceddraft oven at 72 C for 48 h (AOAC, 1980:Section 7.003).", [["samples", "ANATOMY", 64, 71], ["excreta", "ORGANISM_SUBSTANCE", 27, 34], ["a forceddraft oven", "TREATMENT", 75, 93], ["matter", "OBSERVATION", 4, 10]]], ["The gross energy of feed and excreta were determined using an adiabatic bomb calorimeter.", [["excreta", "ORGANISM_SUBSTANCE", 29, 36], ["an adiabatic bomb calorimeter", "TREATMENT", 59, 88], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["energy", "OBSERVATION_MODIFIER", 10, 16]]], ["8 Feed and excreta were analyzed for nitrogen concentration by the macroKjeldahl method; AOAC, 1980:Section 2.057).", [["nitrogen", "CHEMICAL", 37, 45], ["nitrogen", "CHEMICAL", 37, 45], ["excreta", "ORGANISM_SUBSTANCE", 11, 18], ["nitrogen", "SIMPLE_CHEMICAL", 37, 45], ["nitrogen concentration", "TREATMENT", 37, 59]]], ["Nitrogen concentration was multiplied by 6.25 to calculate the protein percentage (AOAC, 1980:Section 14.068).", [["Nitrogen", "CHEMICAL", 0, 8], ["Nitrogen", "CHEMICAL", 0, 8], ["Nitrogen", "SIMPLE_CHEMICAL", 0, 8], ["Nitrogen concentration", "TREATMENT", 0, 22]]], ["The concentration of acid insoluble ash in the feed and excreta was determined by the method described by Vogtmann et al. (1975) .", [["acid insoluble ash", "CHEMICAL", 21, 39], ["excreta", "ORGANISM_SUBSTANCE", 56, 63], ["The concentration of acid insoluble ash", "TREATMENT", 0, 39], ["concentration", "OBSERVATION_MODIFIER", 4, 17], ["acid insoluble", "OBSERVATION_MODIFIER", 21, 35]]], ["The ME n of the diets was calculated using the equation described by Hill and Anderson (1958) .Statistical AnalysisData from Experiments 1, 2, and 3 were analyzed using the General Linear Models procedure of SAS (SAS Institute, 1985) to determine the effects of delayed access to feed and water.", [["Statistical AnalysisData", "TEST", 95, 119], ["Experiments", "TEST", 125, 136]]], ["Significant differences among treatment means were separated by Duncan's multiple range test (Duncan, 1955) with a 5% level of probability.Body Weight and Feed ConsumptionBody weights of poults in Experiment 1 were affected adversely (P \u00a3 0.01) by delayed access to feed and water,TABLE 3.", [["Body", "ANATOMY", 139, 143], ["Body", "ORGANISM_SUBDIVISION", 139, 143], ["poults", "SPECIES", 187, 193], ["Body Weight", "TEST", 139, 150]]], ["Effect of placement time on the feed consumption of poults, Experiments 2 and 3a-c Means in columns and within experiment with no common superscript differ significantly (P \u00a3 0.05).", [["poults", "SPECIES", 52, 58]]], ["1 Means represent feed consumption for a 1-wk period and represent six pens per treatment, 22 female poults per pen at the start of the experiment.", [["poults", "ORGANISM", 101, 107], ["poults", "SPECIES", 101, 107], ["treatment", "TREATMENT", 80, 89], ["feed consumption", "OBSERVATION", 18, 34]]], ["2 Cumulative means represent feed consumption through 28 d of age.", [["feed consumption", "OBSERVATION", 29, 45]]], ["3 Means represent feed consumption for a 1-wk period and represent four pens per treatment, six female poults per pen.", [["poults", "ORGANISM", 103, 109], ["poults", "SPECIES", 103, 109], ["feed consumption", "OBSERVATION", 18, 34]]], ["5 Cumulative means represent feed consumption through 14 d of age. whereby average 10-d BW of poults placed at 30 and 54 h posthatch were 175 and 161 g, respectively, compared with 208 g for poults placed at 6 h posthatch.", [["poults", "ORGANISM", 94, 100], ["poults", "ORGANISM", 191, 197], ["poults", "SPECIES", 94, 100], ["poults", "SPECIES", 191, 197], ["poults", "SPECIES", 191, 197], ["poults", "TREATMENT", 94, 100], ["feed consumption", "OBSERVATION", 29, 45]]], ["Similar effects of delayed placement occurred in Experiments 2 and 3 (Table 2) .", [["delayed placement", "TREATMENT", 19, 36], ["delayed", "OBSERVATION_MODIFIER", 19, 26], ["placement", "OBSERVATION", 27, 36]]], ["The adverse effect on BW for poults placed at 54 h posthatch was still evident when Experiments 2 and 3 were terminated at 28 and 14 d, respectively.", [["poults", "SPECIES", 29, 35], ["The adverse effect", "PROBLEM", 0, 18], ["poults", "TREATMENT", 29, 35], ["adverse", "OBSERVATION_MODIFIER", 4, 11], ["effect", "OBSERVATION_MODIFIER", 12, 18]]], ["Adverse effects on BW due to a 24-h delay in access to feed and water of turkeys also was reported by Chilson and Patrick (1946) and Moran (1978) .", [["turkeys", "SPECIES", 73, 80], ["Adverse effects", "PROBLEM", 0, 15]]], ["In the latter instance, the adverse effect was evident through 14 wk of age.TABLE 3.", [["the adverse effect", "PROBLEM", 24, 42], ["adverse effect", "OBSERVATION", 28, 42]]], ["Effect of placement time on the feed consumption of poults, Experiments 2 and 3Feed consumption in Experiment 1 was less for poults placed at 30 or 54 h posthatch, than that of poults placed at 6 h (data not shown).", [["poults", "ORGANISM", 125, 131], ["poults", "ORGANISM", 177, 183], ["poults", "SPECIES", 52, 58], ["poults", "SPECIES", 125, 131], ["poults", "SPECIES", 177, 183], ["poults", "SPECIES", 125, 131], ["poults", "SPECIES", 177, 183], ["placement", "TREATMENT", 10, 19]]], ["However, because of lack of pen replication, statistical evaluation of these data could not be done.", [["pen replication", "TREATMENT", 28, 43], ["statistical evaluation", "TEST", 45, 67], ["these data", "TEST", 71, 81]]], ["This effect was most evident in the instance of cumulative 28-d feed consumption in Experiment 2.", [["cumulative 28-d feed consumption", "TREATMENT", 48, 80]]], ["Noy and Pinchasov (1993) reported that broiler chicks denied access to feed and water for 24 h posthatch consumed less feed through 40 d of age.", [["chicks", "SPECIES", 47, 53]]], ["This result corresponds to those reported here with turkeys, in that a delay in access to feed and water decreased feed consumption.", [["turkeys", "ORGANISM", 52, 59], ["turkeys", "SPECIES", 52, 59], ["water decreased feed consumption", "TREATMENT", 99, 131]]], ["There were no significant effects (P > 0.05) of delayed access to feed and water on cumulative feed efficiency, which agrees with findings of Noy and Pinchasov (1993) .", [["significant effects", "PROBLEM", 14, 33], ["delayed access to feed", "TREATMENT", 48, 70], ["cumulative feed efficiency", "TREATMENT", 84, 110], ["no", "UNCERTAINTY", 11, 13], ["significant", "OBSERVATION_MODIFIER", 14, 25], ["effects", "OBSERVATION_MODIFIER", 26, 33]]], ["In contrast, Moran (1978) previously reported improved feed to gain ratios between 2 and 6 wk of age when poults were denied feed for 24 h posthatch.", [["poults", "ORGANISM", 106, 112], ["poults", "SPECIES", 106, 112], ["poults", "SPECIES", 106, 112]]], ["Moran (1978) reported 50% greater mortality when poults were deprived of feed for 24 h after hatch compared with fed poults.", [["poults", "ORGANISM", 49, 55], ["poults", "SPECIES", 49, 55], ["poults", "SPECIES", 117, 123], ["poults", "SPECIES", 49, 55]]], ["Chilson and Patrick (1946) also reported greater mortality rates of poults as the delay in access to nourishment increased.", [["poults", "ORGANISM", 68, 74], ["poults", "SPECIES", 68, 74]]], ["In the current study, mortality of poults placed on feed and water at 30 or 54 h posthatch did not differ from that of poults placed on feed and water at 6 h posthatch.Digestive OrgansWeights of the small intestine, pancreas, proventriculus, and gizzard, and the length of the small intestine increased markedly during the 1st wk after hatch (Tables 4 and 5 ).", [["Digestive", "ANATOMY", 168, 177], ["small intestine", "ANATOMY", 199, 214], ["pancreas", "ANATOMY", 216, 224], ["proventriculus", "ANATOMY", 226, 240], ["gizzard", "ANATOMY", 246, 253], ["small intestine", "ANATOMY", 277, 292], ["poults", "ORGANISM", 35, 41], ["poults", "ORGANISM", 119, 125], ["small intestine", "ORGAN", 199, 214], ["pancreas", "ORGAN", 216, 224], ["proventriculus", "ORGAN", 226, 240], ["gizzard", "ORGAN", 246, 253], ["small intestine", "ORGAN", 277, 292], ["poults", "SPECIES", 35, 41], ["poults", "SPECIES", 119, 125], ["poults", "SPECIES", 35, 41], ["poults", "SPECIES", 119, 125], ["the current study", "TEST", 3, 20], ["small intestine", "ANATOMY", 199, 214], ["pancreas", "ANATOMY", 216, 224], ["proventriculus", "ANATOMY", 226, 240], ["gizzard", "ANATOMY", 246, 253], ["length", "OBSERVATION_MODIFIER", 263, 269], ["small intestine", "ANATOMY", 277, 292], ["increased", "OBSERVATION_MODIFIER", 293, 302], ["markedly", "OBSERVATION_MODIFIER", 303, 311]]], ["Growth of the GIT has been shown to exceed that of total BW for the first 6 d of a poult's life .", [["GIT", "ANATOMY", 14, 17], ["GIT", "ORGAN", 14, 17], ["a poult's life", "TREATMENT", 81, 95]]], ["Katanbaf et al. (1988) and Nitsan et al. (1991) emphasized the close relationship between digestive organ development and growth of newly hatched birds.", [["digestive organ", "ANATOMY", 90, 105], ["digestive organ", "MULTI-TISSUE_STRUCTURE", 90, 105], ["birds", "ORGANISM", 146, 151], ["digestive organ development", "TREATMENT", 90, 117], ["digestive organ", "ANATOMY", 90, 105], ["growth", "OBSERVATION_MODIFIER", 122, 128]]], ["It is believed that most of the nutrients available are devoted to the rapid development of the GIT to facilitate nutrient utilization so that rapid increases in BW can occur.Digestive OrgansIn agreement with reports from Murakami et al. (1992) and Uni et al. (1998) , withholding feed and water initially resulted in retarded growth of all segments of the small intestine (Tables 4 and 5 ).", [["GIT", "ANATOMY", 96, 99], ["small intestine", "ANATOMY", 357, 372], ["GIT", "ORGAN", 96, 99], ["intestine", "ORGAN", 363, 372], ["nutrient utilization", "TREATMENT", 114, 134], ["rapid increases in BW", "PROBLEM", 143, 164], ["retarded growth", "PROBLEM", 318, 333], ["retarded", "OBSERVATION_MODIFIER", 318, 326], ["growth", "OBSERVATION_MODIFIER", 327, 333], ["all segments", "ANATOMY_MODIFIER", 337, 349], ["small intestine", "ANATOMY", 357, 372]]], ["In Experiments 1 and 2, absolute weights of the small intestine were less for the first 2 d after hatch when poults were placed 30 h posthatch.", [["small intestine", "ANATOMY", 48, 63], ["small intestine", "ORGAN", 48, 63], ["poults", "ORGANISM", 109, 115], ["poults", "SPECIES", 109, 115], ["poults", "SPECIES", 109, 115], ["small intestine", "ANATOMY", 48, 63]]], ["A 54-h placement resulted in decreased intestinal weights through 5 d of age.", [["intestinal", "ANATOMY", 39, 49], ["intestinal", "ORGAN", 39, 49], ["A 54-h placement", "TREATMENT", 0, 16], ["decreased intestinal weights", "PROBLEM", 29, 57], ["decreased", "OBSERVATION_MODIFIER", 29, 38], ["intestinal", "ANATOMY", 39, 49]]], ["Uni et al. (1998) concluded that depressed intestinal weights may indicate reduced morphological development.Digestive OrgansWeights of the intestinal segments increased markedly in poults within each placement time group in response to consumption of feed and water.", [["intestinal", "ANATOMY", 43, 53], ["Digestive", "ANATOMY", 109, 118], ["intestinal segments", "ANATOMY", 140, 159], ["depressed", "DISEASE", 33, 42], ["intestinal", "ORGAN", 43, 53], ["Digestive", "ORGAN", 109, 118], ["intestinal segments", "MULTI-TISSUE_STRUCTURE", 140, 159], ["poults", "SPECIES", 182, 188], ["depressed intestinal weights", "PROBLEM", 33, 61], ["reduced morphological development", "PROBLEM", 75, 108], ["intestinal", "ANATOMY", 43, 53], ["reduced", "OBSERVATION_MODIFIER", 75, 82], ["intestinal segments", "ANATOMY", 140, 159], ["increased", "OBSERVATION_MODIFIER", 160, 169], ["markedly", "OBSERVATION_MODIFIER", 170, 178]]], ["For example, weights of the duodenum and jejunum of poults deprived of nourishment for 30 h posthatch in Experiment 1 increased 57 and 73%, respectively, within 24 h after feed and water consumption.", [["duodenum", "ANATOMY", 28, 36], ["jejunum", "ANATOMY", 41, 48], ["duodenum", "MULTI-TISSUE_STRUCTURE", 28, 36], ["jejunum", "MULTI-TISSUE_STRUCTURE", 41, 48], ["poults", "SPECIES", 52, 58], ["duodenum", "ANATOMY", 28, 36], ["jejunum", "ANATOMY", 41, 48]]], ["Weights of these intestinal segments of poults deprived of feed and water for 54 h posthatch increased 135 and 100%, respectively, within 24 h of feed and water intake.", [["intestinal", "ANATOMY", 17, 27], ["intestinal segments", "MULTI-TISSUE_STRUCTURE", 17, 36], ["poults", "ORGANISM", 40, 46], ["water", "SIMPLE_CHEMICAL", 155, 160], ["poults", "SPECIES", 40, 46], ["Weights", "TEST", 0, 7], ["intestinal", "ANATOMY", 17, 27], ["segments", "ANATOMY_MODIFIER", 28, 36]]], ["Similar responses were observed for increased weight per length of intestinal segment in Experiments 1 and 2.", [["intestinal", "ANATOMY", 67, 77], ["intestinal segment", "MULTI-TISSUE_STRUCTURE", 67, 85], ["increased weight", "PROBLEM", 36, 52], ["intestinal segment", "ANATOMY", 67, 85]]], ["These data support the observations of Uni et al. (1998) that feed consumption stimulated intestinal development in poults as compared with delayed access to feed.Digestive OrgansWhen expressing the weight of the small intestine segments on a relative basis (grams per 100 g BW), differences were observed due to delayed access to feed and water (Table 6) .", [["intestinal", "ANATOMY", 90, 100], ["Digestive", "ANATOMY", 163, 172], ["small intestine", "ANATOMY", 213, 228], ["intestinal", "ORGAN", 90, 100], ["poults", "ORGANISM", 116, 122], ["small intestine", "ORGAN", 213, 228], ["poults", "SPECIES", 116, 122], ["poults", "SPECIES", 116, 122], ["intestinal", "ANATOMY", 90, 100], ["small", "ANATOMY_MODIFIER", 213, 218], ["intestine", "ANATOMY", 219, 228], ["segments", "ANATOMY_MODIFIER", 229, 237]]], ["A 30-h delay in access to feed and water affected each segment of the small intestine differently.", [["small intestine", "ANATOMY", 70, 85], ["small intestine", "ORGAN", 70, 85], ["A 30-h delay in access to feed", "TREATMENT", 0, 30], ["30-h", "OBSERVATION_MODIFIER", 2, 6], ["small intestine", "ANATOMY", 70, 85]]], ["In Experiment 1, a 30-h delay only resulted in reduced jejunal weights at 2 d of age, whereas in Experiment 2, reduced weights were observed for the duodenum at 4 d of age and the ileum at 3 and 4 d of age with no effect on the weight of the jejunum compared with poults placed at 6 h posthatch.", [["jejunal", "ANATOMY", 55, 62], ["duodenum", "ANATOMY", 149, 157], ["ileum", "ANATOMY", 180, 185], ["jejunum", "ANATOMY", 242, 249], ["jejunal", "MULTI-TISSUE_STRUCTURE", 55, 62], ["duodenum", "ORGAN", 149, 157], ["ileum", "ORGAN", 180, 185], ["jejunum", "ORGAN", 242, 249], ["poults", "SPECIES", 264, 270], ["reduced jejunal weights", "PROBLEM", 47, 70], ["reduced weights", "PROBLEM", 111, 126], ["jejunal", "ANATOMY", 55, 62], ["duodenum", "ANATOMY", 149, 157], ["ileum", "ANATOMY", 180, 185], ["jejunum", "ANATOMY", 242, 249]]], ["Delaying access to feed and water for 54-h posthatch had a more severe and constant effect on relative weights of the small intestine, in which reduced weights were observed on Days 3 and 4 in all segments of the small intestine in Experiments 1 and 2.", [["small intestine", "ANATOMY", 118, 133], ["small intestine", "ANATOMY", 213, 228], ["small intestine", "ORGAN", 118, 133], ["intestine", "ORGAN", 219, 228], ["a more severe and constant effect", "PROBLEM", 57, 90], ["reduced weights", "PROBLEM", 144, 159], ["more severe", "OBSERVATION_MODIFIER", 59, 70], ["constant effect", "OBSERVATION_MODIFIER", 75, 90], ["small intestine", "ANATOMY", 118, 133], ["segments", "ANATOMY_MODIFIER", 197, 205], ["small intestine", "ANATOMY", 213, 228]]], ["In the current study, delaying access to feed and water prolonged the duration of small intestine growth relative to BW.", [["intestine", "ANATOMY", 88, 97], ["intestine", "ORGAN", 88, 97], ["the current study", "TEST", 3, 20], ["delaying access to feed", "TREATMENT", 22, 45], ["small intestine growth", "PROBLEM", 82, 104], ["small", "OBSERVATION_MODIFIER", 82, 87], ["intestine", "ANATOMY", 88, 97]]], ["The small intestine weight of poults placed at 6 and 30 h posthatch increased faster than BW until 5 d of age, but when poults were placed 54 h posthatch, the small intestine increased in weight faster than BW until approximately 15 d of age.Digestive OrgansAs mentioned above, weights of intestinal segments increased markedly within 24 h after the poults denied feed and water for 30 and 54 h posthatch had access to feed and water.", [["intestine", "ANATOMY", 10, 19], ["small intestine", "ANATOMY", 159, 174], ["Digestive", "ANATOMY", 242, 251], ["intestinal", "ANATOMY", 289, 299], ["intestine", "ORGAN", 10, 19], ["poults", "ORGANISM", 30, 36], ["poults", "ORGANISM", 120, 126], ["small intestine", "ORGAN", 159, 174], ["intestinal segments", "MULTI-TISSUE_STRUCTURE", 289, 308], ["poults", "SPECIES", 30, 36], ["poults", "SPECIES", 120, 126], ["poults", "SPECIES", 350, 356], ["poults", "SPECIES", 120, 126], ["poults", "SPECIES", 350, 356], ["The small intestine weight of poults", "TREATMENT", 0, 36], ["Digestive OrgansAs", "PROBLEM", 242, 260], ["small", "OBSERVATION_MODIFIER", 4, 9], ["intestine", "ANATOMY", 10, 19], ["small", "OBSERVATION_MODIFIER", 159, 164], ["intestine", "ANATOMY", 165, 174], ["increased", "OBSERVATION", 175, 184], ["OrgansAs", "OBSERVATION", 252, 260], ["intestinal", "ANATOMY", 289, 299], ["segments", "ANATOMY_MODIFIER", 300, 308], ["increased", "OBSERVATION_MODIFIER", 309, 318], ["markedly", "OBSERVATION_MODIFIER", 319, 327]]], ["These rapid increases in intestinal weights together with lighter concurrent BW resulted in seemingly compensatory development of the intestines.", [["intestinal", "ANATOMY", 25, 35], ["intestines", "ANATOMY", 134, 144], ["intestinal", "ORGAN", 25, 35], ["intestines", "ORGAN", 134, 144], ["These rapid increases in intestinal weights", "PROBLEM", 0, 43], ["seemingly compensatory development of the intestines", "PROBLEM", 92, 144], ["rapid", "OBSERVATION_MODIFIER", 6, 11], ["increases", "OBSERVATION_MODIFIER", 12, 21], ["intestinal", "ANATOMY", 25, 35], ["compensatory", "OBSERVATION", 102, 114], ["intestines", "ANATOMY", 134, 144]]], ["For example, the relative weights of the jejunum of the 6, 30, and 54 h placement groups were 0.98, 1.26, and 1.42 g/100 g, respectively, at 24 h after access to feed and water.", [["jejunum", "ANATOMY", 41, 48], ["jejunum", "MULTI-TISSUE_STRUCTURE", 41, 48], ["jejunum", "ANATOMY", 41, 48]]], ["Although these increases in relative intestinal weights are suggestive of a compensatory response to nutrient intake by previously deprived groups, they did not alleviate the carryover effects of delayed access to feed and water on subsequent growth of the poults in the current study.Digestive OrgansLengths of the small intestinal segments were shorter due to delayed placement on feed and water (Tables 4 and 5).", [["intestinal", "ANATOMY", 37, 47], ["Digestive", "ANATOMY", 285, 294], ["intestinal", "ANATOMY", 322, 332], ["intestinal", "ORGAN", 37, 47], ["poults", "ORGANISM", 257, 263], ["Digestive", "ORGAN", 285, 294], ["intestinal segments", "MULTI-TISSUE_STRUCTURE", 322, 341], ["poults", "SPECIES", 257, 263], ["relative intestinal weights", "PROBLEM", 28, 55], ["the current study", "TEST", 267, 284], ["Digestive OrgansLengths of the small intestinal segments", "TREATMENT", 285, 341], ["delayed placement on feed and water (Tables", "TREATMENT", 362, 405], ["increases", "OBSERVATION_MODIFIER", 15, 24], ["intestinal", "ANATOMY", 37, 47], ["suggestive of", "UNCERTAINTY", 60, 73], ["compensatory response", "OBSERVATION", 76, 97], ["nutrient intake", "OBSERVATION", 101, 116], ["small", "ANATOMY_MODIFIER", 316, 321], ["intestinal segments", "ANATOMY", 322, 341]]], ["In Experiment 1, a 30-h delay in access to feed and water after hatch resulted in reduced lengths of the duodenum at 5 d of age and the jejunum at 2 d of age.", [["duodenum", "ANATOMY", 105, 113], ["jejunum", "ANATOMY", 136, 143], ["duodenum", "ORGAN", 105, 113], ["jejunum", "ORGAN", 136, 143], ["reduced", "OBSERVATION_MODIFIER", 82, 89], ["lengths", "OBSERVATION_MODIFIER", 90, 97], ["duodenum", "ANATOMY", 105, 113], ["jejunum", "ANATOMY", 136, 143]]], ["In Experiment 2, a 30-h delay reduced the length of the duodenal and ileal at 3 d of age and reduced jejunal lengths between 1 and 3 d of age.", [["duodenal", "ANATOMY", 56, 64], ["ileal", "ANATOMY", 69, 74], ["jejunal", "ANATOMY", 101, 108], ["duodenal", "MULTI-TISSUE_STRUCTURE", 56, 64], ["ileal", "MULTI-TISSUE_STRUCTURE", 69, 74], ["jejunal", "MULTI-TISSUE_STRUCTURE", 101, 108], ["reduced jejunal lengths", "PROBLEM", 93, 116], ["duodenal", "ANATOMY", 56, 64], ["ileal", "ANATOMY", 69, 74], ["jejunal", "ANATOMY", 101, 108], ["lengths", "OBSERVATION_MODIFIER", 109, 116]]], ["Poults placed at 54 h posthatch had shorter small intestines between 2 and 5 d of age and at 10 d of age.", [["Poults", "ANATOMY", 0, 6], ["small intestines", "ANATOMY", 44, 60], ["small intestines", "ORGAN", 44, 60], ["Poults", "TREATMENT", 0, 6], ["shorter small intestines", "PROBLEM", 36, 60], ["intestines", "ANATOMY", 50, 60]]], ["Comparing the weight to length ratio (density, grams per centimeter) of the small intestines allows for indirect observation of increases in mucosal mass in the intestine.", [["small intestines", "ANATOMY", 76, 92], ["mucosal", "ANATOMY", 141, 148], ["intestine", "ANATOMY", 161, 170], ["intestines", "ORGAN", 82, 92], ["mucosal", "ORGANISM_SUBDIVISION", 141, 148], ["intestine", "ORGAN", 161, 170], ["length ratio", "TEST", 24, 36], ["indirect observation", "TEST", 104, 124], ["mucosal mass in the intestine", "PROBLEM", 141, 170], ["small intestines", "ANATOMY", 76, 92], ["increases", "OBSERVATION_MODIFIER", 128, 137], ["mucosal", "ANATOMY", 141, 148], ["mass", "OBSERVATION", 149, 153], ["intestine", "ANATOMY", 161, 170]]], ["Lower intestinal density may represent decreased villus height and diameter, which would reduce the digestive and absorptive abilities of the intestines (Uni et al., 1998) .", [["intestinal", "ANATOMY", 6, 16], ["villus", "ANATOMY", 49, 55], ["digestive", "ANATOMY", 100, 109], ["intestines", "ANATOMY", 142, 152], ["intestinal", "ORGAN", 6, 16], ["villus", "TISSUE", 49, 55], ["digestive", "ORGAN", 100, 109], ["intestines", "ORGAN", 142, 152], ["Lower intestinal density", "PROBLEM", 0, 24], ["decreased villus height and diameter", "PROBLEM", 39, 75], ["the digestive and absorptive abilities of the intestines", "PROBLEM", 96, 152], ["intestinal", "ANATOMY", 6, 16], ["density", "OBSERVATION", 17, 24], ["may represent", "UNCERTAINTY", 25, 38], ["decreased", "OBSERVATION", 39, 48], ["villus height", "OBSERVATION", 49, 62], ["diameter", "OBSERVATION_MODIFIER", 67, 75], ["intestines", "ANATOMY", 142, 152]]], ["The effects of delayed placement on the intestinal density of poults varied in each segment of the small intestine.", [["intestinal", "ANATOMY", 40, 50], ["small intestine", "ANATOMY", 99, 114], ["intestinal", "ORGAN", 40, 50], ["poults", "ORGANISM", 62, 68], ["small intestine", "ORGAN", 99, 114], ["poults", "SPECIES", 62, 68], ["delayed placement", "TREATMENT", 15, 32], ["delayed", "OBSERVATION_MODIFIER", 15, 22], ["placement", "OBSERVATION_MODIFIER", 23, 32], ["intestinal density", "OBSERVATION_MODIFIER", 40, 58], ["each segment", "ANATOMY_MODIFIER", 79, 91], ["small intestine", "ANATOMY", 99, 114]]], ["Duodenal density was lower at 1 d of age for both delayed placement groups, continuing through 5 d of age for the 54-h placement group.", [["Duodenal", "ANATOMY", 0, 8], ["Duodenal", "MULTI-TISSUE_STRUCTURE", 0, 8], ["Duodenal density", "PROBLEM", 0, 16], ["both delayed placement groups", "TREATMENT", 45, 74], ["the 54-h placement group", "TREATMENT", 110, 134], ["density", "OBSERVATION", 9, 16], ["lower", "OBSERVATION_MODIFIER", 21, 26]]], ["In the jejunum, placement at 30 h posthatch decreased the density at 5 d and 4 d of age in Experiment 1 and 2, respectively, whereas a 54-h delay resulted in lower densities at 2 and 4 d of age in Experiment 1 and 4 and 5 d of age in Experiment 2.", [["jejunum", "ANATOMY", 7, 14], ["jejunum", "MULTI-TISSUE_STRUCTURE", 7, 14], ["placement", "TREATMENT", 16, 25], ["lower densities", "PROBLEM", 158, 173], ["jejunum", "ANATOMY", 7, 14], ["density", "OBSERVATION", 58, 65], ["lower densities", "OBSERVATION_MODIFIER", 158, 173]]], ["Ileal density was lower at 1 d of age due to a 30-and 54-h delay in Experiment 1.", [["Ileal", "ANATOMY", 0, 5], ["Ileal", "MULTI-TISSUE_STRUCTURE", 0, 5], ["Ileal density", "PROBLEM", 0, 13], ["density", "OBSERVATION", 6, 13], ["lower", "OBSERVATION_MODIFIER", 18, 23]]], ["In Experiment 2, a reduction in ileal density due to a 30-h delay was observed at 2 d of age, whereas a 54-h delay reduced ileal density between 2 and 4 d of age compared with poults placed at 6 h posthatch.", [["ileal", "ANATOMY", 32, 37], ["ileal", "ANATOMY", 123, 128], ["ileal", "MULTI-TISSUE_STRUCTURE", 32, 37], ["ileal", "MULTI-TISSUE_STRUCTURE", 123, 128], ["poults", "SPECIES", 176, 182], ["poults", "SPECIES", 176, 182], ["a reduction in ileal density", "PROBLEM", 17, 45], ["a 54-h delay reduced ileal density", "PROBLEM", 102, 136], ["reduction", "OBSERVATION_MODIFIER", 19, 28], ["ileal", "ANATOMY", 32, 37], ["density", "OBSERVATION", 38, 45], ["ileal", "ANATOMY", 123, 128], ["density", "OBSERVATION", 129, 136]]], ["These results suggest that the presence of feed will stimulate the morphological development of the intestines, in agreement with reports of Uni et al. (1998) .Digestive OrgansIn agreement with reports from Phelps et al. (1987b) , the yolk of poults in the current research was essentially depleted by 5 or 6 d of age (Tables 7 and 8) .", [["intestines", "ANATOMY", 100, 110], ["yolk", "ANATOMY", 235, 239], ["intestines", "ORGAN", 100, 110], ["yolk", "ORGANISM_SUBDIVISION", 235, 239], ["poults", "ORGANISM", 243, 249], ["poults", "SPECIES", 243, 249], ["the yolk of poults", "TREATMENT", 231, 249], ["intestines", "ANATOMY", 100, 110], ["depleted", "OBSERVATION", 290, 298]]], ["Several researchers have shown that denying poults feed and water for 48 h after hatch reduced the uptake of residual yolk (Moran and Reinhart, 1980; Moran, 1989; Pinchasov and Noy, 1993) .", [["yolk", "ANATOMY", 118, 122], ["poults", "ORGANISM", 44, 50], ["yolk", "ORGANISM_SUBSTANCE", 118, 122], ["poults", "SPECIES", 44, 50]]], ["Heavier absolute yolk weights were observed at 5 and 4 d of age in Experiments 1 and 2, respectively, due to delayed placement.", [["yolk", "ANATOMY", 17, 21], ["yolk", "ORGANISM_SUBDIVISION", 17, 21], ["Heavier absolute yolk weights", "TREATMENT", 0, 29], ["delayed placement", "TREATMENT", 109, 126]]], ["In Experiment 2, relative yolk weight (grams yolk per 100 g BW) was greater between 2 and 4 d of age in poults deprived of feed and water 54 h posthatch than in poults placed on feed and water at 6 h posthatch (Table 8 ).", [["yolk", "ANATOMY", 26, 30], ["yolk", "ANATOMY", 45, 49], ["yolk", "ORGANISM_SUBDIVISION", 26, 30], ["yolk", "ORGANISM_SUBDIVISION", 45, 49], ["poults", "ORGANISM", 104, 110], ["poults", "SPECIES", 104, 110], ["poults", "SPECIES", 161, 167], ["poults", "SPECIES", 104, 110], ["poults", "SPECIES", 161, 167]]], ["These observations suggest that poults may have the ability for selective rate of nutrient withdrawal from the yolk when fasted or, as Noy and Sklan (1997) concluded, the effect of feed intake on yolk utilization may be attributed to enhanced transport of yolk to the GIT due to increased intestinal motility and activity after feed and water are ingested.", [["yolk", "ANATOMY", 111, 115], ["yolk", "ANATOMY", 196, 200], ["yolk", "ANATOMY", 256, 260], ["GIT", "ANATOMY", 268, 271], ["intestinal", "ANATOMY", 289, 299], ["poults", "ORGANISM", 32, 38], ["yolk", "ORGANISM_SUBSTANCE", 111, 115], ["yolk", "ORGANISM_SUBDIVISION", 196, 200], ["yolk", "ORGANISM_SUBDIVISION", 256, 260], ["GIT", "ORGAN", 268, 271], ["intestinal", "ORGAN", 289, 299], ["poults", "SPECIES", 32, 38], ["nutrient withdrawal", "PROBLEM", 82, 101], ["yolk utilization", "TREATMENT", 196, 212], ["increased intestinal motility", "PROBLEM", 279, 308], ["increased", "OBSERVATION_MODIFIER", 279, 288], ["intestinal", "ANATOMY", 289, 299], ["motility", "OBSERVATION", 300, 308]]], ["Phelps et al. (1987a) noted that the pancreas is the fastest growing organ in poults during the first 10 d after hatch.", [["pancreas", "ANATOMY", 37, 45], ["organ", "ANATOMY", 69, 74], ["pancreas", "ORGAN", 37, 45], ["organ", "ORGAN", 69, 74], ["poults", "ORGANISM", 78, 84], ["poults", "SPECIES", 78, 84], ["pancreas", "ANATOMY", 37, 45]]], ["Delaying access to feed and water adversely affected the absolute pancreas weight in Experiments 1 and 2 (Tables 7 and 8) , whereby a 30-h placement time resulted in reduced absolute and relative weights of the pancreas at 2 d of age.", [["pancreas", "ANATOMY", 66, 74], ["pancreas", "ANATOMY", 211, 219], ["pancreas", "ORGAN", 66, 74], ["pancreas", "ORGAN", 211, 219], ["Delaying access to feed", "TREATMENT", 0, 23], ["a 30-h placement time", "TREATMENT", 132, 153], ["reduced absolute", "PROBLEM", 166, 182], ["absolute", "OBSERVATION", 57, 65], ["pancreas", "ANATOMY", 66, 74], ["reduced", "OBSERVATION_MODIFIER", 166, 173], ["absolute", "OBSERVATION", 174, 182], ["pancreas", "ANATOMY", 211, 219]]], ["A 54-h placement time depressed pancreas weight between 2 and 4 d of age.", [["pancreas", "ANATOMY", 32, 40], ["depressed", "DISEASE", 22, 31], ["pancreas", "ORGAN", 32, 40], ["A 54-h placement time depressed pancreas weight", "TREATMENT", 0, 47], ["pancreas", "ANATOMY", 32, 40]]], ["In contrast, Pinchasov and Noy (1993) found no difference in relative pancreas weight due to a 24-or 48-h delay in placement time.", [["pancreas", "ANATOMY", 70, 78], ["pancreas", "ORGAN", 70, 78], ["difference in relative pancreas weight", "PROBLEM", 47, 85], ["no", "UNCERTAINTY", 44, 46], ["pancreas", "ANATOMY", 70, 78]]], ["Because digestive enzyme activity in the pancreas is highly correlated to pancreas weight, changes in pancreas weight might represent changes in digestive capability.Digestive OrgansDelaying access to feed and water resulted in decreased weights of the proventriculus and gizzard in Experiments 1 and 2 (Tables 7 and 8 ).", [["pancreas", "ANATOMY", 41, 49], ["pancreas", "ANATOMY", 74, 82], ["pancreas", "ANATOMY", 102, 110], ["digestive", "ANATOMY", 145, 154], ["Digestive", "ANATOMY", 166, 175], ["proventriculus", "ANATOMY", 253, 267], ["gizzard", "ANATOMY", 272, 279], ["digestive", "ORGAN", 8, 17], ["pancreas", "ORGAN", 41, 49], ["pancreas", "ORGAN", 74, 82], ["pancreas", "ORGAN", 102, 110], ["digestive", "ORGAN", 145, 154], ["proventriculus", "ORGAN", 253, 267], ["gizzard", "ORGANISM_SUBDIVISION", 272, 279], ["digestive enzyme activity in the pancreas", "PROBLEM", 8, 49], ["pancreas weight", "TEST", 74, 89], ["changes in pancreas weight", "PROBLEM", 91, 117], ["changes in digestive capability", "PROBLEM", 134, 165], ["Digestive OrgansDelaying access to feed", "TREATMENT", 166, 205], ["decreased weights of the proventriculus", "PROBLEM", 228, 267], ["enzyme activity", "OBSERVATION", 18, 33], ["pancreas", "ANATOMY", 41, 49], ["pancreas", "ANATOMY", 74, 82], ["pancreas", "ANATOMY", 102, 110], ["digestive capability", "OBSERVATION", 145, 165], ["decreased", "OBSERVATION", 228, 237], ["proventriculus", "ANATOMY", 253, 267], ["gizzard", "ANATOMY", 272, 279]]], ["Poults denied feed and water for 30 h posthatch had depressed absolute weights of these organs through 4 d of age, whereas a delay of 54 h posthatch reduced absolute weights through 10 d of age.", [["organs", "ANATOMY", 88, 94], ["depressed", "DISEASE", 52, 61], ["organs", "ORGAN", 88, 94], ["depressed absolute weights", "PROBLEM", 52, 78]]], ["The relative gizzard and proventriculus weights also were depressed at 2 d of age for poults deprived of feed and water for 30 h posthatch.", [["gizzard", "ANATOMY", 13, 20], ["proventriculus", "ANATOMY", 25, 39], ["depressed", "DISEASE", 58, 67], ["gizzard", "ORGANISM_SUBDIVISION", 13, 20], ["proventriculus", "ORGAN", 25, 39], ["poults", "ORGANISM", 86, 92], ["poults", "SPECIES", 86, 92], ["poults", "SPECIES", 86, 92], ["depressed", "PROBLEM", 58, 67], ["gizzard", "OBSERVATION", 13, 20], ["proventriculus weights", "OBSERVATION", 25, 47]]], ["Placement at 54 h posthatch decreased relative weights of the gizzard and proventriculus between 2 and 4 d of age.", [["gizzard", "ANATOMY", 62, 69], ["proventriculus", "ANATOMY", 74, 88], ["gizzard", "ORGANISM_SUBDIVISION", 62, 69], ["proventriculus", "ORGAN", 74, 88], ["Placement", "TREATMENT", 0, 9], ["gizzard", "ANATOMY", 62, 69], ["proventriculus", "ANATOMY_MODIFIER", 74, 88]]], ["These findings contradict those reported by Pinchasov and Noy (1993) , which indicated that delayed placement increased the relative weight of the gizzard.", [["gizzard", "ANATOMY", 147, 154], ["gizzard", "ORGANISM_SUBDIVISION", 147, 154], ["delayed placement", "TREATMENT", 92, 109]]], ["In the current study, delaying access to feed and water resulted in decreased relative weight of the gizzard and proventriculus.Digestive OrgansResearchers have reported increased liver weights due to delayed access to feed and water (Moran, 1989 (Moran, , 1990 Pinchasov and Noy, 1993) , but this effect on liver weights was not observed in the current study.", [["gizzard", "ANATOMY", 101, 108], ["proventriculus", "ANATOMY", 113, 127], ["Digestive", "ANATOMY", 128, 137], ["liver", "ANATOMY", 180, 185], ["liver", "ANATOMY", 308, 313], ["gizzard", "ORGANISM_SUBDIVISION", 101, 108], ["proventriculus", "ORGAN", 113, 127], ["liver", "ORGAN", 180, 185], ["liver", "ORGAN", 308, 313], ["the current study", "TEST", 3, 20], ["increased liver weights", "PROBLEM", 170, 193], ["liver weights", "TEST", 308, 321], ["the current study", "TEST", 342, 359], ["decreased", "OBSERVATION", 68, 77], ["gizzard", "ANATOMY", 101, 108], ["proventriculus", "ANATOMY", 113, 127], ["increased", "OBSERVATION_MODIFIER", 170, 179], ["liver", "ANATOMY", 180, 185], ["liver", "ANATOMY", 308, 313]]], ["In Experiment 1, the effect of a 30-h delay on liver weights was not observed until 10 d of age.", [["liver", "ANATOMY", 47, 52], ["liver", "ORGAN", 47, 52], ["liver weights", "TEST", 47, 60], ["liver", "ANATOMY", 47, 52]]], ["At this time, liver weight was depressed.", [["liver", "ANATOMY", 14, 19], ["depressed", "DISEASE", 31, 40], ["liver", "ORGAN", 14, 19], ["liver weight", "TEST", 14, 26], ["depressed", "PROBLEM", 31, 40], ["liver", "ANATOMY", 14, 19], ["depressed", "OBSERVATION", 31, 40]]], ["A 54-h posthatch placement time decreased the absolute liver weight at 2, 3, 6, and 10 d of age.", [["liver", "ANATOMY", 55, 60], ["liver", "ORGAN", 55, 60], ["A 54-h posthatch placement", "TREATMENT", 0, 26], ["the absolute liver weight", "TREATMENT", 42, 67], ["liver", "ANATOMY", 55, 60]]], ["When expressing the liver weight on a relative basis (grams per 100 g BW) a delay of 54 h posthatch still had an adverse effect on the liver weight at 2 d of age.Digestive OrgansWeight of the bursa of Fabricius was adversely affected by delaying placement 30 h posthatch at 1 d of age, whereas a 54-h posthatch placement decreased bursa weight at 1, 4, 5, and 10 d of age in Experiment 2.", [["liver", "ANATOMY", 20, 25], ["liver", "ANATOMY", 135, 140], ["Digestive", "ANATOMY", 162, 171], ["bursa", "ANATOMY", 192, 197], ["bursa", "ANATOMY", 331, 336], ["liver", "ORGAN", 20, 25], ["liver", "ORGAN", 135, 140], ["bursa", "ORGAN", 192, 197], ["Fabricius", "ORGAN", 201, 210], ["bursa", "ORGANISM_SUBDIVISION", 331, 336], ["an adverse effect", "PROBLEM", 110, 127], ["the liver weight", "TEST", 131, 147], ["a 54-h posthatch placement decreased bursa weight", "TREATMENT", 294, 343], ["liver", "ANATOMY", 20, 25], ["liver", "ANATOMY", 135, 140], ["bursa", "ANATOMY", 192, 197], ["Fabricius", "ANATOMY", 201, 210], ["bursa", "ANATOMY", 331, 336]]], ["On a relative basis, only a delay of 54 h posthatch had an adverse effect on the bursa, and this occurred at 4 d of age.", [["bursa", "ANATOMY", 81, 86], ["bursa", "ORGANISM_SUBDIVISION", 81, 86], ["an adverse effect on the bursa", "PROBLEM", 56, 86], ["adverse effect", "OBSERVATION_MODIFIER", 59, 73], ["bursa", "ANATOMY", 81, 86]]], ["Phelps et al. (1987a) reported that the bursa does not mature until 5 or 6 wk of age, so early reductions in weight may have no real impact on the function of the bursa.", [["bursa", "ANATOMY", 40, 45], ["bursa", "ANATOMY", 163, 168], ["bursa", "ORGAN", 40, 45], ["bursa", "ORGANISM_SUBDIVISION", 163, 168], ["early reductions in weight", "PROBLEM", 89, 115], ["bursa", "ANATOMY", 40, 45], ["bursa", "ANATOMY", 163, 168]]], ["No consistent effects on the weights of the heart or spleen were observed in Experiment 1 due to delayed access to feed and water (data not shown).Selected Digestive EnzymesGreatest specific activities of jejunal maltase were observed when poults were 1 d old (30 h after arrival from hatchery) in Experiment 1 and when poults were 2 d old in Experiment 2 (Tables 9 and 10).", [["heart", "ANATOMY", 44, 49], ["spleen", "ANATOMY", 53, 59], ["jejunal", "ANATOMY", 205, 212], ["heart", "ORGAN", 44, 49], ["spleen", "ORGAN", 53, 59], ["jejunal", "ORGAN", 205, 212], ["maltase", "GENE_OR_GENE_PRODUCT", 213, 220], ["jejunal maltase", "PROTEIN", 205, 220], ["poults", "SPECIES", 240, 246], ["poults", "SPECIES", 320, 326], ["poults", "SPECIES", 240, 246], ["jejunal maltase", "TREATMENT", 205, 220], ["consistent", "OBSERVATION_MODIFIER", 3, 13], ["effects", "OBSERVATION", 14, 21], ["heart", "ANATOMY", 44, 49], ["spleen", "ANATOMY", 53, 59], ["jejunal maltase", "ANATOMY", 205, 220]]], ["Maltase activity decreased thereafter, most rapidly in poults given access to feed and water at 6 h posthatch.", [["Maltase", "GENE_OR_GENE_PRODUCT", 0, 7], ["poults", "ORGANISM", 55, 61], ["poults", "SPECIES", 55, 61], ["poults", "SPECIES", 55, 61], ["Maltase activity", "PROBLEM", 0, 16]]], ["Sell et al. (1991) also reported greatest specific activity of maltase in 1-d-old poults, followed by a decrease in activity until 6 to 7 d of age.", [["maltase", "GENE_OR_GENE_PRODUCT", 63, 70], ["poults", "ORGANISM", 82, 88], ["maltase", "PROTEIN", 63, 70], ["poults", "SPECIES", 82, 88]]], ["Specific activity of maltase has been used as an indicator of enterocyte maturity (Ortega et al., 1995) .", [["enterocyte", "ANATOMY", 62, 72], ["maltase", "GENE_OR_GENE_PRODUCT", 21, 28], ["enterocyte", "CELL", 62, 72], ["maltase", "PROTEIN", 21, 28], ["enterocyte maturity", "PROBLEM", 62, 81]]], ["Thus, the decline in specific activity of the jejunal maltase shortly after access to feed and water may be related to the rapid growth of the intestine that would result in a greater proportion of immature enterocytes containing less active maltase.", [["jejunal", "ANATOMY", 46, 53], ["intestine", "ANATOMY", 143, 152], ["enterocytes", "ANATOMY", 207, 218], ["jejunal maltase", "ORGAN", 46, 61], ["intestine", "ORGAN", 143, 152], ["enterocytes", "CELL", 207, 218], ["maltase", "GENE_OR_GENE_PRODUCT", 242, 249], ["immature enterocytes", "CELL_TYPE", 198, 218], ["maltase", "PROTEIN", 242, 249], ["the decline", "PROBLEM", 6, 17], ["the rapid growth of the intestine", "PROBLEM", 119, 152], ["immature enterocytes", "PROBLEM", 198, 218], ["jejunal maltase", "ANATOMY", 46, 61], ["rapid", "OBSERVATION_MODIFIER", 123, 128], ["growth", "OBSERVATION", 129, 135], ["intestine", "ANATOMY", 143, 152], ["greater", "OBSERVATION_MODIFIER", 176, 183], ["immature enterocytes", "OBSERVATION", 198, 218], ["less", "OBSERVATION_MODIFIER", 230, 234], ["active maltase", "OBSERVATION", 235, 249]]], ["Poults in the current research that were given access to feed and water 54 h posthatch tended to have greater specific activity of maltase in the jejunum (just before they were provided with feed and water) than poults placed at 6 or 30 h posthatch.", [["jejunum", "ANATOMY", 146, 153], ["maltase", "GENE_OR_GENE_PRODUCT", 131, 138], ["jejunum", "ORGAN", 146, 153], ["maltase", "PROTEIN", 131, 138], ["poults", "SPECIES", 212, 218], ["Poults", "TREATMENT", 0, 6], ["jejunum", "ANATOMY", 146, 153]]], ["When comparing the maltase activity on a relative basis (micromoles of maltase hydrolyzed hourly per 100 g of BW), poults placed within 6 h posthatch had the greatest maltase activity at 2 d of age.", [["maltase", "GENE_OR_GENE_PRODUCT", 19, 26], ["maltase", "SIMPLE_CHEMICAL", 71, 78], ["maltase", "GENE_OR_GENE_PRODUCT", 167, 174], ["maltase", "PROTEIN", 19, 26], ["maltase", "PROTEIN", 71, 78], ["maltase", "PROTEIN", 167, 174], ["poults", "SPECIES", 115, 121]]], ["In Experiment 1, the relative maltase activity decreased after 1 through 10 d of age.", [["maltase", "GENE_OR_GENE_PRODUCT", 30, 37], ["maltase", "PROTEIN", 30, 37]]], ["The decrease did not occur until 2 d of age in Experiment 2, continuing until 15 d of age, then increasing through 28 d of age (Tables 9 and 11 ).", [["decrease", "OBSERVATION_MODIFIER", 4, 12]]], ["The high level of maltase activity at 1 d of age suggests that turkey poults have the maltase required to digest maltose immediately after hatch.Selected Digestive EnzymesAt 2 d of age in both experiments, poults allowed access to feed and water 54 h posthatch had the highest specific amylase activity in the pancreas, but by 3 d of age these poults had the lowest activity compared with poults placed at 6 h posthatch (Tables 10 and 11).", [["pancreas", "ANATOMY", 310, 318], ["maltose", "CHEMICAL", 113, 120], ["maltose", "CHEMICAL", 113, 120], ["maltase", "GENE_OR_GENE_PRODUCT", 18, 25], ["turkey poults", "ORGANISM", 63, 76], ["maltase", "GENE_OR_GENE_PRODUCT", 86, 93], ["maltose", "SIMPLE_CHEMICAL", 113, 120], ["poults", "ORGANISM", 206, 212], ["amylase", "GENE_OR_GENE_PRODUCT", 286, 293], ["pancreas", "ORGAN", 310, 318], ["poults", "ORGANISM", 344, 350], ["maltase", "PROTEIN", 18, 25], ["maltase", "PROTEIN", 86, 93], ["amylase", "PROTEIN", 286, 293], ["turkey", "SPECIES", 63, 69], ["poults", "SPECIES", 70, 76], ["poults", "SPECIES", 206, 212], ["poults", "SPECIES", 344, 350], ["poults", "SPECIES", 389, 395], ["turkey", "SPECIES", 63, 69], ["poults", "SPECIES", 206, 212], ["poults", "SPECIES", 389, 395], ["the highest specific amylase activity in the pancreas", "PROBLEM", 265, 318], ["high", "OBSERVATION_MODIFIER", 4, 8], ["pancreas", "ANATOMY", 310, 318], ["lowest activity", "OBSERVATION_MODIFIER", 359, 374]]], ["As observed by Sell et al. (1991) and Krogdahl and Sell (1989) , amylase activity generally increased with age.", [["amylase", "GENE_OR_GENE_PRODUCT", 65, 72], ["amylase", "PROTEIN", 65, 72], ["amylase activity", "TEST", 65, 81], ["increased", "OBSERVATION_MODIFIER", 92, 101]]], ["In the current study, at 1 d of age (30 h posthatch), all poults denied feed and water had greater relative amylase activity than poults placed within 6 h posthatch.", [["poults", "ORGANISM", 58, 64], ["amylase", "GENE_OR_GENE_PRODUCT", 108, 115], ["amylase", "PROTEIN", 108, 115], ["poults", "SPECIES", 58, 64], ["poults", "SPECIES", 130, 136], ["poults", "SPECIES", 58, 64], ["poults", "SPECIES", 130, 136], ["the current study", "TEST", 3, 20]]], ["By 2 d of age, poults denied feed until 54 h posthatch had the highest level of relative amylase activity.", [["poults", "ORGANISM", 15, 21], ["amylase", "GENE_OR_GENE_PRODUCT", 89, 96], ["amylase", "PROTEIN", 89, 96], ["poults", "SPECIES", 15, 21], ["poults", "SPECIES", 15, 21]]], ["However, by Days 3, 4, and 5, poults deprived of feed for 54 h posthatch had the lowest levels of amylase activity per 100 g BW compared with poults placed within 6 h posthatch.", [["poults", "ORGANISM", 30, 36], ["amylase", "GENE_OR_GENE_PRODUCT", 98, 105], ["amylase", "PROTEIN", 98, 105], ["poults", "SPECIES", 30, 36], ["poults", "SPECIES", 142, 148], ["poults", "SPECIES", 142, 148], ["amylase activity", "PROBLEM", 98, 114]]], ["In Experiments 1 and 2, relative amylase activity increased more than 5-fold by 2 d of age, whereas the specific activity increased only 1.5-fold by 2 d of age (Tables 9 and 11 ).", [["amylase", "GENE_OR_GENE_PRODUCT", 33, 40], ["amylase", "PROTEIN", 33, 40], ["relative amylase activity", "TEST", 24, 49]]], ["These results agree with those of Moran (1982) , who reported that chicks have the ability to release sufficient amylase for digestion of carbohydrates, especially right after hatch.", [["carbohydrates", "CHEMICAL", 138, 151], ["chicks", "ORGANISM", 67, 73], ["amylase", "GENE_OR_GENE_PRODUCT", 113, 120], ["amylase", "PROTEIN", 113, 120], ["chicks", "SPECIES", 67, 73], ["digestion of carbohydrates", "PROBLEM", 125, 151], ["right", "ANATOMY_MODIFIER", 164, 169]]], ["However, results of the current research indicate that a 54-h delay in placement may decrease amylase activity enough to affect nutrient utilization between 3 and 4 d of age.Selected Digestive EnzymesIn Experiment 2, specific lipase activity in the pancreas was greatest at 1 d of age, but specific lipase activity decreased rapidly by 3 d of age and then fluctuated without any great change, which agrees with reports from Sell et al. (1991) .", [["pancreas", "ANATOMY", 249, 257], ["amylase", "GENE_OR_GENE_PRODUCT", 94, 101], ["lipase", "GENE_OR_GENE_PRODUCT", 226, 232], ["pancreas", "ORGAN", 249, 257], ["lipase", "GENE_OR_GENE_PRODUCT", 299, 305], ["amylase", "PROTEIN", 94, 101], ["lipase", "PROTEIN", 226, 232], ["lipase", "PROTEIN", 299, 305], ["a 54-h delay in placement", "TREATMENT", 55, 80], ["amylase activity", "PROBLEM", 94, 110], ["Digestive EnzymesIn Experiment", "TEST", 183, 213], ["specific lipase activity", "TEST", 217, 241], ["specific lipase activity", "TEST", 290, 314], ["pancreas", "ANATOMY", 249, 257], ["greatest", "OBSERVATION_MODIFIER", 262, 270]]], ["At 2 d of age, poults denied access to feed and water for 54 h posthatch had the greatest specific and relative lipase activities, but by 3 d of age they had the lowest relative activity compared with poults placed within 6 h posthatch (Tables 10 and 11 ).", [["poults", "ORGANISM", 15, 21], ["lipase", "GENE_OR_GENE_PRODUCT", 112, 118], ["lipase", "PROTEIN", 112, 118], ["poults", "SPECIES", 15, 21], ["poults", "SPECIES", 201, 207], ["poults", "SPECIES", 15, 21], ["poults", "SPECIES", 201, 207]]], ["Krogdahl and Sell (1989) and Escribano et al. (1988) reported that the total lipase activity per pancreas increased slowly between 4 and 10 d of age even though the weight of the pancreas increased rapidly.", [["pancreas", "ANATOMY", 97, 105], ["pancreas", "ANATOMY", 179, 187], ["lipase", "GENE_OR_GENE_PRODUCT", 77, 83], ["pancreas", "ORGAN", 97, 105], ["pancreas", "ORGAN", 179, 187], ["lipase", "PROTEIN", 77, 83], ["the total lipase activity", "TEST", 67, 92], ["pancreas", "ANATOMY", 97, 105], ["increased", "OBSERVATION", 106, 115], ["pancreas", "ANATOMY", 179, 187], ["increased", "OBSERVATION", 188, 197]]], ["In relation to BW, lipase activity increased until 10 d of age, then decreased through 28 d of age in Experiment 2.", [["lipase", "GENE_OR_GENE_PRODUCT", 19, 25], ["lipase", "PROTEIN", 19, 25], ["BW", "TEST", 15, 17], ["lipase activity", "TEST", 19, 34]]], ["Krogdahl and Sell (1989) reported that lipase activity approaches maximum levels between 42 and 56 d of age.", [["lipase", "GENE_OR_GENE_PRODUCT", 39, 45], ["lipase", "PROTEIN", 39, 45], ["lipase activity", "TEST", 39, 54], ["maximum levels", "TEST", 66, 80]]], ["The low lipase activity at hatch without significant improvements during the first 2 wk could partly explain the relatively poor utilization of certain dietary fats by poults during early growth (Krogdahl and Sell, 1989) .Selected Digestive EnzymesAt 2 d of age, specific and relative trypsin activities in the pancreas were highest for poults deprived of feed for 54 h posthatch in Experiment 2 (Table 10 and 11).", [["dietary fats", "ANATOMY", 152, 164], ["pancreas", "ANATOMY", 311, 319], ["lipase", "GENE_OR_GENE_PRODUCT", 8, 14], ["trypsin", "GENE_OR_GENE_PRODUCT", 285, 292], ["pancreas", "ORGAN", 311, 319], ["lipase", "PROTEIN", 8, 14], ["trypsin", "PROTEIN", 285, 292], ["poults", "SPECIES", 168, 174], ["poults", "SPECIES", 337, 343], ["poults", "SPECIES", 337, 343], ["The low lipase activity", "PROBLEM", 0, 23], ["relative trypsin activities in the pancreas", "PROBLEM", 276, 319], ["low lipase", "OBSERVATION_MODIFIER", 4, 14], ["trypsin activities", "OBSERVATION", 285, 303], ["pancreas", "ANATOMY", 311, 319]]], ["By 3 d of age (1 d after access to feed and water), poults denied feed for 54 h posthatch had the lowest specific and relative trypsin activities.", [["poults", "ORGANISM", 52, 58], ["trypsin", "GENE_OR_GENE_PRODUCT", 127, 134], ["trypsin", "PROTEIN", 127, 134], ["poults", "SPECIES", 52, 58]]], ["Trypsin activities, both specific and relative, increased slowly with age, which may help explain the improved utilization of dietary protein with age as reported by Sell et al. (1991) .Selected Digestive EnzymesPoults denied access to feed and water for 54-h posthatch had the highest relative and specific activities of pancreatic amylase, lipase, and trypsin at 2 d of age.", [["pancreatic", "ANATOMY", 322, 332], ["Trypsin", "GENE_OR_GENE_PRODUCT", 0, 7], ["pancreatic amylase", "GENE_OR_GENE_PRODUCT", 322, 340], ["lipase", "GENE_OR_GENE_PRODUCT", 342, 348], ["trypsin", "GENE_OR_GENE_PRODUCT", 354, 361], ["dietary protein", "PROTEIN", 126, 141], ["pancreatic amylase", "PROTEIN", 322, 340], ["lipase", "PROTEIN", 342, 348], ["trypsin", "PROTEIN", 354, 361], ["pancreatic amylase", "TEST", 322, 340], ["lipase", "TEST", 342, 348], ["trypsin", "TEST", 354, 361], ["pancreatic amylase", "ANATOMY", 322, 340]]], ["These high levels agree with the observations of Hulan and Bird (1972) and Krogdahl and Sell (1989) that the act of eating serves as a stimulus to the pancreas to secrete pancreatic juice.", [["pancreas", "ANATOMY", 151, 159], ["pancreatic juice", "ANATOMY", 171, 187], ["pancreas", "ORGAN", 151, 159], ["pancreatic juice", "ORGANISM_SUBSTANCE", 171, 187], ["pancreas", "ANATOMY", 151, 159], ["pancreatic", "ANATOMY", 171, 181]]], ["At 2 d of age, the 54-h treatment group had not yet had access to the stimulus of feed and water, which may have resulted in increased concentrations of digestive enzymes in the pancreas.", [["digestive", "ANATOMY", 153, 162], ["pancreas", "ANATOMY", 178, 186], ["digestive", "ORGAN", 153, 162], ["pancreas", "ORGAN", 178, 186], ["digestive enzymes", "PROTEIN", 153, 170], ["increased concentrations of digestive enzymes in the pancreas", "PROBLEM", 125, 186], ["increased", "OBSERVATION_MODIFIER", 125, 134], ["concentrations", "OBSERVATION_MODIFIER", 135, 149], ["digestive enzymes", "OBSERVATION", 153, 170], ["pancreas", "ANATOMY", 178, 186]]], ["Krogdahl and Sell (1989) postulated that feeding also would stimulate pancreatic enzyme synthesis.", [["pancreatic", "ANATOMY", 70, 80], ["pancreatic", "ORGAN", 70, 80], ["pancreatic enzyme", "PROTEIN", 70, 87], ["pancreatic enzyme synthesis", "PROBLEM", 70, 97], ["pancreatic", "ANATOMY", 70, 80]]], ["This hypothesis could explain why poults placed on feed and water within 6 h Birds denied access to feed and water for 54 h posthatch had a slightly lower (P \u00a3 0.07) ME n value at 4 d of age (Table 12 ) than poults placed within 6 h after hatch.", [["poults", "ORGANISM", 34, 40], ["poults", "SPECIES", 34, 40], ["poults", "SPECIES", 208, 214], ["poults", "SPECIES", 208, 214]]], ["This effect on ME n occurred during the time when greatest physical and functional changes in the intestinal tract were observed.", [["intestinal tract", "ANATOMY", 98, 114], ["intestinal tract", "ORGAN", 98, 114], ["functional changes in the intestinal tract", "PROBLEM", 72, 114], ["functional", "OBSERVATION", 72, 82], ["intestinal tract", "ANATOMY", 98, 114]]], ["The ME n values determined at 4, 7, and 14 d of age, irrespective of placement times, were well below values calculated on the basis of ingredient data presented by the NRC (1994).", [["The ME n values", "TEST", 0, 15]]], ["At 4 d of age the determined ME n value of the diet for poults placed at 54 h posthatch was 10% less than the value determined for poults placed at 6 h posthatch and 23% less than calculated values.", [["poults", "ORGANISM", 56, 62], ["poults", "SPECIES", 56, 62], ["poults", "SPECIES", 131, 137], ["poults", "SPECIES", 56, 62], ["poults", "SPECIES", 131, 137], ["poults", "TREATMENT", 56, 62], ["poults", "TREATMENT", 131, 137]]], ["Soto-Salanova et al. (1991) and Sell (1996) reported the lowest ME n values for diets fed to poults at 4 and 7 d of age.", [["poults", "SPECIES", 93, 99], ["poults", "SPECIES", 93, 99]]], ["The unusually low values obtained when poults were 14 d old in the current study are believed to be due, in part, to a coronavirus infection, which was first noted when poults were 12 d old.", [["coronavirus infection", "DISEASE", 119, 140], ["coronavirus", "ORGANISM", 119, 130], ["poults", "ORGANISM", 169, 175], ["poults", "SPECIES", 39, 45], ["poults", "SPECIES", 169, 175], ["poults", "SPECIES", 169, 175], ["The unusually low values", "PROBLEM", 0, 24], ["the current study", "TEST", 63, 80], ["a coronavirus infection", "PROBLEM", 117, 140], ["unusually", "OBSERVATION_MODIFIER", 4, 13], ["low values", "OBSERVATION_MODIFIER", 14, 24], ["coronavirus", "OBSERVATION_MODIFIER", 119, 130], ["infection", "OBSERVATION", 131, 140]]], ["The infection was confirmed diagnostically at the Iowa State University Veterinary Medical Research Institute.", [["infection", "DISEASE", 4, 13], ["The infection", "PROBLEM", 0, 13], ["infection", "OBSERVATION", 4, 13]]], ["This infection occurred after most of the effects of different placement times on intestinal development were observed and was assumed to not have had much impact on the effects of delayed placement.Selected Digestive EnzymesThe weight of digestive system organs, particularly the small intestine, were inversely proportional to the duration of placement delay.", [["intestinal", "ANATOMY", 82, 92], ["digestive system organs", "ANATOMY", 239, 262], ["small intestine", "ANATOMY", 281, 296], ["infection", "DISEASE", 5, 14], ["intestinal", "ORGAN", 82, 92], ["digestive system", "MULTI-TISSUE_STRUCTURE", 239, 255], ["organs", "ORGAN", 256, 262], ["small intestine", "ORGAN", 281, 296], ["This infection", "PROBLEM", 0, 14], ["different placement", "TREATMENT", 53, 72], ["delayed placement", "TREATMENT", 181, 198], ["Digestive Enzymes", "TEST", 208, 225], ["placement delay", "TREATMENT", 345, 360], ["infection", "OBSERVATION", 5, 14], ["intestinal", "ANATOMY", 82, 92], ["small intestine", "ANATOMY", 281, 296]]], ["The inhibition of the development of these supply organs was transitory.", [["organs", "ANATOMY", 50, 56], ["organs", "ORGAN", 50, 56], ["supply organs", "OBSERVATION", 43, 56], ["transitory", "OBSERVATION_MODIFIER", 61, 71]]], ["By 4 wk of age, no significant physiological or functional differences were observed among supply organs of poults from different placement times.", [["organs", "ANATOMY", 98, 104], ["organs", "ORGAN", 98, 104], ["poults", "ORGANISM", 108, 114], ["poults", "SPECIES", 108, 114], ["significant physiological or functional differences", "PROBLEM", 19, 70], ["different placement times", "TREATMENT", 120, 145], ["no", "UNCERTAINTY", 16, 18], ["significant", "OBSERVATION_MODIFIER", 19, 30]]], ["However, BW was still less at 28 d of age for poults denied feed for 54 h posthatch, showing that retardation of supply organ development had a carry-over effect on performance.", [["organ", "ANATOMY", 120, 125], ["poults", "ORGANISM", 46, 52], ["organ", "ORGAN", 120, 125], ["poults", "SPECIES", 46, 52], ["poults", "SPECIES", 46, 52], ["retardation of supply organ development", "PROBLEM", 98, 137]]], ["Effects on GIT organs were more severe and longer lasting for poults denied feed for 54 h than for those denied feed for 30 h posthatch.", [["GIT organs", "ANATOMY", 11, 21], ["GIT organs", "MULTI-TISSUE_STRUCTURE", 11, 21], ["poults", "SPECIES", 62, 68], ["poults", "SPECIES", 62, 68], ["organs", "ANATOMY", 15, 21]]], ["Results of the current study show that substantial delays in access to feed and water will retard development of the digestive system and limit capabilities of poults to utilize dietary nutrients, resulting in reduced BW.", [["digestive system", "ANATOMY", 117, 133], ["digestive system", "ANATOMICAL_SYSTEM", 117, 133], ["poults", "ORGANISM", 160, 166], ["poults", "SPECIES", 160, 166], ["the current study", "TEST", 11, 28], ["substantial delays", "PROBLEM", 39, 57], ["access to feed", "TREATMENT", 61, 75], ["the digestive system", "TREATMENT", 113, 133], ["dietary nutrients", "TREATMENT", 178, 195], ["reduced BW", "PROBLEM", 210, 220], ["substantial", "OBSERVATION_MODIFIER", 39, 50], ["delays", "OBSERVATION_MODIFIER", 51, 57], ["digestive system", "ANATOMY", 117, 133]]]]}